
<html lang="en"     class="pb-page"  data-request-id="f4492c8d-145a-470a-bf5f-0c0087b4906c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00855;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties" /></meta><meta name="dc.Creator" content="Anders&#xA;Højgaard  Hansen" /></meta><meta name="dc.Creator" content="Eugenia  Sergeev" /></meta><meta name="dc.Creator" content="Daniele  Bolognini" /></meta><meta name="dc.Creator" content="Richard R.  Sprenger" /></meta><meta name="dc.Creator" content="Jeppe Hvidtfeldt  Ekberg" /></meta><meta name="dc.Creator" content="Christer S.  Ejsing" /></meta><meta name="dc.Creator" content="Christine J.  McKenzie" /></meta><meta name="dc.Creator" content="Elisabeth  Rexen Ulven" /></meta><meta name="dc.Creator" content="Graeme  Milligan" /></meta><meta name="dc.Creator" content="Trond  Ulven" /></meta><meta name="dc.Description" content="Free fatty acid receptor 2 (FFA2/GPR43) is a receptor for short-chain fatty acids reported to be involved in regulation of metabolism, appetite, fat accumulation, and inflammatory responses and is ..." /></meta><meta name="Description" content="Free fatty acid receptor 2 (FFA2/GPR43) is a receptor for short-chain fatty acids reported to be involved in regulation of metabolism, appetite, fat accumulation, and inflammatory responses and is ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 24, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00855" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00855" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00855" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00855" /></link>
        
    
    

<title>Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00855" /></meta><meta property="og:title" content="Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0015.jpeg" /></meta><meta property="og:description" content="Free fatty acid receptor 2 (FFA2/GPR43) is a receptor for short-chain fatty acids reported to be involved in regulation of metabolism, appetite, fat accumulation, and inflammatory responses and is a potential target for treatment of various inflammatory and metabolic diseases. By bioisosteric replacement of the central pyrrolidine core of a previously disclosed FFA2 agonist with a synthetically more tractable thiazolidine, we were able to rapidly synthesize and screen analogues modified at both the 2- and 3-positions on the thiazolidine core. Herein, we report SAR exploration of thiazolidine FFA2 agonists and the identification of 31 (TUG-1375), a compound with significantly increased potency (7-fold in a cAMP assay) and reduced lipophilicity (50-fold reduced clogP) relative to the pyrrolidine lead structure. The compound has high solubility, high chemical, microsomal, and hepatocyte stability, and favorable pharmacokinetic properties and was confirmed to induce human neutrophil mobilization and to inhibit lipolysis in murine adipocytes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00855"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00855">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00855&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00855&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00855&amp;href=/doi/10.1021/acs.jmedchem.8b00855" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9534-9550</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00800" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00873" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Anders Højgaard Hansen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anders Højgaard Hansen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anders%0AH%C3%B8jgaard++Hansen">Anders Højgaard Hansen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eugenia Sergeev</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eugenia Sergeev</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eugenia++Sergeev">Eugenia Sergeev</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniele Bolognini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniele Bolognini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Bolognini">Daniele Bolognini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard R. Sprenger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard R. Sprenger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+R.++Sprenger">Richard R. Sprenger</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3947-1606" title="Orcid link">http://orcid.org/0000-0002-3947-1606</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeppe Hvidtfeldt Ekberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeppe Hvidtfeldt Ekberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeppe+Hvidtfeldt++Ekberg">Jeppe Hvidtfeldt Ekberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christer S. Ejsing</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christer S. Ejsing</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christer+S.++Ejsing">Christer S. Ejsing</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christine J. McKenzie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine J. McKenzie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine+J.++McKenzie">Christine J. McKenzie</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5587-0626" title="Orcid link">http://orcid.org/0000-0001-5587-0626</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elisabeth Rexen Ulven</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabeth Rexen Ulven</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</div><div class="loa-info-affiliations-info">Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth++Rexen+Ulven">Elisabeth Rexen Ulven</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1243-7587" title="Orcid link">http://orcid.org/0000-0003-1243-7587</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Graeme Milligan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graeme Milligan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graeme++Milligan">Graeme Milligan</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Trond Ulven</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Trond Ulven</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</div><div class="loa-info-affiliations-info">Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#f38786b380869d97dd9886dd9798"><span class="__cf_email__" data-cfemail="493d3c093a3c272d67223c672d22">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Trond++Ulven">Trond Ulven</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8135-1755" title="Orcid link">http://orcid.org/0000-0002-8135-1755</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00855&amp;href=/doi/10.1021%2Facs.jmedchem.8b00855" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9534–9550</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 May 2018</li><li><span class="item_label"><b>Published</b> online</span>24 September 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00855" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00855</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00855"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3607</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00855" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anders\nHøjgaard&quot;,&quot;last_name&quot;:&quot;Hansen&quot;},{&quot;first_name&quot;:&quot;Eugenia&quot;,&quot;last_name&quot;:&quot;Sergeev&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Bolognini&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;R. Sprenger&quot;},{&quot;first_name&quot;:&quot;Jeppe&quot;,&quot;last_name&quot;:&quot;Hvidtfeldt Ekberg&quot;},{&quot;first_name&quot;:&quot;Christer&quot;,&quot;last_name&quot;:&quot;S. Ejsing&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;J. McKenzie&quot;},{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;Rexen Ulven&quot;},{&quot;first_name&quot;:&quot;Graeme&quot;,&quot;last_name&quot;:&quot;Milligan&quot;},{&quot;first_name&quot;:&quot;Trond&quot;,&quot;last_name&quot;:&quot;Ulven&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9534-9550&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00855&quot;},&quot;abstract&quot;:&quot;Free fatty acid receptor 2 (FFA2/GPR43) is a receptor for short-chain fatty acids reported to be involved in regulation of metabolism, appetite, fat accumulation, and inflammatory responses and is a potential target for treatment of various inflammatory and metabolic diseases. By bioisosteric replacement of the central pyrrolidine core of a previously disclosed FFA2 agonist with a synthetically more tractable thiazolidine, we were able to rapidly synthesize and screen analogues modified at both the 2- and 3-positions on the thiazolidine core. Herein, we report SAR exploration of thiazolidine FFA2 agonists and the identification of 31 (TUG-1375), a compound with significantly increased potency (7-fold in a cAMP assay) and reduced lipophilicity (50-fold reduced clogP) relative to the pyrrolidine lead structure. The compound has high solubility, high chemical, microsomal, and hepatocyte stability, and favorable pharmacokinetic properties and was confirmed to induce human neutrophil mobilization and to inhibit li&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00855&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00855" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00855&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00855" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00855&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00855" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00855&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00855&amp;href=/doi/10.1021/acs.jmedchem.8b00855" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00855" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00855" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00855%26sid%3Dliteratum%253Aachs%26pmid%3D30247908%26genre%3Darticle%26aulast%3DHansen%26date%3D2018%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2BThiazolidine%2BFree%2BFatty%2BAcid%2BReceptor%2B2%2BAgonist%2Bwith%2BFavorable%2BPharmacokinetic%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9534%26epage%3D9550%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292164" title="Pyrrolidines">Pyrrolidines</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290888" title="Liquid liquid equilibrium">Liquid liquid equilibrium</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Free fatty acid receptor 2 (FFA2/GPR43) is a receptor for short-chain fatty acids reported to be involved in regulation of metabolism, appetite, fat accumulation, and inflammatory responses and is a potential target for treatment of various inflammatory and metabolic diseases. By bioisosteric replacement of the central pyrrolidine core of a previously disclosed FFA2 agonist with a synthetically more tractable thiazolidine, we were able to rapidly synthesize and screen analogues modified at both the 2- and 3-positions on the thiazolidine core. Herein, we report SAR exploration of thiazolidine FFA2 agonists and the identification of <b>31</b> (TUG-1375), a compound with significantly increased potency (7-fold in a cAMP assay) and reduced lipophilicity (50-fold reduced clog<i>P</i>) relative to the pyrrolidine lead structure. The compound has high solubility, high chemical, microsomal, and hepatocyte stability, and favorable pharmacokinetic properties and was confirmed to induce human neutrophil mobilization and to inhibit lipolysis in murine adipocytes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The short-chain free fatty acid receptor FFA2 (formerly GPR43) is a G-protein-coupled receptor that is activated by physiological concentrations of short-chain fatty acids (SCFAs), primarily acetate and propionate.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> FFA2 is expressed in a variety of tissues including immune cells,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> adipocytes,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> pancreatic β-cells,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and enteroendocrine L-cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Colonic fermentation of dietary fiber produces large amounts of SCFAs, and results indicate that an interplay between FFA2 and dietary fiber via colonic fermentation to produce SCFAs is implicated in promoting a healthy composition of microorganisms in the gut.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Fiber-rich diets and SCFAs can counteract colitis,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> and exacerbated inflammation in colitis models has been reported for FFA2-knockout mice.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, others have found that FFA2-knockout mice exhibited reduced inflammatory responses in colitis models,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and it is currently unclear if antagonists or agonists are preferable for the treatment of intestinal inflammation. So far, the antagonist GLPG0974 (<b>1</b>, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) is the only FFA2 modulator that has undergone clinical trials but unfortunately failed to meet end points against ulcerative colitis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. FFA2 Modulators<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>clogP values are calculated using ChemBioDraw v16.0.1.4. pIC<sub>50</sub> for <b>1</b> and pEC<sub>50</sub> for <b>2</b> and <b>3</b> are previously reported.<a onclick="showRef(event, 'ref28 ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref30 ref32">(28,30,32)</a></p></p></figure><div class="NLM_p">Dietary fiber is also known to exert positive effects in diabetic subjects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Acetate has been shown to potentiate glucose-stimulated insulin secretion from β-cells in an FFA2-dependent manner,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and SCFAs were able to promote secretion of the incretin glucagon-like peptide-1 (GLP-1) from colonic cultures through FFA2<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and both GLP-1 and the appetite regulating peptide YY (PYY) in vivo,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> indicating that activation of FFA2 could have beneficial effects on type 2 diabetes (T2D). Interestingly and in contrast, loss of FFA2 and FFA3 was found to improve insulin secretion and glucose tolerance.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Moreover, SCFA-mediated activation of FFA2 has been found to suppress adipose insulin signaling, leading to reduced fat accumulation in adipose tissue, and to promote GLP-1 secretion in the gut.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Thus, both agonists and antagonists of FFA2 are considered to be potential therapeutics for treatment of T2D and obesity.<a onclick="showRef(event, 'ref5 ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref5 ref19 ref20 ref21 ref22 ref23 ref24 ref25">(5,19−25)</a> Several FFA2 agonists have been disclosed, including an allosteric agonist series from Amgen represented by <b>2</b> (known as AMG7703 or 4-CMTB) and an orthosteric agonist series originating from Euroscreen represented by <b>3</b>.<a onclick="showRef(event, 'ref20 ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref20 ref26 ref27 ref28 ref29 ref30">(20,26−30)</a> A recent study found that agonist <b>4</b>, also originating from Euroscreen,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> caused only marginal GLP-1 secretion but led to significant PYY mucosal responses, inhibited insulin-promoted fat accumulation and intestinal functions, and suppressed food intake, supporting FFA2 as a possible antiobesity target.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">The FFA2 agonists disclosed hitherto have relatively high lipophilicity, which is associated with several undesired properties,<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> and only moderate potency (e.g., see <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). Furthermore, the allosteric agonist <b>2</b> has solubility issues and has been reported to give results that differ from orthosteric FFA2 agonists,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and the orthosteric agonist <b>3</b> was found to have stability issues.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> We therefore wished to explore <b>4</b>, an FFA2 agonist reported to have properties useful for in vivo studies.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Initially, we sought to explore the SAR around the pyrrolidine scaffold of <b>4</b>; however, the synthetic route to obtain this class of FFA2 agonists is rather lengthy and precludes efficient exploration of parts of the molecule. We therefore opted for replacing the central pyrrolidine by a thiazolidine. This replacement strategy has previously been employed for HIV protease inhibitors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Herein, we report SAR investigations of substituted thiazolidine FFA2 agonists and the discovery of an FFA2 agonist with improved potency, reduced lipophilicity, and favorable physicochemical and pharmacokinetic properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">Pyrrolidine ligands were synthesized in seven linear steps from <span class="smallcaps smallerCapital">l</span>-pyroglutamic acid (<b>5</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) essentially as previously described by Euroscreen,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> with the modifications that the ring opening by aryllithium was allowed to reach room temperature and that the amide coupling with pyrrolidine <b>6</b> was performed with bis(tetramethylene)fluoroformamidinium hexafluorophosphate (BTFFH).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolidines <b>4</b> and <b>37</b> from <span class="smallcaps smallerCapital">l</span>-Pyroglutamic Acid<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, rt, 70%; (b) Boc<sub>2</sub>O, DMAP, DCM, rt, 4 h, 98%; (c) (i) 1-iodo-2-chlorobenzene, <i>n</i>-BuLi, THF, 20 min at −78 °C → rt; (ii) sat. aq NH<sub>4</sub>Cl, 67%; (d) TFA, DCM, rt, 98%; (e) NaBH<sub>3</sub>CN, AcOH (cat.), MeOH, rt, 71% (<i>cis</i>/<i>trans</i> 2:1, 49%/22%); (f) carboxylic acid, BTFFH, DIPEA, DCM, 80 °C, 8 h, 75%; (g) LiOH (aq), THF, rt, 42–93%.</p></p></figure><div class="NLM_p">Thiazolidine ligands were synthesized in three steps by condensation of (<i>R</i>)-Cys-OMe hydrochloride with benzaldehydes via <b>7a</b>–<b>j</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). In contrast to the pyrrolidine route, this strategy allowed rapid access also to variations on the 2-position of the thiazolidine scaffold in a single step from readily available starting materials<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and formation of the desired (2<i>R</i>,4<i>R</i>)-thiazolidine amide as the major product in the next step.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of (2<i>R</i>,4<i>R</i>)-<i>N</i>-Acylthiazolidine-4-carboxylic Acids from (<i>R</i>)-Cys-OMe<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>O/EtOH 1:1, KHCO<sub>3</sub>, rt, 4–24 h, 63–81%; (b) benzoyl chlorides, Et<sub>3</sub>N, −10 °C → rt, THF, 1–14 h, 21–83%; (c) LiI, EtOAc, 80 °C, 24–92%.</p></p></figure><div class="NLM_p">Condensation of (<i>R</i>)-Cys-OMe hydrochloride with aldehydes produced mixtures of C(2) epimeric methyl (4<i>R</i>)-2-arylthiazolidine-4-carboxylates (<b>7a</b>–<b>j</b>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> To obtain the (2<i>R</i>,4<i>R</i>)-configuration, <b>7a</b>–<b>j</b> were treated with Et<sub>3</sub>N and subsequently reacted with the relevant acid chlorides to give the desired (2<i>R</i>,4<i>R</i>)-products.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Finally, demethylation using LiI in EtOAc afforded the corresponding (2<i>R</i>,4<i>R</i>)-<i>N</i>-acylthiazolidine-4-carboxylic acids.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">A second set of analogues aimed at exploring the <i>N</i>-benzoyl part of the ligands was synthesized from central intermediates <b>8a</b>,<b>b</b> by Suzuki–Miyaura or Sonogashira cross-coupling followed by demethylation, affording the desired biarylic compounds in low to good yields (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Biaryl Analogues via Coupling Reactions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ArB(OH)<sub>2</sub> or ArBPin, Pd(PPh<sub>3</sub>)<sub>4</sub>, MeOH, toluene, 6–27 h, 20–86%; or ArCCH, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, 4 h, rt, 76%; (b) LiI, EtOAc, 80 °C, 37–78%.</p></p></figure><div class="NLM_p">The crystal structure of <b>14</b> confirms unambiguously the (2<i>R</i>,4<i>R</i>)-configuration of thiazolidine substituents (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). A relatively short intramolecular hydrogen bond of 2.598(2) Å is found between the carboxylic acid and pyridine group. The crystal packing (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Supporting Information, Figure S1</a>) shows no significant intermolecular interactions stronger than van de Waals forces. The intramolecular hydrogen bond is a likely reason for why crystals suitable for structural information were obtained for this compound but for none of the others. At physiological pH with the carboxylic acid ionized, the pyridyl hydrogen bond will be absent and the overall conformation is expected to be different. It is therefore not possible to draw conclusions regarding the configuration around the amide in the active conformation of <b>14</b>. In fact, rather than the (<i>Z</i>)-configuration apparent in the crystal structure of <b>14</b>, computer minimizations indicate a general preference for the (<i>E</i>)-configuration around the amide in the compound series.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Perspective view of <b>14</b> drawn with 50% probability ellipsoids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological Testing and SAR Analysis</h3><div class="NLM_p">Compounds were tested on the human (h)FFA2 receptor using both a bioluminescence resonance energy transfer (BRET)-based β-arrestin-2 interaction assay and a cAMP inhibition assay. The former assay is an upstream signaling assay measuring BRET arising from agonist-mediated recruitment of β-arrestin-2 to FFA2, and the latter assay evaluates inhibition of forskolin-induced production of cAMP facilitated by coupling of FFA2 to Gα<sub>i/o</sub> proteins.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">The FFA2 agonist activity of <b>4</b> was confirmed in both assays. Compound <b>4</b> has previously been reported with an EC<sub>50</sub> of 81 nM.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We obtained somewhat lower potencies of 1.2 μM in the β-arrestin-2 assay and 0.53 μM in the cAMP assay. We were pleased to find that the thiazolidine analog <b>9</b> had only moderately decreased potency in both the BRET and the cAMP assay (ΔpEC<sub>50</sub> = −0.67 and −0.31, respectively) relative to pyrrolidine <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The easy access to substituted thiazolidines enabled a rapid screen of variations in the 2-position of the thiazolidine scaffold for 2-methoxy-1,1′-biphenyl derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Investigations at the Thiazolidine 2-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">BRET-based β-arrestin-2 recruitment assay. Efficacy (<i>E</i><sub>max</sub>) is relative to propionate.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">cAMP FFA2 assay. Efficacy (<i>E</i><sub>max</sub>) is relative to propionate.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">clogP values were calculated using ChemBioDraw v16.0.1.4.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">BRET/cAMP LLE values (LLE = pEC<sub>50</sub> – clogP).</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">50% activation at 100 μM.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">No response up to 30 μM.</p></div></div><div></div></div><div class="NLM_p">Compared to 2-chlorophenyl (<b>9</b>), 3-chlorophenyl (<b>10</b>) or 4-chlorophenyl (<b>11</b>) led to a decrease in potencies in the β-arrestin-2 assay, whereas <b>11</b> retained potency in the cAMP assay. Thus, the 3-position appeared to be disfavored and 4-position substitution may be a route to G-protein-biased ligands. Substituting the 2-chloro by bromo (<b>12</b>) or hydrogen (<b>13</b>) retained potency in both assays.</div><div class="NLM_p">Installation of 2-pyridyl (<b>14</b>) or 2-furyl (<b>15</b>) onto the thiazolidine scaffold eroded potency in the β-arrestin-2 assay compared to the phenyl derivatives but mostly preserved potency in the cAMP assay, again suggesting a route to G-protein-biased agonists. Since the goal was both to increase potency and decrease lipophilicity, values for ligand-lipophilicity efficiency (LLE)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> based on calculated lipophilicity of the neutral compounds (clogP) were also used to guide the optimization. The hydrophilic pyridyl led to a marked improvement in LLE for <b>14</b> compared to all previous compounds including <b>4</b> but insufficient potency. The introduction of a <i>tert</i>-butyl group in the 2-position of the thiazolidine scaffold resulted in a compound (<b>16</b>) that only caused 50% receptor activation at 100 μM. Replacing sulfur with oxygen on <b>16</b> led to a completely inactive compound (<b>17</b>); hence, the oxazolidine scaffold was not explored further.</div><div class="NLM_p">We next directed attention to the <i>N</i>-acyl substituent. As evident from <b>18</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), the biphenyl system is important for activity, as removing the terminal ring leads to complete loss of activity. Removing only the 2′-methoxy (<b>19</b>) also resulted in a pronounced loss of potency in both assays, as did moving the terminal phenyl to the 3-position (<b>20</b>). The 2′-fluoro-3′-methoxy (<b>21</b>) and the 4′-methoxy (<b>22</b>) analogues both led to decreased potency in both assays relative to the 2′-methoxy analogue <b>9</b>. Compared to <b>19</b>, installation of either acetyl (<b>23</b>) or nitrile (<b>24</b>) in the 4-position markedly boosted potency in both β-arresin-2 and cAMP assays, indicating that certain hydrogen bond accepting groups are favored in this region.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Investigation of the <i>N</i>-Acyl Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">BRET-based β arrestin-2 recruitment assay. Efficacy (<i>E</i><sub>max</sub>) is relative to propionate.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">cAMP FFA2 assay. Efficacy (<i>E</i><sub>max</sub>) is relative to propionate.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">clogP values were calculated using ChemBioDraw v16.0.1.4.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">LLE = pEC<sub>50</sub>(β-arrestin/cAMP) – clogP.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">No response up to 30 μM.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Average response at highest concentration relative to propionate.</p></div></div><div></div></div><div class="NLM_p">Replacing the 2′-methoxy (<b>9</b>) with 2′-chloro (<b>25</b>) or 2′-methyl (<b>26</b>) resulted in a marked potency boost in the cAMP assay for <b>25</b>, whereas 2′-methoxyphenyl remained the preferred ring system in the β-arrestin-2 assay (<b>9</b> > <b>25</b> ∼ <b>26</b>).</div><div class="NLM_p">Extension of the biphenyl <b>19</b> by insertion of acetylene between the rings (<b>28</b>) caused a minor loss of potency in the cAMP assay but no changes in the β-arrestin-2 assay. In a parallel manner, alkyne extension of 2-methoxyphenyl (<b>9</b>) into <b>29</b> reduced potency in the β-arrestin-2 assay but preserved activity in the cAMP assay.</div><div class="NLM_p">Overall, 4-biphenyl compounds with the terminal phenyl ring carrying lipophilic (<b>25</b>, <b>26</b>) or moderately hydrophilic (<b>9</b>) substituents in the <i>ortho</i>-position showed higher potencies than a nonsubstituted phenyl analogue such as <b>19</b> or <b>20</b>, indicating that a nonplanar biphenyl conformation is favored for optimal binding of this compound class.</div><div class="NLM_p">With this and the encouraging results from <b>23</b> and <b>24</b> in mind, we wished to explore biaryl systems with <i>ortho</i>-substituted polar heterocycles as the terminal ring. Satisfyingly, installation of 1-methyl-1<i>H</i>-pyrazolyl produced a significantly improved compound (<b>30</b>), whereas introduction of 3,5-dimethylisoxazolyl (<b>31</b>) appeared as the most potent compound of the series with a pEC<sub>50</sub> of 7.11 in the cAMP assay and an LLE increased by 2.3 relative to the initial pyrrolidine <b>4</b>. Replacement of the methyl groups of <b>31</b> by phenyl and cyclopropyl (<b>32</b>) resulted in a 40-fold lower potency in the β-arrestin-2 assay, indicating a limit to the acceptable steric bulk in this region.</div><div class="NLM_p">Having identified 4-(3,5-dimethylisoxazolyl)benzoyl as a preferred N-substituent, we directed the attention back to the 2-substituent of the thiazolidine scaffold to screen for improved substituents in a second iteration (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This effort showed again that the 2-chloro (<b>31</b>) was clearly favored over a naked phenyl (<b>33</b>). The same was true for 2-ethynyl (<b>34</b>) and 2-methoxy (<b>35</b>). Furthermore, increasing the polarity by installation of 2-pyridyl (<b>36</b>) resulted in a weakly potent agonist in the β-arrestin-2 assay, whereas <b>36</b> was devoid of any activity when evaluated in the cAMP assay. Since pyridyl analog <b>14</b> was a reasonably potent compound in both β-arrestin-2 and cAMP assays, the observation that <b>36</b> lost activity is likely explained by this compound being too polar to effectively reach the lipophilic binding site of FFA2.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Variations in the 2-Position and Pyrrolidine Analogue with the Optimized Acyl Part</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0013.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0014.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">BRET-based β arrestin-2 recruitment assay. Efficacy (<i>E</i><sub>max</sub>) is relative to propionate.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">cAMP FFA2 assay. Efficacy (<i>E</i><sub>max</sub>) is relative to propionate.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">clogP values were calculated using ChemBioDraw v16.0.1.4.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">BRET/cAMP LLE values (LLE = pEC<sub>50</sub> – clogP).</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">No response up to 30 μM.</p></div></div><div></div></div><div class="NLM_p">As the initial idea was to use the thiazolidine as a bioisostere for pyrrolidine in the optimization of the compound series, the corresponding pyrrolidine <b>37</b> of thiazolidine <b>31</b> was synthesized and tested (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Although pyrrolidine <b>37</b> displayed appreciable FFA2 activity, its potency was lower than that of <b>31</b>.</div><div class="NLM_p">The occasionally diverging results in the cAMP and β-arrestin-2 assays illustrate that potencies in the functional assays do not directly reflect receptor affinity. To better understand the relationship between affinity and functional activity, we proceeded with further examination of <b>31</b> and selected analogs in an FFA2 competition binding assay using a radiolabeled version of antagonist <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). It has previously been confirmed that <b>1</b> and radiotracer [<sup>3</sup>H]-<b>1</b> are orthosteric ligands and fully displaceable by propionate and the synthetic orthosteric agonist <b>3</b>.<a onclick="showRef(event, 'ref32 ref41'); return false;" href="javascript:void(0);" class="ref ref32 ref41">(32,41)</a> Pyrrolidines <b>4</b> and <b>37</b> and thiazolidines <b>9</b>, <b>13</b>, <b>19</b>, and <b>31</b> were also all confirmed to fully displace [<sup>3</sup>H]-<b>1</b>. Parent pyrrolidine <b>4</b> exhibited a moderate binding affinity, and the corresponding thiazolidine (<b>9</b>) was found to be a slightly stronger binder, in contrast to the slightly lower potency observed in both functional assays. Upon comparing <b>9</b> with the analogue lacking the 2-chloro substituent of the 2-aryl (<b>13</b>) or lacking the 2′-methoxy (<b>19</b>) substituent at the biphenyl system, it becomes clear that both these features contribute significantly to the affinity (Δp<i>K</i><sub>i</sub> = 0.55 and 0.46, respectively). The most potent thiazolidine (<b>31</b>) was indeed found to also exhibit the highest binding affinity within this selection. The corresponding pyrrolidine (<b>37</b>) displayed a significantly weaker binding affinity when compared to <b>31</b> (Δp<i>K</i><sub>i</sub> = −0.29), which correlated well with the observed differences in functional potency between these two compounds. Hence, for isoxazoles <b>31</b> and <b>37</b>, the thiazolidine central scaffold boosted both affinity and receptor activation compared to the pyrrolidine. Replacement of the 2-methoxyphenyl (<b>9</b>) by the more polar 3,5-dimethylisoxazole (<b>31</b>) not only gave rise to the more potent thiazolidine-based agonist (<b>31</b>) but also reduced lipophilicity resulting in a marked improvement in LLE over <b>4</b> (ΔLLE = 2.27), and <b>31</b> indeed exhibits the highest LLE of all compounds in the study.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Affinities of Compounds for FFA2</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">6.32 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">6.47 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">5.92 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">6.01 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">6.69 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">6.40 ± 0.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Binding affinities of agonists determined using [<sup>3</sup>H]-<b>1</b> in radioligand binding assays.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Modeling</h3><div class="NLM_p">To better understand the interaction of <b>31</b> with FFA2, the compound was docked in a previously established homology model of the receptor.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The lowest energy pose of <b>31</b> is depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Compound <b>31</b> was found to effectively engage Arg180 and Arg255 via ionic and hydrogen bonding interactions, an observation that is in agreement with previous reports that both residues are known to be vital for receptor binding and activation.<a onclick="showRef(event, 'ref30 ref41'); return false;" href="javascript:void(0);" class="ref ref30 ref41">(30,41)</a> Simultaneously, the carboxylate carbonyl also interacted with the conserved Tyr238 through hydrogen bonding. The 2-chlorophenyl moiety situated <i>cis</i> to the carboxylate was observed to interact with Phe89 via displaced π–π interactions, where the chloro substituent appears to orient the phenyl for optimal contact. Furthermore, the dimethylisoxazole ring formed π–cation interactions with Lys65 and edge-to-face π–π interactions with Trp75 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Supporting Information, Figure S2</a>). The shown pose also reflects higher energy poses. No alternative low-energy pose was identified.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lowest energy pose of <b>31</b> (gray) docked into hFFA2 (gold) with strongly interacting residues shown (cyan) and hydrogen bonds highlighted (yellow stipples). (A) Receptor as ribbon viewed from the angle of helix 4 and 5. (B) Same pose with receptor as surface viewed from the angle of helix 3 and 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Overall, groups of <b>31</b> found in the SAR analysis to be crucial for binding, such as 2-chlorophenyl and dimethylisoxazole, were confirmed by docking to contribute to the ligand receptor interaction, further supporting the proposed binding pose of <b>31</b> in hFFA2. Notably, both the carboxylate and the amide carbonyl of <b>31</b> were oriented toward the two arginine residues and Arg255 interacted directly with both groups through hydrogen bonds (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Characterization of <b>31</b></h3><div class="NLM_p">Since <b>31</b> showed the highest potency and LLE based on calculated lipophilicity in both functional assays and the binding assay, it was decided to characterize its properties in further detail. Thus, <b>31</b> was tested and confirmed to be active on the murine FFA2 orthologue (pEC<sub>50</sub> = 6.44 ± 0.13 in the cAMP assay). The compound was found to be inactive up to 100 μM concentration at the closely related SCFA receptor FFA3 (formerly GPR41) and evoked no significant agonist or antagonist response in the long-chain fatty acid receptors FFA1 (GPR40) and FFA4 (GPR120) or in nuclear receptors PPARα, PPARγ, PPARδ, LXRα, and LXRβ at 10 μM (see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Previous FFA2 ligands are generally, apart from SCFAs, lipophilic compounds. In contrast, experimental lipophilicity of <b>31</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) was found to be in the lower part of the optimal range,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> giving an LLE of 6.2 based on the cAMP assay and measured lipophilicity. The compound also showed high aqueous solubility and chemical stability (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Recovery after incubation with PBS at pH 7.4 or with fasted-state simulated gastric or intestinal fluid (FaSSGF/FaSSIF) was close to quantitative, indicating excellent chemical stability. Investigation of metabolic stability of <b>31</b> in mouse liver microsomes also resulted in a high recovery.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Physicochemical Properties</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center"><b>31</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i> (<i>n</i>-octanol/PBS, pH 7.4)</td><td class="colsep0 rowsep0" align="left">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aqueous solubility (PBS, pH 7.4)</td><td class="colsep0 rowsep0" align="left">182 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chemical stability</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PBS, 37 °C, 3 weeks</td><td class="colsep0 rowsep0" align="left">97.6%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FaSSIF, 2 h</td><td class="colsep0 rowsep0" align="left">95%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FaSSGF, 2 h</td><td class="colsep0 rowsep0" align="left">100%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metabolic stability (MLM, remaining, 1 h)</td><td class="colsep0 rowsep0" align="left">82%</td></tr></tbody></table></div></div><div class="NLM_p">Hepatocyte stability is a better approximation to the in vivo properties than liver microsomes since mitochondrial metabolism and conjugation processes also take place. Incubation of <b>31</b> with primary mouse hepatocytes gave a recovery of 72% after 2 h and low intrinsic clearance (<8 (μL/min)/10<sup>6</sup> cells), indicating high metabolic stability in mouse hepatocytes (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Supporting Information, Figure S3 and Table S6</a>).</div><div class="NLM_p">The pharmacokinetic profile of <b>31</b> was investigated in mice to establish its properties as a tool for in vivo studies, revealing a satisfactory half-life of 2 h and a moderate to low clearance of 20.3 mL min<sup>–1</sup> kg<sup>–1</sup> in mice (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Oral dosing of 10 mg/kg resulted in a maximal plasma concentration of 6.5 μM after 15 min and a bioavailability of 32%. Furthermore, ip administration of <b>31</b> at 5 mg/kg in mice and analysis of plasma concentrations indicated an AUC<sub>0–∞</sub> of 60 500 (ng/mL)·min a half-life of 82 min and thus a favorable profile relative to <b>4</b> (AUC<sub>0–∞</sub> ≈ 25 000 (ng/mL)·min, <i>t</i><sub>1/2</sub> ≈ 50 min).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Properties in Mice<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center"><b>31</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Intravenous Administration</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">138 min</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub></td><td class="colsep0 rowsep0" align="left">246 000 ng min mL<sup>–1</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub></td><td class="colsep0 rowsep0" align="left">4050 mL kg<sup>–1</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>total</sub></td><td class="colsep0 rowsep0" align="left">20.3 mL min<sup>–1</sup> kg<sup>–1</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Oral Administration</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">15 min</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">2880 ng mL<sup>–1</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub></td><td class="colsep0 rowsep0" align="left">156 000 ng min mL<sup>–1</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left">32%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Administered at 10 mg/kg po and 5 mg/kg iv in Balb/c mice.</p></div></div></div><div class="NLM_p">Agonist <b>3</b> has been shown to affect inflammatory responses in human neutrophils via FFA2 by induction of intracellular calcium and superoxide production.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Propionate is known to exert beneficial anti-inflammatory effects,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and the elimination of FFA2 from mice has previously been shown to cause increased inflammation in tissue models.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although the FFA2 antagonist <b>1</b> failed to meet the end point in clinical trials with ulcerative colitis patients, the compound was found to modulate neutrophil recruitment,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and the therapeutic potential of FFA2 modulation in inflammatory disease is still not clear, especially since neutrophil recruitment may have both beneficial and detrimental effects.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Hence, <b>31</b> and propionate were examined for their ability to promote human neutrophil migration, as it is already established that antagonists, such as <b>1</b>, can inhibit chemotaxis in vitro and that acetate can induce chemotaxis in mouse neutrophils.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> Compound <b>31</b> at 1 μM significantly induced migration of human neutrophils at a level comparable to propionate (C3) at a physiologically relevant concentration,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> an effect that was more than doubled at 10 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ability of propionate (C3) and <b>31</b> to induce neutrophil migration relative to the highly potent chemotactic factor fMLP (<i>n</i> = 4–6): (∗) <i>p</i> < 0.05, (∗∗∗) <i>p</i> < 0.01; one-way ANOVA followed by Dunnett post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SCFAs have been shown to inhibit lipolysis in adipocytes mediated through FFA2 via the Gα<sub>i</sub> pathway.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In this study we demonstrate that thiazolidine <b>31</b>, in particular when evaluated in cAMP assays, is a potent agonist of hFFA2 with retained activity at mFFA2. Therefore, <b>31</b> was evaluated for its ability to inhibit isoproterenol-induced lipolysis in murine adipocytes, a process known to be Gα<sub>i</sub> dependent.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Even though <b>31</b> is slightly less potent on murine FFA2, <b>31</b> was, as predicted, 50-fold more potent than propionate in inhibiting lipolysis in isoproterenol-stimulated adipocytes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of isoproterenol-induced lipolysis by propionate (pEC<sub>50</sub> = 3.6 ± 0.4) and <b>31</b> (pEC<sub>50</sub> = 5.3 ± 0.6) in murine adipocytes (<i>n</i> = 3–4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Substitution of the central pyrrolidine of a published FFA2 agonist by a synthetically more tractable thiazolidine and rapid screening of substituents at this scaffold led to the discovery of the potent and selective FFA2 agonist <b>31</b>, a compound with lipophilicity in the lower part of the optimal range and therefore also high LLE. The compound furthermore has excellent solubility, high chemical, microsomal, and hepatocyte stability, and favorable pharmacokinetic properties. Compound <b>31</b> was able to induce migration of human neutrophils and to inhibit lipolysis in murine adipocytes. Collectively, these properties render <b>31</b> an interesting tool compound for further exploration of FFA2 as a potential therapeutic target for treatment of inflammatory and metabolic diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis</h3><div class="NLM_p last">All commercial starting materials and solvents were used without further purification unless otherwise stated. THF was freshly distilled from sodium/benzophenone. MeOH was freshly distilled from Mg. DCM was freshly distilled and stored over 4 Å sieves. TLC was performed on TLC silica gel 60 F254 plates (Merck) and visualized at 254 nm or by staining with ninhydrin, KMnO<sub>4</sub>, or FeCl<sub>3</sub> stains. Petroleum ether (PE) refers to alkanes with bp 60–80 °C. Water used in reactions was demineralized, and water used for freeze-drying was filtered Milli-Q. Purification by flash chromatography was carried out using silica gel 60 (0.040–0.063 mm, Merck). Test compounds suspended in Milli-Q water (1 mL/10 mg, 3 drops MeCN) were lyophilized on a Heto Drywinner freeze-dryer. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 400 and 101 MHz, respectively, on a Bruker Avance III 400 at 300 K. Spectra were calibrated relative to residual solvent peaks: <sup>1</sup>H NMR (CDCl<sub>3</sub>), 7.26 ppm; <sup>13</sup>C NMR (CDCl<sub>3</sub>), 77.16 ppm; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 2.50 ppm; <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>), 39.52 ppm; <sup>1</sup>H NMR (CD<sub>3</sub>OD), 3.31 ppm; <sup>13</sup>C NMR (CD<sub>3</sub>OD), 49.00 ppm; <sup>1</sup>H NMR (CD<sub>2</sub>Cl<sub>2</sub>), 5.32 ppm; <sup>13</sup>C NMR (CD<sub>2</sub>Cl<sub>2</sub>), 53.84 ppm. Rotamer chemical shift values in <sup>1</sup>H NMR are marked by “∗” and have been assigned where possible. Rotamer peaks in <sup>1</sup>H NMR are labeled by an integral equal to that of its main partner. <sup>1</sup>H and <sup>13</sup>C spectra of <b>31</b> were obtained at 600 and 151 MHz, respectively, on an Agilent NMRS 600 at the indicated temperature (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Supporting Information</a>). High-resolution mass spectra (HRMS) were recorded on a Bruker micrOTOF-Q II (ESI). Specific optical rotation was recorded on Anton Paar MCP 100 polarimeter. Purity was determined by HPLC and confirmed by inspection of NMR spectra (<sup>1</sup>H and <sup>13</sup>C NMR). HPLC analysis was performed using a Dionex 120 C18 column (5 μm, 4.6 mm × 150 mm); flow, 1 mL/min; 10% MeCN in water (0–1 min), 10–100% MeCN in water (1–10 min), 100% MeCN (11–15 min), with both solvents containing 0.1% formic acid as modifier; UV detection at 254 nm. All test compounds were of ≥ 95% purity. None of the test compounds contain substructures associated with pan-assay interfering activities (PAINS)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> by inspection or by screening for PAINS or aggregators at <a href="http://zinc15.docking.org/patterns/home" class="extLink">http://zinc15.docking.org/patterns/home</a>.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl (4<i>R</i>)-2-(2-Chlorophenyl)thiazolidine-4-carboxylate (<b>7a</b>)</h3><div class="NLM_p last"><span class="smallcaps smallerCapital">l</span>-Cysteine methyl ester hydrochloride (1.51 g, 8.80 mmol) was dissolved in water (6.6 mL), and potassium bicarbonate (879 mg, 8.78 mmol) was added followed by a solution of 2-chlorobenzaldehyde (2.49 g, 18.1 mmol) in EtOH (6.6 mL). The reaction was stirred at rt for 12 h, whereafter the reaction mixture was diluted with water and extracted with DCM (×3). The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography (EtOAc/PE, 1:5) to give <b>7a</b> as a light yellow oil (1.68 g, 75% yield, 40% minor isomer and 60% major isomer): <i>R</i><sub><i>f</i></sub> = 0.22 (EtOAc/PE, 1:5); <sup>1</sup>H NMR for minor isomer (400 MHz, CDCl<sub>3</sub>) δ 7.81 (dd, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.50–7.24 (m, 6H) [minor and major], 6.04 (br s, 1H), 4.14–4.06 (m, 1H), 3.90 (s, 3H), 3.56 (dd, <i>J</i> = 10.3, 6.9 Hz, 1H), 3.24–3.14 (m, 2H) [minor and major], 2.83 (br s, 1H); <sup>1</sup>H NMR for major isomer (400 MHz, CDCl<sub>3</sub>) δ 7.66 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.50–7.23 (m, 6H) [minor and major], 6.18 (s, 1H), 4.34 (app t, <i>J</i> = 6.6 Hz, 1H), 3.91 (s, 3H), 3.43 (dd, <i>J</i> = 10.6, 6.5 Hz, 1H), 3.24–3.16 (m, 2H) [minor and major], 3.15 (br s, 1H); <sup>13</sup>C NMR for mixture of diastereomers (101 MHz, CDCl<sub>3</sub>) δ 172.2, 171.7, 140.2, 136.0, 133.9, 133.1, 130.0, 129.9, 129.8, 128.7, 128.3, 127.5, 127.0, 126.7, 68.5, 67.4, 65.6, 65.1, 52.8, 52.7, 39.1, 37.6; HRMS (ESI) calcd for C<sub>11</sub>H<sub>12</sub>ClNNaO<sub>2</sub>S (M + Na<sup>+</sup>), 280.0169; found, 280.0162.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Methyl (4<i>R</i>)-2-(3-Chlorophenyl)thiazolidine-4-carboxylate (<b>7b</b>)</h3><div class="NLM_p last">The title compound was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (119 mg, 1.16 mmol) and 3-chlorobenzaldehyde (328 mg, 2.33 mmol) and obtained after flash chromatography (EtOAc/PE, 1:5) as a light yellow oil (214 mg, 71% yield, 44% minor isomer and 56% major isomer): <i>R</i><sub><i>f</i></sub> = 0.16 (EtOAc/PE, 1:5); <sup>1</sup>H NMR for minor isomer (400 MHz, CDCl<sub>3</sub>) δ 7.50–7.48 (m, 1H), 7.41–7.28 (m, 4H) [minor and major], 7.25–7.20 (m, 2H) [minor and major], 5.78 (s, 1H), 4.12 (app t, <i>J</i> = 6.6 Hz, 1H), 3.79 (s, 3H), 3.37 (dd, <i>J</i> = 10.6, 7.0 Hz, 1H), 3.18–3.06 (m, 2H) [minor and major], 2.92 (br s, 1H); <sup>1</sup>H NMR for major isomer (400 MHz, CDCl<sub>3</sub>) δ 7.54–7.52 (m, 1H), 7.41–7.28 (m, 4H) [minor and major], 7.25–7.20 (m, 2H) [minor and major], 5.50 (br s, 1H), 4.01–3.93 (m, 1H), 3.80 (s, 3H), 3.45 (dd, <i>J</i> = 10.3, 7.1 Hz, 1H), 3.18–3.06 (m, 2H) [minor and major], 2.62 (br s, 1H); <sup>13</sup>C NMR for mixture of diastereomers (101 MHz, CDCl<sub>3</sub>) δ 172.1, 171.5, 143.9, 140.4, 134.6, 134.4, 130.0, 129.74, 129.0, 128.0, 127.8, 127.1, 125.9, 125.3, 71.8, 69.9, 65.6, 64.2, 52.7, 52.7, 39.2, 38.2; HRMS (ESI) calcd for C<sub>11</sub>H<sub>13</sub>ClNO<sub>2</sub>S (M + H<sup>+</sup>), 258.0350; found, 258.0356.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl (4<i>R</i>)-2-(4-Chlorophenyl)thiazolidine-4-carboxylate (<b>7c</b>)</h3><div class="NLM_p last">The title compound was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (200 mg, 1.17 mmol) and 4-chlorobenzaldehyde (328 mg, 2.33 mmol) and obtained after flash chromatography (EtOAc/PE, 1:5) as a light yellow oil (208 mg, 69% yield, 42% minor isomer and 58% major isomer): <i>R</i><sub><i>f</i></sub> = 0.19 (EtOAc/PE, 1:5); <sup>1</sup>H NMR for minor isomer (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.25 (m, 4H), 5.77 (s, 1H), 4.13 (t, <i>J</i> = 6.5 Hz, 1H), 3.78 (s, 3H), 3.36 (dd, <i>J</i> = 10.6, 7.0 Hz, 1H), 3.16 (dd, <i>J</i> = 10.6, 6.1 Hz, 1H), 2.67 (br s, 2H) [minor and major]; <sup>1</sup>H NMR for major isomer (400 MHz, CDCl<sub>3</sub>) δ 7.48–7.39 (m, 4H), 5.51 (s, 1H), 3.97 (dd, <i>J</i> = 8.8, 7.2 Hz, 1H), 3.45 (dd, <i>J</i> = 10.3, 7.1 Hz, 1H), 3.79 (s, 3H), 3.10 (dd, <i>J</i> = 10.3, 9.0 Hz, 1H), 2.67 (br s, 2H) [minor and major]; <sup>13</sup>C NMR for mixture of diastereomers (101 MHz, CDCl<sub>3</sub>) δ 172.1, 171.5, 140.1, 136.8, 134.5, 133.6, 128.9, 128.9, 128.5, 128.4, 71.8, 70.0, 65.5, 64.2, 52.7, 52.6, 39.2, 38.1; HRMS (ESI) calcd for C<sub>11</sub>H<sub>13</sub>ClNO<sub>2</sub>S (M + H<sup>+</sup>), 258.0350; found, 258.0361.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Methyl (<i>R</i>)-2-(Pyridin-2-yl)thiazolidine-4-carboxylate (<b>7e</b>)</h3><div class="NLM_p last">The title compound was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (200 mg, 1.16 mmol) and picolinaldehyde (187 mg, 1.75 mmol) and obtained after flash chromatography (EtOAc/PE, 1:1) as a clear oil (165 mg, 63% yield, 45% minor isomer and 55% major isomer): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:1); <sup>1</sup>H NMR for minor isomer (400 MHz, CDCl<sub>3</sub>) δ 8.57 (d, <i>J</i> = 4.8 Hz, 1H), 7.72–7.61 (m, 2H) [minor and major], 7.35–7.27 (m, 2H) [minor and major], 7.26–7.17 (m, 2H) [minor and major], 5.85 (s, 1H), 4.56 (dd, <i>J</i> = 6.4, 4.6 Hz, 1H), 3.80 (s, 3H), 3.63 (br s, 2H) [minor and major], 3.41–3.31 (m, 2H); <sup>1</sup>H NMR for major isomer (400 MHz, CDCl<sub>3</sub>) δ 8.63 (d, <i>J</i> = 4.8 Hz, 1H), 7.72–7.61 (m, 2H) [minor and major], 7.35–7.27 (m, 2H) [minor and major], 7.26–7.17 (m, 2H) [minor and major], 5.66 (s, 1H), 4.04 (dd, <i>J</i> = 9.7, 6.7 Hz, 1H), 3.83 (s, 3H), 3.63 (br s, 2H) [minor and major], 3.45 (dd, <i>J</i> = 10.1, 6.7 Hz, 1H), 3.09 (t, <i>J</i> = 9.9 Hz, 1H); <sup>13</sup>C NMR for mixture of diastereomers (101 MHz, CDCl<sub>3</sub>) δ 172.2, 171.2, 158.7, 156.8, 149.9, 149.6, 136.8, 136.8, 123.4, 123.0, 122.1, 121.6, 71.6, 71.1, 66.3, 65.6, 52.6 [minor and major], 39.4, 38.7; HRMS (ESI) calcd for C<sub>10</sub>H<sub>12</sub>N<sub>2</sub>NaO<sub>2</sub>S (M + Na<sup>+</sup>) 247.0512, found 247.0524.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Methyl (4<i>R</i>)-2-(2-Methoxyphenyl)thiazolidine-4-carboxylate (<b>7f</b>)</h3><div class="NLM_p last">The title compound was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (254 mg, 1.48 mmol) and 2-methoxybenzaldehyde (199 mg, 1.46 mmol) and obtained after flash chromatography (EtOAc/PE, 1:4) as a clear oil (297 mg, 81% yield, 40% minor isomer and 60% major isomer): <i>R</i><sub><i>f</i></sub> = 0.21 (EtOAc/PE, 1:4); <sup>1</sup>H NMR for minor isomer (400 MHz, CDCl<sub>3</sub>) δ 7.42 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.25–7.19 (m, 1H), 7.00–6.92 (m, 2H), 5.99 (br s, 1H), 4.25 (app t, <i>J</i> = 6.6 Hz, 1H), 3.85 (s, 3H), 3.79 (s, 6H) [minor and major], 3.29 (dd, <i>J</i> = 10.4, 6.6 Hz, 1H), 3.06 (br s, 2H) [minor and major], 3.12–3.00 (m, 2H) [minor and major]; <sup>1</sup>H NMR for major isomer (400 MHz, CDCl<sub>3</sub>) δ 7.49 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.32–7.26 (m, 1H), 6.92–6.83 (m, 2H), 5.83 (s, 1H), 3.98–3.91 (m, 1H), 3.86 (s, 3H), 3.79 (s, 6H) [minor and major], 3.42 (dd, <i>J</i> = 10.1, 6.8 Hz, 1H), 3.06 (br s, 2H) [minor and major], 3.12–3.00 (m, 2H) [minor and major]; <sup>13</sup>C NMR for mixture of diastereomers (101 MHz, CDCl<sub>3</sub>) δ 172.3, 171.8, 157.4, 156.8, 130.1, 129.7, 128.7, 127.8, 126.2, 125.8, 120.9, 120.5, 111.2, 110.7, 67.7, 66.0, 65.8, 64.9, 55.7, 55.5, 52.51, 52.49, 39.0, 37.6; HRMS (ESI) calcd for C<sub>12</sub>H<sub>16</sub>NO<sub>3</sub>S (M + H<sup>+</sup>) 254.0845, found 254.0855.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl (4<i>R</i>)-2-Phenylthiazolidine-4-carboxylate (<b>7g</b>)</h3><div class="NLM_p last">The title compound was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (327 mg, 1.91 mmol) and benzaldehyde (288 μL, 2.83 mmol) and obtained after flash chromatography (EtOAc/PE, 1:4) as a clear oil (340 mg, 80% yield, 37% minor isomer and 63% major isomer): <i>R</i><sub><i>f</i></sub> = 0.32 (EtOAc/PE, 1:4); <sup>1</sup>H NMR for minor isomer (400 MHz, CDCl<sub>3</sub>) δ 7.49–7.46 (m, 2H), 7.39–7.22 (m, 6H) [minor and major], 5.81 (s, 1H), 4.20 (app t, <i>J</i> = 6.1 Hz, 1H), 3.77 (s, 3H), 3.37 (dd, <i>J</i> = 10.6, 7.1 Hz, 1H), 3.19 (dd, <i>J</i> = 10.6, 5.8 Hz, 1H), 2.84 (br s, 1H); <sup>1</sup>H NMR for major isomer (400 MHz, CDCl<sub>3</sub>) δ 7.54–7.49 (m, 2H), 7.39–7.22 (m, 6H) [minor and major], 5.55 (s, 1H), 4.02–3.93 (m, 1H), 3.78 (s, 3H), 3.45 (dd, <i>J</i> = 10.3, 7.1 Hz, 1H), 3.10 (dd, <i>J</i> = 10.1, 9.2 Hz, 1H), 2.66 (br s, 1H); <sup>13</sup>C NMR for mixture of diastereomers (101 MHz, CDCl<sub>3</sub>) δ 172.2, 171.6, 141.2, 138.3, 128.73, 128.72, 128.5, 127.9, 127.5, 127.0, 72.7, 70.9, 65.6, 64.4, 52.6, 52.5, 39.3, 38.2; HRMS (ESI) calcd for C<sub>11</sub>H<sub>13</sub>NNaO<sub>2</sub>S (M + Na<sup>+</sup>) 246.0559, found 246.0565.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-iodobenzoyl)thiazolidine-4-carboxylate (<b>8a</b>)</h3><div class="NLM_p last">A predried vial with <b>7a</b> (926 mg, 3.59 mmol) in THF (7.4 mL, anhydrous) was cooled to −10 °C and to it was added triethylamine (1.25 mL, 8.97 mmol) dropwise. After stirring for 15 min at rt the solution was evaporated, the triethylammonium salt was redissolved in THF (11 mL), and the solution was cooled to −10 °C. 4-Iodobenzoyl chloride (1.05 g, 3.95 mmol) dissolved in THF (15 mL, anhydrous) was added dropwise, and the reaction mixture was allowed to reach rt. After stirring at rt for 4 h the solvent was evaporated off, to the crude residue was added water (18 mL), and the mixture was acidified with 1 M HCl (pH 2–3) and extracted with EtOAc (×3). The organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography (EtOAc/PE, 1:3) to give central intermediate <b>8a</b> as a white foam (1.43 g, 82% yield): <i>R</i><sub><i>f</i></sub> = 0.21 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 6.4 Hz, 1H), 7.64–7.47 (m, 2H), 7.40–7.31 (m, 2H), 7.30–7.22 (m, 1H), 7.07–6.91 (m, 2H), 6.17 (br s, 1H), 5.07 (app s, 1H), 3.86 (s, 3H), 3.45–3.32 (m, 1H), 3.20 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.3, 169.9, 138.9, 137.3, 134.1, 131.4, 129.8, 129.2, 128.5, 127.5, 127.3, 97.6, 65.8, 65.5, 52.8, 31.1; HRMS (ESI) calcd for C<sub>18</sub>H<sub>16</sub>ClINO<sub>3</sub>S (M + H<sup>+</sup>) 487.9579, found 487.9573. [α]<sup>20</sup><sub>D</sub> +45° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(3-iodobenzoyl)thiazolidine-4-carboxylate (<b>8b</b>)</h3><div class="NLM_p last">The title compound was prepared as described for <b>8a</b> using <b>7a</b> (300 mg, 0.16 mmol) and 3-iodobenzoyl chloride (347 mg, 0.13 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a colorless oil (237 mg, 42% yield): <i>R</i><sub><i>f</i></sub> = 0.26 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 7.1 Hz, 1H), 7.68 (d, <i>J</i> = 7.3 Hz, 1H), 7.57–7.48 (m, 1H), 7.40 (t, <i>J</i> = 7.2 Hz, 1H), 7.35 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.29 (d, <i>J</i> = 7.3 Hz, 1H), 7.24–7.17 (m, 1H), 7.01–6.91 (m, 1H), 6.15 (s, 1H), 5.13–4.96 (m, 1H), 3.89 (s, 3H), 3.47–3.32 (m, 1H), 3.32–3.15 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.5, 169.3, 139.7, 139.1, 136.6, 136.2, 131.6, 130.0, 129.4, 127.8, 127.6, 126.1, 93.8, 65.8, 65.6, 53.0, 31.4; HRMS (ESI) calcd for C<sub>18</sub>H<sub>15</sub>ClINNaO<sub>3</sub>S (M + Na<sup>+</sup>) 509.9398, found 509.9393.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>9</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound <b>9a</b> was prepared as described for <b>8a</b> using <b>7a</b> (100 mg, 0.39 mmol) and 2′-methoxybiphenyl-4-carbonyl chloride (107 mg, 0.44 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear viscous oil (141 mg, 77% yield): <i>R</i><sub><i>f</i></sub> = 0.20 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 7.0 Hz, 1H), 7.49–7.19 (m, 9H), 7.07–6.91 (m, 2H), 6.32 (br s, 1H), 5.18–5.08 (m, 1H), 3.89 (br s, 3H), 3.76 (s, 3H), 3.45–3.34 (m, 1H), 3.27–3.18 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.0, 170.8, 156.5, 141.4, 139.5, 133.0, 131.7, 130.7, 129.9, 129.6, 129.4, 129.3, 129.1, 127.9, 127.4, 126.9, 121.0, 111.5, 66.1, 65.9, 55.6, 52.8, 31.3; HRMS (ESI) calcd for C<sub>25</sub>H<sub>23</sub>ClNO<sub>4</sub>S (M + H<sup>+</sup>) 468.1031, found 468.1028.</div><div class="NLM_p last"><i>Step 2:</i> Methyl ester <b>9a</b> (40 mg, 86 μmol) and LiI (46 mg, 0.34 mmol) were dissolved in degassed EtOAc (120 μL), the vial was capped, flushed with argon (×3), and the reaction stirred at 80 °C in the dark. To the reaction mixture were added water and 1 M HCl (1:1), and extraction was with EtOAc (×3). The combined organic phases were washed with NaHSO<sub>3</sub>, water, and brine. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography (EtOAc/PE, 2:1 [1% AcOH]) to give the title compound <b>9</b> after freeze-drying as an amorphous solid (20 mg, 51% yield): <i>R</i><sub><i>f</i></sub> = 0.13 (EtOAc/PE, 2:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (d, <i>J</i> = 6.1 Hz, 1H), 7.45–7.40 (m, 2H), 7.39–7.29 (m, 5H), 7.29–7.21 (m, 2H), 7.05–6.93 (m, 2H), 6.37 (br s, 1H), 5.28–5.16 (m, 1H), 3.77 (s, 3H), 3.50–3.35 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 172.6, 156.6, 141.9, 138.9, 132.4, 131.7, 130.8, 130.1, 129.6, 129.5, 129.5, 129.4, 127.6, 127.0, 121.1, 111.6, 66.6, 66.1, 55.7, 31.0; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 476.0694, found 476.0680. HPLC: <i>t</i><sub>R</sub> = 12.28 min, 98.4%. [α]<sup>20</sup><sub>D</sub> +13° (<i>c</i> 0.25, DCM).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2<i>R</i>,4<i>R</i>)-2-(3-Chlorophenyl)-3-(<b>2</b>′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>10</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound <b>10a</b> was prepared as described for <b>8a</b> using <b>7b</b> (100 mg, 0.39 mmol) and 2′-methoxybiphenyl-4-carbonyl chloride (105 mg, 0.43 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear viscous oil (152 mg, 83% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71–7.64 (m, 1H), 7.57 (d, <i>J</i> = 5.8 Hz, 1H), 7.48–7.41 (m, 4H), 7.35–7.22 (m, 4H), 7.06–6.92 (m, 2H), 6.15 (br s, 1H), 5.17 (app s, 1H), 3.85 (s, 3H), 3.79 (s, 3H), 3.47–3.14 (m, 2H); <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>) δ 171.0, 170.5, 156.5, 143.5, 141.4, 134.4, 133.5, 130.8, 129.8, 129.6, 129.5, 129.4, 128.2, 127.2, 126.9, 125.2, 121.0, 111.4, 67.8, 65.2, 55.6, 52.9, 32.0; HRMS (ESI) calcd for C<sub>25</sub>H<sub>22</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 490.0850, found 490.0830.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>10</b> was prepared as described for <b>9</b> using methyl ester <b>10a</b> (100 mg, 0.21 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (65 mg, 67% yield): <i>R</i><sub><i>f</i></sub> = 0.16 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61–7.39 (m, 5H), 7.37–7.30 (m, 2H), 7.29–7.22 (m, 3H), 7.05–6.92 (m, 2H), 6.68 (br s, 1H), 6.16 (br s, 1H), 5.23 (app s, 1H), 3.78 (s, 3H), 3.49–3.35 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.5, 172.1, 156.5, 142.8, 141.9, 134.7, 132.7, 130.9, 130.0, 129.8, 129.5, 129.4, 128.5, 127.0, 124.9, 121.1, 111.5, 68.3, 65.0, 55.7, 31.6; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 476.0694, found 476.0687. HPLC: <i>t</i><sub>R</sub> = 12.10 min, 97.6%. [α]<sup>20</sup><sub>D</sub> +23° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2<i>R</i>,4<i>R</i>)-2-(4-Chlorophenyl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>11</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound <b>11a</b> was prepared as described for <b>8a</b> using <b>7c</b> (99 mg, 0.39 mmol) and 2′-methoxybiphenyl-4-carbonyl chloride (107 mg, 0.44 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear viscous oil (131 mg, 73% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.63–7.57 (m, 2H), 7.47–7.42 (m, 4H), 7.36–7.20 (m, 4H), 7.09–6.92 (m, 2H), 6.17 (br s, 1H), 5.15 (app s, 1H), 3.84 (br s, 3H), 3.79 (s, 3H), 3.44–3.14 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.0, 170.6, 156.5, 141.3, 140.1, 133.8, 133.6, 130.8, 129.6, 129.5, 129.4, 128.7, 128.5, 126.9, 121.0, 111.4, 67.7, 65.2, 55.6, 52.9, 32.0; HRMS (ESI) calcd for C<sub>25</sub>H<sub>23</sub>ClNO<sub>4</sub>S (M + H<sup>+</sup>) 468.1031, found 468.1009.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>11</b> was prepared as described for <b>9</b> using methyl ester <b>11a</b> (44 mg, 94 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (56 mg, 24% yield): <i>R</i><sub><i>f</i></sub> = 0.17 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52–7.18 (m, 10H), 7.09–6.91 (m, 2H), 6.18 (br s, 1H), 5.22 (app s, 1H), 3.79 (s, 3H), 3.48–3.33 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.7, 172.0, 156.5, 141.9, 139.2, 134.2, 132.7, 130.8, 129.8, 129.5, 129.4, 128.9, 128.2, 127.0, 121.1, 111.5, 68.4, 65.2, 55.7, 31.5; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 476.0694, found 476.0688. HPLC: <i>t</i><sub>R</sub> = 12.17 min, 100%. [α]<sup>20</sup><sub>D</sub> +31° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (2<i>R</i>,4<i>R</i>)-2-(2-Bromophenyl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>12</b>)</h3><div class="NLM_p"><i>Step 1: Methyl (2R,4R)-2-(2-Bromophenyl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylate (<b>7i</b>).</i> The thiazolidine was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (201 mg, 1.17 mmol) and 2-bromobenzaldehyde (431 mg, 2.33 mmol). Crude methyl (4<i>R</i>)-2-(2-bromophenyl)thiazolidine-4-carboxylate (<b>7i</b>) was used without further purification in the next step.</div><div class="NLM_p"><i>Step 2: Methyl (2R,4R)-2-(2-Bromophenyl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylate (<b>12a</b>).</i> Using the crude <b>7i</b> (95 mg) and 2′-methoxybiphenyl-4-carbonyl chloride (77 mg, 0.31 mmol), the title compound was prepared as described for <b>8a</b> and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear viscous oil (31 mg, 20% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J</i> = 7.4 Hz, 1H), 7.55 (dd, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.47–7.36 (m, 4H), 7.34–7.28 (m, 2H), 7.25–7.16 (m, 2H), 7.06–6.92 (m, 2H), 6.27 (br s, 1H), 5.17–5.07 (m, 1H), 3.90 (br s, 3H), 3.76 (s, 3H), 3.41–3.33 (m, 1H), 3.28–3.18 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.1, 170.8, 156.6, 141.5, 133.3, 130.8, 129.7, 129.5, 129.43, 129.35, 128.2, 128.1, 127.0, 121.1, 111.6, 68.5, 66.3, 55.7, 52.9, 31.2; HRMS (ESI) calcd for C<sub>25</sub>H<sub>23</sub>BrNO<sub>4</sub>S (M + H<sup>+</sup>) 512.0526, found 512.0520.</div><div class="NLM_p last"><i>Step 3:</i> The title compound <b>12</b> was prepared as described for <b>9</b> using methyl ester <b>12a</b> (31 mg, 61 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [2% AcOH]) and subsequent freeze-drying as a beige amorphous solid (16 mg, 54% yield): <i>R</i><sub><i>f</i></sub> = 0.23 (EtOAc/PE, 1:1 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 4.4 Hz, 1H), 7.50 (d, <i>J</i> = 7.8 Hz, 1H), 7.41–7.33 (m, 3H), 7.33–7.27 (m, 2H), 7.25–7.23 (m, 1H), 7.20–7.09 (m, 2H), 7.03–6.89 (m, 2H), 6.25 (br s, 1H), 5.20–5.13 (m, 1H), 3.72 (s, 3H), 3.40–3.31 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.0, 172.6, 156.6, 141.7, 140.6, 133.3, 132.6, 130.8, 129.6, 129.5, 129.4, 128.3, 128.0, 127.0, 121.8, 121.0, 111.6, 69.2, 67.0, 55.7, 30.9; HRMS (ESI) calcd for C<sub>24</sub>H<sub>21</sub>BrNO<sub>4</sub>S (M + H<sup>+</sup>) 498.0369, found 498.0345. HPLC: <i>t</i><sub>R</sub> = 12.36 min, 99.8%. [α]<sup>20</sup><sub>D</sub> +17° (<i>c</i> 0.3, DCM).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (2<i>R</i>,4<i>R</i>)-3-(2′-Methoxybiphenyl-4-carbonyl)-2-phenylthiazolidine-4-carboxylic Acid (<b>13</b>)</h3><div class="NLM_p"><i>Step 1: Methyl (2R,4R)-2-Phenylthiazolidine-4-carboxylate (<b>7g</b>).</i> The thiazolidine was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (201 mg, 1.17 mmol) and benzaldehyde (247 mg, 2.33 mmol). Crude methyl (4<i>R</i>)-2-phenylthiazolidine-4-carboxylate (<b>7g</b>) was used without further purification in the next step.</div><div class="NLM_p"><i>Step 2: Methyl (2R,4R)-3-(2′-Methoxybiphenyl-4-carbonyl)-2-phenylthiazolidine-4-carboxylate (<b>13a</b>).</i> Using crude <b>7g</b> (105 mg) and 2′-methoxybiphenyl-4-carbonyl chloride (128 mg, 0.52 mmol), the title compound was prepared as described for <b>8a</b> and obtained after flash chromatography (EtOAc/PE, 1:3) as a white foam (146 mg, 72% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71–7.56 (m, 2H), 7.47–7.18 (m, 9H), 7.04–6.91 (m, 2H), 6.19 (br s, 1H), 5.17 (app s, 1H), 3.83 (br s, 3H), 3.76 (s, 3H), 3.44–3.16 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.1, 170.6, 156.5, 141.6, 141.2, 133.6, 130.8, 129.6, 129.5, 129.3, 128.5, 127.9, 127.0, 126.8, 121.0, 111.4, 68.5, 65.2, 55.6, 52.8, 31.9; HRMS (ESI) calcd for C<sub>25</sub>H<sub>24</sub>NO<sub>4</sub>S (M + H<sup>+</sup>) 434.1421, found 434.1412.</div><div class="NLM_p last"><i>Step 3:</i> The title compound <b>13</b> was prepared as described for <b>9</b> using methyl ester <b>13a</b> (100 mg, 0.23 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (67 mg, 69% yield): <i>R</i><sub><i>f</i></sub> = 0.23 (EtOAc/PE, 1:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.79 (br s, 1H), 7.46–7.39 (m, 6H), 7.35–7.29 (m, 3H), 7.28–7.21 (m, 2H), 7.02–6.90 (m, 2H), 6.22 (br s, 1H), 5.24 (app s, 1H), 3.76 (s, 3H), 3.47–3.34 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.7, 172.3, 156.5, 141.7, 140.7, 132.8, 130.8, 129.6, 129.4, 128.7, 128.2, 127.0, 126.6, 121.0, 111.5, 69.1, 65.0, 55.6, 31.4; HRMS (ESI) calcd for C<sub>24</sub>H<sub>22</sub>NO<sub>4</sub>S (M + H<sup>+</sup>) 420.1264, found 420.1259. HPLC: <i>t</i><sub>R</sub> = 11.70 min, 97.6%. [α]<sup>20</sup><sub>D</sub> +22° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2<i>R</i>,4<i>R</i>)-3-(2′-Methoxybiphenyl-4-carbonyl)-2-(pyridin-2-yl)thiazolidine-4-carboxylic Acid (<b>14</b>)</h3><div class="NLM_p"><i>Step 1:</i> The thiazolidine was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (150 mg, 0.87 mmol) and picolinaldehyde (187 mg, 1.75 mmol). Crude methyl (4<i>R</i>)-2-(pyridin-2-yl)thiazolidine-4-carboxylate (<b>7e</b>) was used without further purification in the next step.</div><div class="NLM_p"><i>Step 2: Methyl (2R,4R)-3-(2</i>′<i>-Methoxybiphenyl-4-carbonyl)-2-(pyridin-2-yl)thiazolidine-4-carboxylate (<b>14a</b>).</i> Using crude <b>7e</b> (95 mg) and 2′-methoxybiphenyl-4-carbonyl chloride (116 mg, 0.47 mmol), methyl ester <b>14a</b> was prepared as described for <b>8a</b> and obtained after flash chromatography (EtOAc/PE, 1:2 → 1:1) as a clear viscous oil (77 mg, 42% yield): <i>R</i><sub><i>f</i></sub> = 0.35 (DCM with 2% MeOH); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (d, <i>J</i> = 4.7 Hz, 1H), 8.15–7.99 (m, 1H), 7.80–7.71 (m, 1H), 7.44–7.37 (m, 3H), 7.37–7.27 (m, 2H), 7.26–7.16 (m, 2H), 7.05–6.91 (m, 2H), 6.18 (br s, 1H), 5.25 (app s, 1H), 3.85 (br s, 3H), 3.77 (s, 3H), 3.42–3.32 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) 171.1, 170.9, 156.5, 149.6, 141.4, 137.1, 133.4, 130.8, 129.6, 129.3, 126.9, 122.7, 121.0, 120.6, 111.4, 69.6, 65.2, 55.6, 52.8, 32.0; HRMS (ESI) calcd for C<sub>24</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 435.1373, found 435.1395.</div><div class="NLM_p last"><i>Step 3:</i> The title compound <b>14</b> was prepared as described for <b>9</b> using methyl ester <b>14a</b> (75 mg, 0.17 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 2:1 → EtOAc [1% AcOH]) as brown crystals (53 mg, 73% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 2:1 [1% AcOH]); dec 114–120 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (d, <i>J</i> = 4.8 Hz, 1H), 7.88 (br s, 1H), 7.61–7.49 (m, 4H), 7.45–7.39 (m, 1H), 7.37–7.30 (m, 1H), 7.29–7.13 (m, 2H), 7.07–6.95 (m, 2H), 6.63 (br s, 1H), 5.14 (app s, 1H), 3.79 (s, 3H), 3.58–3.41 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.4, 170.1, 157.4, 156.5, 147.4, 141.7, 139.6, 133.2, 130.8, 129.9, 129.5, 129.3, 126.7, 124.3, 123.3, 121.0, 111.4, 67.6, 65.9, 55.6, 37.5; HRMS (ESI) calcd for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>NaO<sub>4</sub>S (M + Na<sup>+</sup>) 443.1036, found 443.1056. HPLC: <i>t</i><sub>R</sub> = 10.25 min, 99.5%. [α]<sup>20</sup><sub>D</sub> +59° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2<i>R</i>,4<i>R</i>)-2-(Furan-2-yl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>15</b>)</h3><div class="NLM_p"><i>Step 1: Methyl (2R,4R)-2-(Furan-2-yl)-3-thiazolidine-4-carboxylate (<b>7j</b>).</i> The thiazolidine was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (150 mg, 0.87 mmol) and 2-furancarboxaldehyde (168 mg, 1.75 mmol). Crude methyl (4<i>R</i>)-2-(furan-2-yl)thiazolidine-4-carboxylate (<b>7j</b>) was used without further purification in the next step.</div><div class="NLM_p"><i>Step 2: Methyl (2R,4R)-2-(Furan-2-yl)-3-(2</i>′<i>-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylate (<b>15a</b>).</i> Using crude <b>7j</b> (91 mg) and 2′-methoxybiphenyl-4-carbonyl chloride (116 mg, 0.47 mmol), the title compound <b>15a</b> was prepared as described for <b>8a</b> and obtained after flash chromatography (EtOAc/PE, 1:3) as a brown viscous oil (46 mg, 25% yield): <i>R</i><sub><i>f</i></sub> = 0.21 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.59–7.48 (m, 4H), 7.42–7.39 (m, 1H), 7.36–7.31 (m, 1H), 7.29 (dd, <i>J</i> = 7.5, 1.7 Hz, 1H), 7.05–7.00 (m, 2H), 6.87–6.78 (m, 1H), 6.37 (dd, <i>J</i> = 3.1, 1.8 Hz, 1H), 6.14 (br s, 1H), 5.25–5.08 (m, 1H), 3.80 (s, 6H), 3.48–3.34 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.5, 156.5, 152.4, 142.8, 141.5, 133.2, 130.9, 129.7, 129.4, 127.2, 121.1, 111.5, 110.7, 109.4, 63.6, 62.7, 55.7, 52.9, 32.4; HRMS (ESI) calcd for C<sub>23</sub>H<sub>22</sub>NO<sub>5</sub>S (M + H<sup>+</sup>) 424.1213, found 424.1222.</div><div class="NLM_p last"><i>Step 3:</i> The title compound <b>15</b> was prepared as described for <b>9</b> using methyl ester <b>15a</b> (43 mg, 0.10 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a whitish amorphous powder (33 mg, 80% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55–7.49 (m, 4H), 7.38 (d, <i>J</i> = 1.3 Hz, 1H), 7.36–7.30 (m, 1H), 7.28–7.24 (m, 1H), 7.06–6.93 (m, 2H), 6.70 (d, <i>J</i> = 2.8 Hz, 1H), 6.36–6.32 (m, 1H), 6.15 (br s, 1H), 5.22–5.12 (m, 1H), 3.78 (s, 3H), 3.53–3.36 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 171.7, 156.5, 151.8, 143.0, 141.9, 132.7, 130.9, 129.8, 129.47, 129.45, 127.2, 121.1, 111.5, 110.9, 109.3, 63.9, 63.0, 55.7, 31.9; HRMS (ESI) calcd for C<sub>22</sub>H<sub>19</sub>NNaO<sub>5</sub>S (M + Na<sup>+</sup>) 432.0876, found 432.0877. HPLC: <i>t</i><sub>R</sub> = 11.84 min, 98.8%. [α]<sup>20</sup><sub>D</sub> −1° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>R</i>,4<i>R</i>)-2-(<i>tert</i>-Butyl)-3-(2′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>16</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>16a</b>) was prepared as described for <b>8a</b> using <b>7d</b> (62 mg, 0.31 mmol) and 2′-methoxybiphenyl-4-carbonyl chloride (84 mg, 0.34 mmol) and obtained after flash chromatography (DCM/PE, 1:1 → DCM → DCM/EtOAc 1:1) as a clear oil (63 mg, 50% yield): <i>R</i><sub><i>f</i></sub> = 0.34 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58–7.55 (m, 4H), 7.38–7.28 (m, 2H), 7.06–6.96 (m, 2H), 5.75 (br s, 1H), 4.93 (app s, 1H), 3.80 (s, 3H), 3.73 (s, 3H), 3.36 (dd, <i>J</i> = 11.6, 5.9 Hz, 1H), 3.22–3.11 (m, 1H), 1.04 (s, 9H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.1, 171.1, 156.5, 140.6, 135.0, 130.8, 129.7, 129.3, 126.8, 121.1, 111.5, 73.5, 66.0, 55.7, 52.6, 38.8, 33.7, 27.2; HRMS (ESI) calcd for C<sub>23</sub>H<sub>27</sub>NNaO<sub>4</sub>S (M + Na<sup>+</sup>) 436.1530, found 436.1672.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>16</b> was prepared as described for <b>9</b> using methyl ester <b>16a</b> (48 mg, 0.12 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:3 [1% AcOH]) to give a cloudy oil (28 mg, 60% yield): <i>R</i><sub><i>f</i></sub> = 0.23 (EtOAc/PE, 1:3 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.67–7.53 (m, 4H), 7.39–7.30 (m, 2H), 7.08–6.98 (m, 2H), 5.47 (br s, 1H), 5.15–5.00 (m, 1H), 3.82 (s, 3H), 4.00–3.12 (m, 2H), 0.88 (s, 9H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.8, 170.2, 155.6, 140.8, 132.0, 129.9, 129.0, 128.6, 128.3, 126.2, 120.1, 110.6, 74.1, 64.2, 54.7, 38.3, 31.1, 26.1; HRMS (ESI) calcd for C<sub>22</sub>H<sub>25</sub>NNaO<sub>4</sub>S (M + Na<sup>+</sup>) 422.1397, found 422.1393. HPLC: <i>t</i><sub>R</sub> = 12.64 min, 99.8%. [α]<sup>20</sup><sub>D</sub> −100° (<i>c</i> 0.5, DCM).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (2<i>R</i>,4<i>R</i>)-3-Benzoyl-2-(2-chlorophenyl)thiazolidine-4-carboxylic Acid (<b>18</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>18a</b>) was prepared as described for <b>8a</b> using <b>7a</b> (156 mg, 0.60 mmol) and benzoyl chloride (79 μL, 0.68 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear oil (125 mg, 57% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 7.0 Hz, 1H), 7.45–7.13 (m, 8H), 6.20 (br s, 1H), 5.09 (app s, 1H), 3.86 (s, 3H), 3.42–3.30 (m, 1H), 3.27–3.15 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.0, 170.6, 139.4, 134.9, 131.6, 130.8, 129.8, 129.1, 128.3, 127.7, 127.3, 126.9, 65.9, 65.7, 52.8, 31.3; HRMS (ESI) calcd for C<sub>18</sub>H<sub>16</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 384.0432, found 384.0447.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>18</b> was prepared as described for <b>9</b> using methyl ester <b>18a</b> (114 mg, 0.32 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc [1% AcOH]) and subsequent freeze-drying as white crystals (59 mg, 53% yield): <i>R</i><sub><i>f</i></sub> = 0.18 (EtOAc [1% AcOH]); mp 166–172 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.39 (br s, 1H), 8.14 (d, <i>J</i> = 7.3 Hz, 1H), 7.43–7.30 (m, 4H), 7.30–7.18 (m, 4H), 6.22 (br s, 1H), 5.29–5.08 (m, 1H), 3.48–3.39 (m, 1H), 3.38–3.28 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.2, 172.2, 138.9, 134.5, 131.6, 131.2, 129.9, 129.3, 128.4, 127.6, 127.5, 127.1, 66.2, 66.0, 31.1; HRMS (ESI) calcd for C<sub>17</sub>H<sub>14</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 370.0275, found 370.0285. HPLC: <i>t</i><sub>R</sub> = 11.73 min, 95.2%. [α]<sup>20</sup><sub>D</sub> +30° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2<i>R</i>,4<i>R</i>)-3-([1,1′-Biphenyl]-4-carbonyl)-2-(2-chlorophenyl)thiazolidine-4-carboxylic Acid (<b>19</b>)</h3><div class="NLM_p"><i>Step 1:</i> To a vial charged with <b>8a</b> (99 mg, 0.20 mmol) and phenylboronic acid (25 mg, 0.20 mmol) were added toluene (1.3 mL) and MeOH (0.7 mL). The reaction mixture was purged with argon (×5), and to it were added Pd(PPh<sub>3</sub>)<sub>4</sub> (12 mg, 11 μmol) and aqueous Na<sub>2</sub>CO<sub>3</sub> (170 μL, 4.0 M). The reaction was capped and stirred at 80 °C overnight under argon, then treated with water and extracted with EtOAc (×3), washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo, and the methyl ester of the title compound (<b>19a</b>) was obtained after flash chromatography (EtOAc/PE, 1:3) as a viscous oil (58 mg, 65% yield): <i>R</i><sub><i>f</i></sub> = 0.24 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (d, <i>J</i> = 7.0 Hz, 1H), 7.56–7.51 (m, 2H), 7.47–7.32 (m, 9H), 7.31–7.25 (m, 1H), 6.30 (br s, 1H), 5.21–5.09 (m, 1H), 3.90 (s, 3H), 3.43–3.36 (m, 1H), 3.28–3.18 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.9, 170.8, 143.8, 140.0, 133.5, 131.7, 130.0, 129.2, 129.0, 128.1, 127.9, 127.8, 127.4, 127.2, 127.0, 66.1, 65.9, 52.9, 31.3; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 460.0745, found 460.0725.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>19</b> was prepared as described for <b>9</b> using methyl ester <b>19a</b> (57 mg, 0.13 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (41 mg, 75% yield): <i>R</i><sub><i>f</i></sub> = 0.16 (EtOAc/PE, 1:1 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (d, <i>J</i> = 4.6 Hz, 1H), 7.74–7.63 (m, 1H), 7.54–7.50 (m, 2H), 7.50–7.39 (m, 4H), 7.39–7.32 (m, 4H), 7.30–7.20 (m, 1H), 6.33 (br s, 1H), 5.24 (app s, 1H), 3.49–3.35 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.6, 172.3, 144.2, 139.9, 138.9, 133.0, 131.7, 130.1, 129.4, 129.0, 128.2, 127.8, 127.6, 127.3, 127.1, 66.5, 66.1, 31.0; HRMS (ESI) calcd for C<sub>23</sub>H<sub>19</sub>ClNO<sub>3</sub>S (M + H<sup>+</sup>) 424.0769, found 424.0783. HPLC: <i>t</i><sub>R</sub> = 12.33 min, 97.8%. [α]<sup>20</sup><sub>D</sub> +39° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>R</i>,4<i>R</i>)-3-([1,1′-Biphenyl]-3-carbonyl)-2-(2-chlorophenyl)thiazolidine-4-carboxylic Acid (<b>20</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>20a</b>) was prepared as described for <b>19a</b> using <b>8b</b> (84 mg, 0.172 mmol) and phenylboronic acid (21 mg, 0.172 mmol) and obtained after flash chromatography (EtOAc/PE, 2:3) as a clear viscous oil (45 mg, 63% yield): <i>R</i><sub><i>f</i></sub> = 0.24 (EtOAc/PE, 2:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 6.6 Hz, 1H), 7.65–7.52 (m, 1H), 7.49–7.24 (m, 9H), 7.18–6.99 (m, 2H), 6.26 (br s, 1H), 5.21–5.07 (m, 1H), 3.90 (s, 3H), 3.47–3.33 (m, 1H), 3.30–3.14 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.3, 170.7, 141.0, 139.8, 135.3, 131.8, 130.0, 129.5, 129.2, 129.1, 128.8, 128.0, 127.7, 127.6, 126.9, 126.2, 125.7, 66.0, 52.9, 31.3; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 460.0745, found 460.0742.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>20</b> was prepared as described for <b>9</b> using methyl ester <b>20a</b> (41 mg, 94 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (13 mg, 33% yield): <i>R</i><sub><i>f</i></sub> = 0.24 (EtOAc/PE, 1:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20–8.05 (m, 1H), 7.60 (d, <i>J</i> = 5.6 Hz, 1H), 7.46–7.23 (m, 9H), 7.18–7.00 (m, 2H), 6.26 (br s, 1H), 5.20 (app s, 1H), 3.49–3.26 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.6 (br), 141.2, 139.7, 139.2, 134.9, 131.8, 130.1, 129.8, 129.3, 129.2, 128.9, 127.8, 126.9, 126.2, 125.8, 66.7, 66.1, 31.0; HRMS (ESI) calcd for C<sub>23</sub>H<sub>18</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 446.0588, found 446.0578. HPLC: <i>t</i><sub>R</sub> = 12.94 min, 97.3%. [α]<sup>20</sup><sub>D</sub> −2° (<i>c</i> 0.1, DCM).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(2′-fluoro-3′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>21</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>21a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (101 mg, 0.21 mmol) and (2-fluoro-3-methoxyphenyl)boronic acid (39 mg, 0.23 mmol) and obtained after flash chromatography (EtOAc/PE, 1:4) as a clear oil (77 mg, 76% yield): <i>R</i><sub><i>f</i></sub> = 0.25 (EtOAc/PE, 1:4); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 6.7 Hz, 1H), 7.45–7.23 (m, 7H), 7.15–7.06 (m, 1H), 6.99–6.87 (m, 2H), 6.28 (br s, 1H), 5.13 (app s, 1H), 3.90 (s, 6H), 3.45–3.32 (m, 1H), 3.30–3.15 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.8, 170.7, 150.9, 148.4 (d, <i>J</i> = 11.5 Hz), 139.4, 138.3, 134.0, 131.7, 129.9, 129.2, 129.0, 128.9, 128.8, 127.9, 127.4, 127.2, 124.1 (d, <i>J</i> = 4.3 Hz), 121.8, 112.9, 66.0, 65.8, 56.5, 52.9, 31.3; HRMS (ESI) calcd for C<sub>25</sub>H<sub>21</sub>ClFNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 508.0756, found 508.0767.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>21</b> was prepared as described for <b>9</b> using methyl ester <b>21a</b> (78 mg, 0.16 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (28 mg, 37% yield): <i>R</i><sub><i>f</i></sub> = 0.14 (EtOAc/PE, 1:2 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (d, <i>J</i> = 5.9 Hz, 1H), 7.44–7.30 (m, 6H), 7.27–7.21 (m, 1H), 7.10 (td, <i>J</i> = 8.1, 1.2 Hz, 1H), 6.96 (td, <i>J</i> = 8.1, 1.4 Hz, 1H), 6.93–6.89 (m, 1H), 6.32 (br s, 1H), 5.28–5.15 (m, 1H), 3.91 (s, 3H), 3.50–3.32 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.6, 171.2, 150.0, 147.4 (d, <i>J</i> = 11.8 Hz), 137.7, 132.5, 130.7, 129.1, 128.4, 128.2, 127.8, 127.7, 126.6, 126.3, 123.2 (d, <i>J</i> = 3.6 Hz), 120.9, 112.1, 65.4, 65.0, 55.6, 30.0; HRMS (ESI) calcd for C<sub>24</sub>H<sub>19</sub>ClFNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 494.0600, found 494.0596. HPLC: <i>t</i><sub>R</sub> = 12.60 min, 99.4%. [α]<sup>20</sup><sub>D</sub> +32° (<i>c</i> 0.4, DCM).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4′-methoxybiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>22</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>22a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (96, 0.20 mmol) and (4-methoxyphenyl)boronic acid (31 mg, 0.21 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear viscous oil (42 mg, 46% yield): <i>R</i><sub><i>f</i></sub> = 0.26 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 7.2 Hz, 1H), 7.48 (d, <i>J</i> = 8.6 Hz, 2H), 7.42–7.38 (m, 3H), 7.38–7.27 (m, 4H), 6.98–6.92 (m, 2H), 6.29 (br s, 1H), 5.18–5.07 (m, 1H), 3.89 (s, 3H), 3.83 (s, 3H), 3.43–3.35 (m, 1H), 3.28–3.18 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.1, 170.8, 159.8, 143.4, 139.6, 132.8, 132.5, 131.7, 130.0, 129.2, 128.3, 127.8, 127.4, 126.4, 114.4, 66.1, 66.0, 55.5, 52.9, 31.3; HRMS (ESI) calcd for C<sub>25</sub>H<sub>22</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 490.0850, found 490.0861.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>22</b> was prepared as described for <b>9</b> using methyl ester <b>22a</b> (41 mg, 87 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (29 mg, 73% yield): <i>R</i><sub><i>f</i></sub> = 0.32 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.09 (d, <i>J</i> = 5.8 Hz, 1H), 7.46–7.41 (m, 2H), 7.39–7.29 (m, 6H), 7.26–7.21 (m, 1H), 6.96–6.89 (m, 2H), 6.30 (br s, 1H), 5.26–5.13 (m, 1H), 3.83 (s, 3H), 3.44–3.31 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 172.4, 159.9, 143.7, 139.0, 132.3, 131.6, 130.1, 129.4, 128.4, 127.9, 127.6, 126.5, 114.5, 66.6, 66.3, 55.5, 30.9; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 476.0694, found 476.0693. HPLC: <i>t</i><sub>R</sub> = 12.79 min, 100%. [α]<sup>20</sup><sub>D</sub> +47° (<i>c</i> 0.4, DCM).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>R</i>,4<i>R</i>)-3-(4′-Acetylbiphenyl-4-carbonyl)-2-(2-chlorophenyl)thiazolidine-4-carboxylic Acid (<b>23</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>23a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (88 mg, 0.18 mmol) and (4-acetylphenyl)boronic acid (32 mg, 0.19 mmol) and obtained after flash chromatography (EtOAc/PE, 1:2) as a white solid (42 mg, 48% yield): <i>R</i><sub><i>f</i></sub> = 0.22 (EtOAc/PE, 1:2); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J</i> = 6.4 Hz, 1H), 8.03–7.98 (m, 2H), 7.62 (d, <i>J</i> = 8.2 Hz, 2H), 7.51–7.45 (m, 2H), 7.44–7.38 (m, 2H), 7.35 (dd, <i>J</i> = 7.9, 1.2 Hz, 2H), 7.29 (d, <i>J</i> = 7.2 Hz, 1H), 6.26 (br s, 1H), 5.20–5.06 (m, 1H), 3.90 (s, 3H), 3.45–3.36 (m, 1H), 3.29–3.18 (m, 1H), 2.62 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 197.7, 170.7, 144.5, 142.4, 139.4, 136.5, 134.4, 131.7, 130.0, 129.3, 129.1, 127.9, 127.5, 127.4, 127.2, 66.1, 65.9, 53.0, 31.3, 26.8; HRMS (ESI) calcd for C<sub>26</sub>H<sub>23</sub>ClNO<sub>4</sub>S (M + H<sup>+</sup>) 480.1031, found 480.1054.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>23</b> was prepared as described for <b>9</b> using methyl ester <b>23a</b> (42 mg, 86 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [2% AcOH]) and subsequent freeze-drying as a white solid (31 mg, 78% yield): <i>R</i><sub><i>f</i></sub> = 0.17 (EtOAc/PE, 1:1 [2% AcOH]); mp 202–208 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 5.0 Hz, 1H), 7.97 (d, <i>J</i> = 8.3 Hz, 2H), 7.55 (d, <i>J</i> = 7.9 Hz, 2H), 7.47–7.39 (m, 2H), 7.39–7.29 (m, 4H), 7.29–7.21 (m, 1H), 6.26 (br s, 1H), 5.26–5.11 (m, 1H), 3.48–3.31 (m, 2H), 2.62 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 197.8, 172.7, 172.0, 144.3, 142.7, 139.0, 136.6, 134.0, 131.6, 130.1, 129.4, 129.1, 128.0, 127.6, 127.4, 127.3, 66.5, 31.0, 26.8; HRMS (ESI) calcd for C<sub>25</sub>H<sub>20</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 488.0694, found 488.0695. HPLC: <i>t</i><sub>R</sub> = 12.18 min, 95.7%. [α]<sup>20</sup><sub>D</sub> +64° (<i>c</i> 0.4, DCM).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4′-cyanobiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>24</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>24a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (81 mg, 0.17 mmol) and (4-cyanophenyl)boronic acid (26 mg, 0.18 mmol) and obtained after flash chromatography (EtOAc/PE, 2:7) as a white viscous oil (31 mg, 41% yield): <i>R</i><sub><i>f</i></sub> = 0.27 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 6.4 Hz, 1H), 7.74–7.70 (m, 2H), 7.64–7.60 (m, 2H), 7.49–7.33 (m, 6H), 7.32–7.28 (m, 1H), 6.24 (br s, 1H), 5.24–5.06 (m, 1H), 3.91 (s, 3H), 3.47–3.37 (m, 1H), 3.29–3.16 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.6, 170.5, 144.5, 141.6, 139.4, 134.9, 132.8, 131.7, 130.0, 129.4, 128.0, 127.9, 127.5, 127.2, 118.8, 111.8, 66.0, 65.8, 53.0, 31.3; HRMS (ESI) calcd for C<sub>25</sub>H<sub>19</sub>ClN<sub>2</sub>NaO<sub>3</sub>S (M + Na<sup>+</sup>) 485.0697, found 485.0696.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>24</b> was prepared as described for <b>9</b> using methyl ester <b>24a</b> (31 mg, 67 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (21 mg, 69% yield): <i>R</i><sub><i>f</i></sub> = 0.15 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 6.0 Hz, 1H), 7.73–7.67 (m, 2H), 7.61–7.55 (m, 2H), 7.46–7.31 (m, 6H), 7.29–7.21 (m, 1H), 6.25 (br s, 1H), 5.24–5.14 (m, 1H), 3.47–3.39 (m, 1H), 3.39–3.31 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.7, 171.7, 144.3, 141.9, 138.9, 134.5, 132.8, 131.6, 130.1, 129.5, 128.1, 127.9, 127.6, 127.3, 118.7, 111.9, 66.4, 66.3, 31.0; HRMS (ESI) calcd for C<sub>24</sub>H<sub>17</sub>ClN<sub>2</sub>NaO<sub>3</sub>S (M + Na<sup>+</sup>) 471.0541, found 471.0554. HPLC: <i>t</i><sub>R</sub> = 12.30 min, 95.8%. [α]<sup>20</sup><sub>D</sub> +59° (<i>c</i> 0.5, DCM).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (2<i>R</i>,4<i>R</i>)-3-(2′-Chlorobiphenyl-4-carbonyl)-2-(2-chlorophenyl)thiazolidine-4-carboxylic Acid (<b>25</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>25a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (98 mg, 0.20 mmol) and (2-chlorophenyl)boronic acid (34 mg, 0.22 mmol) and obtained after flash chromatography (EtOAc/PE, 1:5) as a viscous oil (80 mg, 84% yield): <i>R</i><sub><i>f</i></sub> = 0.16 (EtOAc/PE, 1:5); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 6.9 Hz, 1H), 7.60–7.12 (m, 11H), 6.30 (br s, 1H), 5.21–5.07 (m, 1H), 3.90 (s, 3H), 3.44–3.33 (m, 1H), 3.29–3.19 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.8, 170.7, 141.9, 139.5, 139.3, 133.9, 132.4, 131.7, 131.2, 130.1, 129.9, 129.4, 129.2, 129.1, 127.9, 127.4, 127.0, 126.8, 65.9, 65.7, 52.9, 31.4; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>Cl<sub>2</sub>NO<sub>3</sub>S (M + H<sup>+</sup>) 472.0535, found 472.0576.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>25</b> was prepared as described for <b>9</b> using methyl ester <b>25a</b> (81 mg, 0.17 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (56 mg, 72% yield): <i>R</i><sub><i>f</i></sub> = 0.19 (EtOAc/PE, 1:2 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (br s, 1H), 8.08 (d, <i>J</i> = 5.4 Hz, 1H), 7.46–7.42 (m, 1H), 7.39–7.21 (m, 10H), 6.34 (br s, 1H), 5.31–5.16 (m, 1H), 3.66–3.29 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 172.2, 142.4, 139.4, 138.7, 133.5, 132.5, 131.7, 131.2, 130.2, 130.1, 129.6, 129.4, 129.2, 127.6, 127.3, 127.0, 126.9, 66.3, 66.0, 31.3; HRMS (ESI) calcd for C<sub>23</sub>H<sub>17</sub>Cl<sub>2</sub>NNaO<sub>3</sub>S (M + Na<sup>+</sup>) 480.0198, found 480.0186. HPLC: <i>t</i><sub>R</sub> = 13.33 min, 96.8%. [α]<sup>20</sup><sub>D</sub> +73° (<i>c</i> 1.0, MeOH).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(2′-methylbiphenyl-4-carbonyl)thiazolidine-4-carboxylic Acid (<b>26</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester or the title compound (<b>26a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (100 mg, 0.21 mmol) and <i>o</i>-tolylboronic acid (31 mg, 0.23 mmol) and obtained after flash chromatography (EtOAc/PE, 1:5) as a clear viscous oil (81 mg, 86% yield): <i>R</i><sub><i>f</i></sub> = 0.25 (EtOAc/PE, 1:5); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 7.3 Hz, 1H), 7.41–7.35 (m, 1H), 7.32–7.11 (m, 10H), 6.30 (br s, 1H), 5.14 (app s, 1H), 3.90 (s, 3H), 3.45–3.33 (m, 1H), 3.31–3.22 (m, 1H), 2.17 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.0, 170.7, 144.6, 140.8, 139.4, 135.3, 133.3, 131.6, 130.5, 129.8, 129.6, 129.2, 129.1, 127.9, 127.8, 127.4, 126.8, 125.9, 65.8, 65.7, 52.9, 31.5, 20.3; HRMS (ESI) calcd for C<sub>25</sub>H<sub>22</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 474.0901, found 474.0922.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>26</b> was prepared as described for <b>9</b> using methyl ester <b>26a</b> (81 mg, 0.18 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:3 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (54 mg, 54% yield): <i>R</i><sub><i>f</i></sub> = 0.24 (EtOAc/PE, 1:3 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (d, <i>J</i> = 7.2 Hz, 1H), 8.04 (br s, 1H), 7.56–6.99 (m, 11H), 6.34 (br s, 1H), 5.37–5.14 (m, 1H), 3.51–3.34 (m, 2H), 2.17 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.0, 171.3, 144.0, 139.8, 137.9, 134.3, 131.8, 130.6, 129.5, 128.9, 128.6, 128.4, 128.3, 126.9, 126.7, 126.6, 125.9, 125.0, 65.2, 64.9, 30.2, 19.4; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 460.0745, found 460.0738. HPLC: <i>t</i><sub>R</sub> = 13.53 min, 97.2%. [α]<sup>20</sup><sub>D</sub> +38° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-(5-methylthiophen-2-yl)benzoyl)thiazolidine-4-carboxylic Acid (<b>27</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>27a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (106 mg, 0.22 mmol) and 5-methylthiophene-2-boronic acid pinacol ester (51 mg, 0.23 mmol) and obtained after flash chromatography (EtOAc/PE, 1:5) as a red oil (78 mg, 78% yield): <i>R</i><sub><i>f</i></sub> = 0.20 (EtOAc/PE, 1:5); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 7.2 Hz, 1H), 7.43–7.35 (m, 5H), 7.32–7.28 (m, 2H), 7.11 (d, <i>J</i> = 3.5 Hz, 1H), 6.72–6.70 (m, 1H), 6.28 (br s, 1H), 5.17–5.04 (m, 1H), 3.88 (s, 3H), 3.41–3.33 (m, 1H), 3.25–3.16 (m, 1H), 2.48 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.7, 141.0, 140.6, 139.4, 137.2, 132.8, 131.7, 130.0, 129.2, 128.0, 127.8, 127.4, 126.6, 125.0, 124.2, 66.1, 65.9, 52.9, 31.2, 15.6; HRMS (ESI) calcd for C<sub>23</sub>H<sub>21</sub>ClNO<sub>3</sub>S<sub>2</sub> (M + H<sup>+</sup>) 458.0646, found 458.0640.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>27</b> was prepared as described for <b>9</b> using methyl ester <b>27a</b> (65 mg, 0.14 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (48 mg, 75% yield): <i>R</i><sub><i>f</i></sub> = 0.27 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (d, <i>J</i> = 5.9 Hz, 1H), 7.79 (br s, 1H), 7.44–7.33 (m, 4H), 7.30–7.22 (m, 3H), 7.11 (d, <i>J</i> = 3.6 Hz, 1H), 6.74–6.68 (m, 1H), 6.31 (br s, 1H), 5.24–5.11 (m, 1H), 3.47–3.30 (m, 2H), 2.49 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 172.1, 141.2, 140.5, 138.9, 137.7, 132.3, 131.6, 130.2, 129.4, 128.1, 127.6, 127.5, 126.6, 125.1, 124.4, 66.6, 66.2, 30.9, 15.6; HRMS (ESI) calcd for C<sub>22</sub>H<sub>18</sub>ClNNaO<sub>3</sub>S<sub>2</sub> (M + Na<sup>+</sup>) 466.0309, found 466.0296. HPLC: <i>t</i><sub>R</sub> = 13.43 min, 98.6%. [α]<sup>20</sup><sub>D</sub> +38° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-(phenylethynyl)benzoyl)thiazolidine-4-carboxylic Acid (<b>28</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>28a</b>) was prepared as described for <b>8a</b> using <b>7a</b> (111 mg, 0.43 mmol) and 4-(phenylethynyl)benzoyl chloride (113 mg, 0.47 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as a clear viscous oil (127 mg, 65% yield): <i>R</i><sub><i>f</i></sub> = 0.31 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (d, <i>J</i> = 7.0 Hz, 1H), 7.53–7.45 (m, 2H), 7.41–7.19 (m, 10H), 6.21 (br s, 1H), 5.10 (app s, 1H), 3.87 (s, 3H), 3.46–3.30 (m, 1H), 3.29–3.13 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.5, 170.4, 139.2, 134.2, 133.1, 131.7, 131.4, 129.9, 129.2, 128.7, 128.4, 127.7, 127.4, 127.1, 126.0, 122.7, 91.6, 88.5, 65.9, 65.7, 52.8, 31.2; HRMS (ESI) calcd for C<sub>26</sub>H<sub>21</sub>ClNO<sub>3</sub>S (M + H<sup>+</sup>) 462.0925, found 462.0938.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>28</b> was prepared as described for <b>9</b> using methyl ester <b>28a</b> (83 mg, 0.18 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (67 mg, 83% yield): <i>R</i><sub><i>f</i></sub> = 0.25 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 7.3 Hz, 1H), 8.04–7.93 (m, 1H), 7.52–7.47 (m, 2H), 7.42–7.32 (m, 7H), 7.29–7.23 (m, 2H), 6.24 (br s, 1H), 5.23–5.15 (m, 1H), 3.50–3.42 (m, 1H), 3.38–3.30 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.0, 171.6, 138.8, 133.7, 131.8, 131.6, 130.1, 129.4, 128.8, 128.5, 127.6, 127.5, 127.3, 126.5, 122.8, 91.9, 88.5, 66.3, 66.1, 31.0; HRMS (ESI) calcd for C<sub>25</sub>H<sub>18</sub>ClNNaO<sub>3</sub>S (M + Na<sup>+</sup>) 470.0588, found 470.0597. HPLC: <i>t</i><sub>R</sub> = 13.58 min, 98.7%. [α]<sup>20</sup><sub>D</sub> +61° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-((2-methoxyphenyl)ethynyl)benzoyl)thiazolidine-4-carboxylic Acid (<b>29</b>)</h3><div class="NLM_p"><i>Step 1:</i> To a predried vial charged with <b>8a</b> (72 mg, 0.15 mmol) and 1-ethynyl-2-methoxybenzene (26 mg, 0.19 mmol) was added THF (1.2 mL, anhydrous). The reaction mixture was purged with argon (×3), and to it were added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (6 mg, 9.0 μmol), CuI (4 mg, 22 μmol), and Et<sub>3</sub>N (81 μL, 0.58 mmol). The reaction was capped and stirred at rt for 4 h under argon, whereafter the mixture was concentrated in vacuo. The methyl ester <b>29a</b> was obtained after flash chromatography (EtOAc/PE, 1:3) as a white oil (55 mg, 76% yield): <i>R</i><sub><i>f</i></sub> = 0.17 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (d, <i>J</i> = 7.1 Hz, 1H), 7.46 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.44–7.34 (m, 4H), 7.34–7.23 (m, 4H), 6.97–6.84 (m, 2H), 6.21 (br s, 1H), 5.10 (app s, 1H), 3.89 (s, 6H), 3.43–3.34 (m, 1H), 3.27–3.18 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.7, 160.1, 139.4, 134.0, 133.8, 131.5, 130.3, 130.0, 129.3, 127.7, 127.4, 127.1, 126.5, 120.6, 112.0, 110.8, 92.6, 88.2, 66.1, 65.9, 55.9, 53.0, 31.2; HRMS (ESI) calcd for C<sub>27</sub>H<sub>22</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 514.0850, found 514.0766.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>29</b> was prepared as described for <b>9</b> using methyl ester <b>29a</b> (55 mg, 0.11 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (39 mg, 72% yield): <i>R</i><sub><i>f</i></sub> = 0.23 (EtOAc/PE, 1:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (d, <i>J</i> = 6.6 Hz, 1H), 7.50–7.21 (m, 9H), 6.98–6.86 (m, 2H), 6.25 (br s, 1H), 5.25–5.08 (m, 1H), 3.90 (s, 3H), 3.47–3.40 (m, 1H), 3.40–3.33 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.8, 171.9, 160.2, 138.8, 133.8, 133.5, 131.6, 130.4, 130.2, 129.5, 128.0, 127.6, 127.5, 127.2, 126.9, 120.7, 112.0, 110.9, 92.5, 88.5, 66.4, 66.1, 56.0, 30.9; HRMS (ESI) calcd for C<sub>26</sub>H<sub>20</sub>ClNNaO<sub>4</sub>S (M + Na<sup>+</sup>) 500.0694, found 500.0714. HPLC: <i>t</i><sub>R</sub> = 13.23 min, 96.2%. [α]<sup>20</sup><sub>D</sub> +68° (<i>c</i> 1.0, DCM).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzoyl)thiazolidine-4-carboxylic Acid (<b>30</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>30a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (93 mg, 0.19 mmol) and 1-methyl-1<i>H</i>-pyrazole-5-boronic acid pinacol ester (41 mg, 0.19 mmol) and obtained after flash chromatography (EtOAc/PE, 1:1) as a clear viscous oil (17 mg, 20% yield): <i>R</i><sub><i>f</i></sub> = 0.17 (EtOAc/PE, 1:1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 6.7 Hz, 1H), 7.48 (d, <i>J</i> = 1.8 Hz, 1H), 7.43–7.21 (m, 7H), 6.28 (d, <i>J</i> = 1.5 Hz, 1H), 6.24 (br s, 1H), 5.18–5.06 (m, 1H), 3.90 (s, 3H), 3.82 (s, 3H), 3.46–3.37 (m, 1H), 3.30–3.20 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.6, 170.4, 142.5, 139.2, 138.7, 134.8, 133.1, 131.6, 130.0, 129.4, 128.6, 128.0, 127.54, 127.45, 106.5, 65.9, 65.6, 53.0, 37.6, 31.4; HRMS (ESI) calcd for C<sub>22</sub>H<sub>21</sub>ClN<sub>3</sub>O<sub>3</sub>S (M + H<sup>+</sup>) 442.0987, found 442.1007.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>30</b> was prepared as described for <b>9</b> using methyl ester <b>30a</b> (17 mg, 39 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (12 mg, 71% yield): <i>R</i><sub><i>f</i></sub> = 0.14 (EtOAc [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.28 (d, <i>J</i> = 7.2 Hz, 1H), 7.55 (d, <i>J</i> = 1.9 Hz, 1H), 7.40–7.21 (m, 7H), 6.29 (d, <i>J</i> = 1.2 Hz, 1H), 6.25 (br s, 1H), 5.26–5.15 (m, 1H), 3.84 (s, 3H), 3.52–3.43 (m, 1H), 3.42–3.32 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.4, 171.1, 142.8, 139.1, 138.5, 134.9, 132.9, 131.5, 129.9, 129.4, 128.7, 128.0, 127.6, 125.4, 106.6, 66.2, 66.1, 37.4, 31.4; HRMS (ESI) calcd for C<sub>21</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub>S (M + H<sup>+</sup>) 428.0830, found 428.0836. HPLC: <i>t</i><sub>R</sub> = 10.84 min, 98.1%. [α]<sup>20</sup><sub>D</sub> +31° (<i>c</i> 0.2, DCM).</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)thiazolidine-4-carboxylic Acid (<b>31</b>)</h3><div class="NLM_p"><i>Step 2:</i> The methyl ester of the title compound (<b>31a</b>) was prepared as described for <b>19a</b> using <b>8a</b> (106 mg, 0.22 mmol) and 3,5-dimethylisoxazole-4-boronic acid pinacol ester (51 mg, 0.23 mmol) and obtained after flash chromatography (EtOAc/PE, 1:3) as white needles (63 mg, 63% yield): <i>R</i><sub><i>f</i></sub> = 0.14 (EtOAc/PE, 1:3); mp 146–148 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 6.9 Hz, 1H), 7.44–7.36 (m, 1H), 7.36–7.22 (m, 4H), 7.19–7.01 (m, 2H), 6.25 (br s, 1H), 5.20–5.08 (m, 1H), 3.91 (s, 3H), 3.48–3.38 (m, 1H), 3.33–3.22 (m, 1H), 2.35 (s, 3H), 2.21 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.6, 165.7, 158.4, 139.2, 134.0, 133.1, 131.5, 129.8, 129.3, 128.9, 128.0, 127.5, 115.9, 65.8, 65.5, 52.9, 31.5, 11.6, 10.7; HRMS (ESI) calcd for C<sub>23</sub>H<sub>21</sub>ClN<sub>2</sub>NaO<sub>4</sub>S (M + Na<sup>+</sup>) 479.0803, found 479.0812.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>31</b> was prepared as described for <b>9</b> using methyl ester <b>31a</b> (61 mg, 0.13 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:2 → EtOAc [2% AcOH]) and subsequent freeze-drying gave <b>31</b> as a powder (25 mg, 42% yield): <i>R</i><sub><i>f</i></sub> = 0.21 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ 8.35 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.42–7.34 (m, 3H), 7.33–7.29 (m, 1H), 7.29–7.26 (m, 3H), 6.41 (s, 1H), 5.02 (t, <i>J</i> = 6.5 Hz, 1H), 3.62 (dd, <i>J</i> = 12.0, 6.6 Hz, 1H), 3.30 (dd, <i>J</i> = 12.1, 6.4 Hz, 1H), 2.35 (s, 3H), 2.17 (s, 3H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ 170.5, 168.9, 164.8, 157.3, 138.2, 134.6, 131.3, 130.6, 128.62, 128.55, 128.1, 127.7, 126.7, 126.3, 114.9, 64.9, 63.9, 32.1, 10.5, 9.5; HRMS (ESI) calcd for C<sub>22</sub>H<sub>19</sub>ClN<sub>2</sub>NaO<sub>4</sub>S (M + Na<sup>+</sup>) 465.0646, found 465.0627. HPLC: <i>t</i><sub>R</sub> = 11.65 min, 98.3%. [α]<sup>20</sup><sub>D</sub> +72° (<i>c</i> 0.5, MeOH).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (2<i>R</i>,4<i>R</i>)-2-(2-Chlorophenyl)-3-(4-(5-cyclopropyl-3-phenylisoxazol-4-yl)benzoyl)thiazolidine-4-carboxylic Acid (<b>32</b>)</h3><div class="NLM_p"><i>Step 1: Methyl (2R,4R)-2-(2-Chlorophenyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl)thiazolidine-4-carboxylate.</i> In a vial, a mixture of <b>8a</b> (120 mg, 0.25 mmol), bis(pinacolato)diboron (69 mg, 0.27 mmol), and potassium acetate (61 mg, 0.62 mmol) in DMF (0.35 mL) was purged with argon (×5), followed by the addition of 1,1′-bis(phenylphosphino)ferrocene palladium dichloride (9.0 mg, 12.30 μmol), and the mixture was again purged with argon (×5). The reaction was capped and stirred at 50 °C under argon until consumption of starting material (20 h). The reaction was treated with water and extracted with EtOAc (×5), washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>.</div><div class="NLM_p"><i>Step 2: 5-Cyclopropyl-4-iodo-3-phenylisoxazole.</i> To (<i>Z</i>)-3-cyclopropyl-1-phenylprop-2-yn-1-one <i>O</i>-methyl oxime (69 mg, 0.35 mmol) dissolved in dry DCM (3.5 mL) was added IBr (143 mg, 0.69 mmol), and the reaction was stirred at rt until consumption of starting material. The reaction mixture was washed with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, extracted with DCM (×5), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude 5-cyclopropyl-4-iodo-3-phenylisoxazole was filtered through a plug of silica using PE (1% EtOAc) and used without further purification in the next step.</div><div class="NLM_p"><i>Step 3: Methyl (2R,4R)-2-(2-Chlorophenyl)-3-(4-(5-cyclopropyl-3-phenylisoxazol-4-yl)benzoyl)thiazolidine-4-carboxylate (<b>32a</b>).</i> In a vial, to crude boronate from step 1 (100 mg) were added crude 5-cyclopropyl-4-iodo-3-phenylisoxazole (55 mg, 0.18 mmol) and XPhos Pd G4 precatalyst (3.8 mg, 4.4 μmol). The vial was capped and purged with argon (×5). Reactants were dissolved in THF (0.41 mL, degassed), after which K<sub>3</sub>PO<sub>4</sub> (0.82 mL, 0.5 M, degassed) was added and the reaction was stirred at 80 °C for 5 h under argon. The reaction was treated with water and extracted with EtOAc (×5), washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The title compound was obtained after flash chromatography (EtOAc/PE, 1:3) as a cloudy viscous oil (25 mg, 26% yield): <i>R</i><sub><i>f</i></sub> = 0.20 (EtOAc/PE, 1:3); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.34 (d, <i>J</i> = 7.3 Hz, 1H), 7.41–7.28 (m, 8H), 7.27–7.22 (m, 2H), 7.17–7.06 (m, 2H), 6.23 (s, 1H), 5.17–5.03 (m, 1H), 3.90 (s, 3H), 3.41 (dd, <i>J</i> = 6.4, 12.1 Hz, 1H), 3.29–3.19 (m, 1H), 1.98–1.89 (m, 1H), 1.20–1.12 (m, 2H), 1.06–0.97 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.9, 170.6, 161.2, 139.4, 134.1, 133.3, 131.5, 129.9, 129.9, 129.6, 129.3, 128.8, 128.7, 128.5, 127.9, 127.5, 127.4, 114.4, 65.9, 65.8, 53.0, 31.4, 8.4, 7.8; HRMS (ESI) calcd for C<sub>30</sub>H<sub>25</sub>ClN<sub>2</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 545.1296, found 545.1309.</div><div class="NLM_p last"><i>Step 4:</i> The title compound <b>32</b> was prepared as described for <b>9</b> using methyl ester <b>32a</b> (27 mg, 49 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (19 mg, 75% yield): <i>R</i><sub><i>f</i></sub> = 0.17 (EtOAc/PE, 1:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (d, <i>J</i> = 6.8 Hz, 1H), 7.40–7.27 (m, 8H), 7.25–7.19 (m, 2H), 7.18–7.09 (m, 2H), 6.27 (s, 1H), 5.25–5.12 (m, 1H), 3.52–3.32 (m, 2H), 1.99–1.87 (m, 1H), 1.20–1.14 (m, 2H), 1.05–0.99 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.7, 172.0, 171.0, 161.2, 138.9, 133.6, 131.5, 130.01, 129.95, 129.7, 129.5, 128.7, 128.5, 127.6, 127.4, 114.3, 66.3, 66.0, 31.2, 8.5, 7.8; HRMS (ESI) calcd for C<sub>29</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>4</sub>S (M + Na<sup>+</sup>) 553.0959, found 553.0965. HPLC: <i>t</i><sub>R</sub> = 13.58 min, 98.8%.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (2<i>R</i>,4<i>R</i>)-3-(4-(3,5-Dimethylisoxazol-4-yl)benzoyl)-2-phenylthiazolidine-4-carboxylic Acid (<b>33</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>33a</b>) was prepared as described for <b>8a</b> using <b>7g</b> (55 mg, 0.25 mmol) and 4-(3,5-dimethylisoxazol-4-yl)benzoyl chloride (64 mg, 0.27 mmol) and obtained after flash chromatography (EtOAc/PE, 2:5) as a clear viscous oil (30 mg, 29% yield): <i>R</i><sub><i>f</i></sub> = 0.22 (EtOAc/PE, 1:1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.65–7.54 (m, 2H), 7.45–7.36 (m, 2H), 7.36–7.30 (m, 2H), 7.30–7.24 (m, 1H), 7.19–7.05 (m, 2H), 6.09 (br s, 1H), 5.19 (app s, 1H), 3.86 (s, 3H), 3.50–3.23 (m, 2H), 2.36 (s, 3H), 2.22 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.5, 170.4, 165.7, 158.5, 141.2, 134.7, 133.1, 128.9, 128.6, 128.1, 127.8, 126.9, 116.0, 68.3, 65.2, 52.9, 32.4, 11.7, 10.9; HRMS (ESI) calcd for C<sub>23</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 423.1373, found 423.1381.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>33</b> was prepared as described for <b>9</b> using methyl ester <b>33a</b> (30 mg, 71 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 1:1 [2% AcOH]) and subsequent freeze-drying as a white amorphous powder (18 mg, 61% yield): <i>R</i><sub><i>f</i></sub> = 0.14 (EtOAc/PE, 1:1 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56–7.34 (m, 4H), 7.33–7.20 (m, 3H), 7.19–7.08 (m, 2H), 6.12 (br s, 1H), 5.24 (app s, 1H), 3.50–3.37 (m, 2H), 2.36 (s, 3H), 2.22 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.7, 171.9, 165.8, 158.5, 140.5, 134.1, 133.5, 129.0, 128.8, 128.3, 127.8, 126.7, 116.0, 68.9, 65.3, 31.7, 11.7, 10.9; HRMS (ESI) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 409.1217, found 409.1228. HPLC: <i>t</i><sub>R</sub> = 10.98 min, 99.9%. [α]<sup>20</sup><sub>D</sub> +44° (<i>c</i> 0.3, DCM).</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (2<i>R</i>,4<i>R</i>)-3-(4-(3,5-Dimethylisoxazol-4-yl)benzoyl)-2-(2-ethynylphenyl)thiazolidine-4-carboxylic Acid (<b>34</b>)</h3><div class="NLM_p"><i>Step 1: Methyl (4R)-2-(2-Ethynylphenyl)thiazolidine-4-carboxylate (<b>7h</b>).</i> The thiazolidine was prepared as described for <b>7a</b> using <span class="smallcaps smallerCapital">l</span>-cysteine methyl ester hydrochloride (352 mg, 2.05 mmol) and 2-ethynylbenzaldehyde (315 mg, 2.42 mmol). The crude was filtered through silica (EtOAc/PE, 1:3) and concentrated in vacuo to give the crude <b>7h</b>, which was used in the next step without further purification.</div><div class="NLM_p"><i>Step 2: Methyl (2R,4R)-3-(4-(3,5-Dimethylisoxazol-4-yl)benzoyl)-2-(2-ethynylphenyl)thiazolidine-4-carboxylate (<b>34a</b>).</i> Using crude <b>7h</b> (69 mg) and 4-(3,5-dimethylisoxazol-4-yl)benzoyl chloride (72 mg, 0.31 mmol), the title compound was prepared as described for <b>8a</b> and obtained after flash chromatography (EtOAc/PE, 1:2) as a clear oil (26 mg, 21% yield): <i>R</i><sub><i>f</i></sub> = 0.26 (EtOAc/PE, 1:1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (d, <i>J</i> = 7.8 Hz, 1H), 7.48–7.43 (m, 1H), 7.40 (d, <i>J</i> = 7.3 Hz, 1H), 7.36–7.20 (m, 3H), 7.17–6.98 (m, 2H), 6.38 (br s, 1H), 5.21–5.04 (m, 1H), 3.90 (s, 3H), 3.46–3.39 (m, 1H), 3.31 (s, 1H), 3.36–3.22 (m, 1H), 2.34 (s, 3H), 2.20 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.7, 170.5, 165.7, 158.5, 144.4, 134.3, 133.1, 132.9, 129.6, 128.9, 127.9, 127.6, 126.4, 119.5, 116.1, 84.9, 80.6, 66.4, 65.7, 52.9, 31.8, 11.6, 10.8; HRMS (ESI) calcd for C<sub>25</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 447.1373, found 447.1391.</div><div class="NLM_p last"><i>Step 3:</i> The title compound <b>34</b> was prepared as described for <b>9</b> using methyl ester <b>34a</b> (27 mg, 60 μmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 2:1 [1% AcOH]) and subsequent freeze-drying as a brownish amorphous powder (18 mg, 70% yield): <i>R</i><sub><i>f</i></sub> = 0.16 (EtOAc/PE, 3:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.59 (br s, 1H), 8.03 (d, <i>J</i> = 6.6 Hz, 1H), 7.48–7.36 (m, 2H), 7.36–7.20 (m, 3H), 7.17–7.03 (m, 2H), 6.43 (br s, 1H), 5.27–5.19 (m, 1H), 3.53–3.41 (m, 2H), 3.30 (s, 1H), 2.35 (s, 3H), 2.21 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.5, 171.8, 165.8, 158.5, 143.7, 133.8, 133.3, 133.2, 129.8, 129.1, 128.0, 127.6, 126.1, 119.5, 116.1, 85.0, 80.5, 66.9, 65.9, 31.5, 11.6, 10.8; HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>N<sub>2</sub>NaO<sub>4</sub>S (M + Na<sup>+</sup>) 455.1036, found 455.1058. HPLC: <i>t</i><sub>R</sub> = 11.25 min, 99.0%. [α]<sup>20</sup><sub>D</sub> +84° (<i>c</i> 0.2, DCM).</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (2<i>R</i>,4<i>R</i>)-3-(4-(3,5-Dimethylisoxazol-4-yl)benzoyl)-2-(2-methoxyphenyl)thiazolidine-4-carboxylic Acid (<b>35</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>35a</b>) was prepared as described for <b>8a</b> using <b>7f</b> (69 mg, 0.27 mmol) and 4-(3,5-dimethylisoxazol-4-yl)benzoyl chloride (71 mg, 0.30 mmol) and obtained after flash chromatography (EtOAc/PE, 1:2) as a clear oil (91 mg, 74% yield): <i>R</i><sub><i>f</i></sub> = 0.26 (EtOAc/PE, 1:1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18 (d, <i>J</i> = 6.0 Hz, 1H), 7.47–7.33 (m, 2H), 7.34–7.26 (m, 1H), 7.18–7.02 (m, 3H), 6.84 (d, <i>J</i> = 8.1 Hz, 1H), 6.26 (br s, 1H), 5.17–5.07 (m, 1H), 3.89 (br s, 3H), 3.73 (br s, 3H), 3.44–3.32 (m, 1H), 3.29–3.18 (m, 1H), 2.35 (s, 3H), 2.21 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.6, 170.5, 165.5, 158.3, 155.2, 134.3, 132.9, 130.5, 129.2, 128.6, 127.8, 126.9, 120.9, 115.9, 110.6, 65.6, 63.1, 55.5, 52.7, 31.5, 11.6, 10.7; HRMS (ESI) calcd for C<sub>24</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub>S (M + H<sup>+</sup>) 453.1479, found 453.1459.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>35</b> was prepared as described for <b>9</b> using methyl ester <b>35a</b> (91 mg, 0.20 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc/PE, 3:1 [1% AcOH]) and subsequent freeze-drying as a white amorphous powder (41 mg, 46% yield): <i>R</i><sub><i>f</i></sub> = 0.12 (EtOAc/PE, 3:1 [1% AcOH]); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.28 (br s, 1H), 8.11 (d, <i>J</i> = 4.8 Hz, 1H), 7.69–7.39 (m, 1H), 7.36–7.16 (m, 4H), 7.08–6.87 (m, 2H), 6.18 (br s, 1H), 4.98–4.88 (m, 1H), 3.91–3.73 (m, 1H), 3.62 (s, 3H), 3.33–3.05 (m, 1H), 2.36 (s, 3H), 2.18 (s, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 169.3, 165.5, 157.9, 155.0, 134.5, 131.7, 129.8, 128.9, 128.3, 126.9, 126.6, 120.3, 115.2, 110.8, 64.9, 61.7, 55.5, 31.3, 11.2, 10.3; HRMS (ESI) calcd for C<sub>23</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub>S (M + H<sup>+</sup>) 439.1322, found 439.1318. HPLC: <i>t</i><sub>R</sub> = 11.11 min, 96.4%. [α]<sup>20</sup><sub>D</sub> +89° (<i>c</i> 1.0, MeOH).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (2<i>R</i>,4<i>R</i>)-3-(4-(3,5-Dimethylisoxazol-4-yl)benzoyl)-2-(pyridin-2-yl)thiazolidine-4-carboxylic Acid (<b>36</b>)</h3><div class="NLM_p"><i>Step 1:</i> The methyl ester of the title compound (<b>36a</b>) was prepared as described for <b>8a</b> using <b>7e</b> (70.0 mg, 0.31 mmol) and 4-(3,5-dimethylisoxazol-4-yl)benzoyl chloride (77 mg, 0.33 mmol) and obtained after flash chromatography (EtOAc/PE, 2:1) as a brownish viscous oil (95 mg, 73% yield): <i>R</i><sub><i>f</i></sub> = 0.21 (DCM [4% MeOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55–8.37 (m, 1H), 8.16–8.00 (m, 1H), 7.83–7.64 (m, 1H), 7.57–6.74 (m, 5H), 6.41* (br s, 1H<sup>1</sup>), 6.07 (app m, 1H<sup>1</sup>), 5.63–5.52* (m, 1H<sup>2</sup>), 5.35–4.94 (m, 1H<sup>2</sup>), 3.82 (br s, 3H<sup>3</sup>), 3.64* (s, 3H<sup>3</sup>), 3.52–3.16 (m, 2H), 2.31 (s, 3H), 2.17 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.6, 170.4, 165.6, 158.3, 149.6, 149.4, 137.1, 134.3, 133.1, 128.9, 127.6, 122.7, 120.6, 115.8, 69.4, 65.0, 52.9, 52.8, 31.8, 11.6, 10.7; HRMS (ESI) calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 424.1326, found 424.1317.</div><div class="NLM_p last"><i>Step 2:</i> The title compound <b>36</b> was prepared as described for <b>9</b> using methyl ester <b>36a</b> (51 mg, 0.12 mmol) and LiI (4 equiv) and obtained after flash chromatography (EtOAc [5% AcOH]) and subsequent freeze-drying as a brownish amorphous powder (32 mg, 65% yield): <i>R</i><sub><i>f</i></sub> = 0.15 (EtOAc [5% AcOH]); <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.61–8.30 (m, 2H), 7.99–7.68 (m, 2H), 7.46–7.11 (m, 4H), 6.54* (s, 1H), 6.11 (br s, 1H), 5.08 (app s, 1H), 4.86* (app s, 1H), 3.66–3.35 (m, 2H), 2.46–2.33 (m, 3H), 2.29–2.14 (m, 3H); <sup>13</sup>C NMR (101 MHz, MeOH-<i>d</i><sub>4</sub>) δ 176.0, 172.4, 167.4, 161.7, 160.8, 159.8, 149.2, 148.4, 139.7, 137.0, 136.5, 133.8, 130.2, 128.9, 128.4, 124.4, 123.6, 117.2, 70.3, 69.1, 36.5, 33.5, 11.4, 10.6; HRMS (ESI) calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>S (M + H<sup>+</sup>) 410.1169, found 410.1153. HPLC: <i>t</i><sub>R</sub> = 8.86 min, 97.9%. [α]<sup>20</sup><sub>D</sub> +116° (<i>c</i> 0.5, DCM).</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Synthesis of (2<i>S</i>,5<i>R</i>)-5-(2-Chlorophenyl)-1-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)pyrrolidine-2-carboxylic Acid (<b>37</b>)</h3><div class="NLM_p"><i>Step 1: Methyl (2S,5R)-5-(2-Chlorophenyl)-1-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)pyrrolidine-2-carboxylate (<b>37a</b>).</i> In a predried vial, to a suspension of 4-(3,5-dimethylisoxazol-4-yl)benzoic acid (24 mg, 0.11 mmol; see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Supporting Information</a>) and BTFFH (40 mg, 0.13 mmol) in dry DCM (110 μL) under argon was added DIPEA (65 μL, 0.38 mmol), and the reaction was stirred for 2 h at rt. To the in situ generated acid fluoride was added <b>6</b> (20 mg, 83 μmol) dissolved in dry DCM (100 μL). The vial was sealed, and the reaction was heated to 80 °C and stirred overnight. The reaction mixture was cooled to rt, water was added, the aqueous phase was extracted with EtOAc (×5), and the combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to obtain <b>37</b> after flash chromatography (EtOAc/PE, 1:2) as a clear viscous oil (32 mg, 86%): <i>R</i><sub><i>f</i></sub> = 0.14 (EtOAc/PE, 1:2); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 7.7 Hz, 1H), 8.16–8.08 (m, 1H)*, 7.65–7.54 (m, 2H)*, 7.34–7.24 (m, 3H), 7.19–7.09 (m, 2H), 7.02 (d, <i>J</i> = 7.9 Hz, 2H), 5.69–5.57 (m, 1H)*, 5.41–5.31 (m, 1H), 4.81 (t, <i>J</i> = 7.2 Hz, 1H), 4.58–4.50 (m, 1H)*, 3.89 (s, 3H), 3.71 (s, 3H)*, 2.47–2.35 (m, 2H), 2.32 (s, 3H), 2.18 (s, 3H), 2.17–2.09 (m, 1H), 2.03–1.95 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 170.7, 165.6, 158.6, 140.4, 135.0, 132.2, 131.7, 129.2, 128.7, 128.6, 127.6, 127.3, 116.2, 61.6, 61.2, 52.5, 34.4, 27.6, 11.5, 10.7; HRMS (ESI) calcd for C<sub>24</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub> (M + H<sup>+</sup>), 439.1419; found, 439.1420.</div><div class="NLM_p last"><i>Step 2: (2S,5R)-5-(2-Chlorophenyl)-1-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)pyrrolidine-2-carboxylic Acid (<b>37</b>)</i>. Ester <b>37a</b> (16 mg, 37 μmol) was dissolved in freshly distilled THF (0.4 mL), LiOH<sub>aq</sub> (0.12 mL, 0.6 M) was added, and the reaction was run at rt until full conversion of starting material as indicated by HPLC. The reaction mixture was quenched with HCl (1 M) until pH 2, diluted with water, extracted with EtOAc (×5), and the organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give the title compound <b>37</b> as a cloudy viscous oil (15 mg, 93% yield): <i>R</i><sub><i>f</i></sub> = 0.23 (EtOAc/PE, 1:2 [2% AcOH]); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.73–7.59 (m, 1H), 7.33–7.21 (m, 3H), 7.17–7.03 (m, 4H), 5.43 (t, <i>J</i> = 6.2 Hz, 1H), 4.97 (t, <i>J</i> = 6.5 Hz, 1H), 2.53–2.25 (m, 3H), 2.32 (s, 3H), 2.19 (s, 3H), 2.04–1.97 (m, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.9, 172.8, 165.7, 158.6, 139.5, 134.0, 132.9, 131.8, 129.4, 128.9, 128.1, 127.9, 127.3, 116.1, 62.6, 62.3, 34.2, 26.6, 11.6, 10.7; HRMS (ESI) calcd for C<sub>23</sub>H<sub>21</sub>ClN<sub>2</sub>NaO<sub>4</sub> (M + Na<sup>+</sup>) 447.1082, found 447.1066. HPLC: <i>t</i><sub>R</sub> = 11.32 min, 99.8%. [α]<sup>20</sup><sub>D</sub> −33° (<i>c</i> 0.4, DCM).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Crystallography</h3><div class="NLM_p last">Data for <b>14</b> were collected at 100(1) K on a Synergy, Dualflex, AtlasS2 diffractometer using Cu Kα radiation (λ = 1.541 84 Å) and the CrysAlis PRO 1.171.39.12b suite.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Using SHELXLE,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> the structure was solved by dual space methods (SHELXT<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a>) and refined on <i>F</i><sup>2</sup> using all the reflections (SHELXL-2016<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a>). All the non-hydrogen atoms were refined using anisotropic atomic displacement parameters. Hydrogen atoms were inserted at calculated positions using a riding model except for the H1 of the carboxylate group, which was located in the difference map and its coordinates were refined. The absolute configuration was unambiguously established from the crystallographic data. Parameters for data collection and refinement are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Molecular Modeling</h3><div class="NLM_p last">A homology model of hFFA2 in complex with <b>1</b> was obtained as described previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The model was based on a crystal structure of hFFA1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PHU">4PHU</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> As <b>31</b> fully displaces [<sup>3</sup>H]-<b>1</b> at increasing concentrations in a radioligand binding assay (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), the compound was docked into the binding site defined by <b>1</b>. Prior to docking, <b>31</b> was prepared (LigPrep, version 2.7, Schrödinger, LLC) using the OPLS-2005 force field.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Ionization states were generated using Epik at pH 7.0 ± 2.0 (Epik, version 2.5, Schrödinger, LLC). Induced-fit docking was performed using the IFD 2006 protocol (Glide version 5.9, Schrödinger, LLC; Prime version 3.2, Schrödinger, LLC). Ligand conformational sampling was executed using default settings; initial Glide docking was performed using standard settings; the maximum number of poses of <b>31</b> was restricted to 20. Redocking was executed for <b>31</b>-hFFA2 complexes within 30 kcal/mol of the lowest energy ligand–protein complex. Residues were refined within 5 Å of bound <b>31</b>.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> In Vitro Assays. β-Arrestin-2 Interaction Assay</h3><div class="NLM_p last">HEK293T cells were maintained in Dulbecco’s modification of Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 1× penicillin/streptomycin mixture (Sigma) at 37 °C and 5% CO<sub>2</sub>. Cells were grown to 60% density and co-transfected at a 4:1 ratio with plasmids encoding an eYFP-tagged form of the receptor construct of interest and a β-arrestin-2 fused to Renilla luciferase using a polyethyleneimine-based transfection protocol.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Cells were transferred into white 96-well plates at 24 h post-transfection and incubated for 24 h at 37 °C. Immediately prior to conducting the assay, cells were washed, and the culture medium was replaced with Hanks’ balanced salt solution. To quantify β-arrestin-2 recruitment to the receptor induced by FFA2 agonists, the Renilla luciferase substrate coelenterazine h (Nanolight Tech, Pinetop, CA) was added to a final concentration of 2.5 μM, and cells were incubated for 5 min at 37 °C. Next, varying concentrations of agonist were added, and cells were incubated for an additional 10 min at 37 °C. BRET resulting from receptor-β-arrestin-2 interaction was assessed by measuring the ratio of luminescence at 535 and 475 nm using a PHERAstar FS plate reader fitted with the BRET1 optic module (BMG Labtech, Aylesbury, U.K.). pEC<sub>50</sub> values were determined with at least three independent replicates.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> cAMP Assay</h3><div class="NLM_p last">All cAMP experiments were performed using Flp-In T-REx 293 cells modified to express receptors of interest in an inducible manner, which were maintained in DMEM without sodium pyruvate supplemented with 10% fetal bovine serum, 1× penicillin/streptomycin mixture, 5 μg/mL blasticidin, and 200 μg/mL hygromycin B.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Experiments were carried out using a homogeneous time-resolved FRET-based detection kit (Cis-Bio Bioassays, Codolet, France) in accordance with the manufacturer’s protocol. Cells were plated at 2000 cells/well in low-volume white 384-well plates. The ability of compounds to inhibit 1 μM forskolin-induced cAMP production was quantified following a 30 min incubation of agonist compounds with cells, which were induced to express receptors of interest by a 16 h treatment with 100 ng/mL doxycycline. pEC<sub>50</sub> values were determined with at least three independent replicates.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Radioligand Binding Assay</h3><div class="NLM_p last">Radioligand competition binding experiments were performed as established previously.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The radioligand [<sup>3</sup>H]-<b>1</b> at approximately <i>K</i><sub>d</sub> concentration was incubated with varying concentrations of unlabeled compounds and 5 μg of purified membranes isolated from Flp-In T-REx cells induced to express the receptor construct of interest. Nonspecific binding of the radioligand was determined in the presence of 10 μM CATPB.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> After a 2 h incubation at 25 °C, bound [<sup>3</sup>H]-<b>1</b> and free [<sup>3</sup>H]-<b>1</b> were separated by rapid vacuum filtration and radioactivity was quantified by liquid scintillation spectrometry. To determine the affinity of unlabeled ligands in terms of <i>K</i><sub>i</sub> values, competition binding curves were fit to an inverse three-parameter sigmoidal one-site <i>K</i><sub>i</sub> value fit with radioligand affinity and concentration as constraints. <i>K</i><sub>i</sub> values were determined with <i>n</i> = 6 independent experiments for <b>31</b> and with <i>n</i> = 3 for all other compounds.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Isolation of Human Neutrophils and Migration Assay</h3><div class="NLM_p last">Neutrophils were isolated from human whole blood as described previously.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> After isolation, neutrophils were immediately resuspended in RPMI 1640 containing 0.5% fatty acid-free bovine serum albumin. Test compounds were prepared at the indicated concentrations in the same buffer and added at the bottom of a 96-well plate (Sigma-Aldrich). Inserts were then mounted to the plate, and neutrophils were added (3000 cells/μL). Cells were incubated at 37 °C for 1.5 h, and migrated cells were then collected and ATP content was assessed using ATPlite luminescence assay system (PerkinElmer) according to the manufacturer’s instructions. Each experiment was performed with <i>n</i> = 4–6 independent replicates.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Derivation of Primary Mouse Adipocytes and Lipolysis Assay</h3><div class="NLM_p last">Epididymal fat was collected from male mice, and isolation of preadipocytes was obtained as described previously.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Animals were cared for in accordance with national guidelines on animal experimentation. Preadipocytes were subsequently differentiated in DMEM medium (DMEM, 10% fetal bovine serum, 4 mM glutamine, 10 mM HEPES, 10 μg/mL insulin, 25 μg/mL sodium ascorbate, 10 μM rosiglitazone) for 8 days. After this, mature adipocytes were challenged with test compounds and glycerol production was quantified as previously reported.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Each experiment was performed with <i>n</i> = 3–4 independent replicates.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Chemical Stability</h3><div class="NLM_p last">A 10 mM stock solution of <b>31</b> in DMSO was diluted in phosphate buffer (10 mM, pH = 7.4) obtaining 1.2 mL of 50 μM compound solution in phosphate buffer. The sample was shaken (650 rpm) at 37 °C, and samples were taken out at different time intervals during the 3-week experiment. The study was performed in duplicate, each parallel and with double injection. The stability was calculated based on peak area of the 0 point sample.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Stability in Simulated Gastric and Intestinal Fluids</h3><div class="NLM_p last">FaSSIF and FaSSGF were prepared in accordance with the manufacturer’s procedure. A 50 μM solution of <b>31</b> was prepared from FaSSIF/FaSSGF and a 10 mM stock solution of <b>31</b> in DMSO, and the samples were incubated in a thermomixer (37 °C, 650 rpm) for 0 and 120 min. Afterward, the samples were quenched with acetonitrile (+0.5% HCOOH), centrifuged for 10 min at 10 000 rpm and the supernatant was analyzed by HPLC. The stability was calculated based on peak area of the 0 point sample. The study was performed in duplicate. Average values are reported.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Microsomal Stability</h3><div class="NLM_p last">Microsomal stability was studied in mouse liver microsomes (0.5 mg/mL) at a final test compound concentration of 1 μM, essentially as previously described.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In brief, prewarmed (37 °C) 0.1 M PBS<sub>7.4</sub> was added to 10 mM NADPH in PBS and test compound <b>31</b> (1 mM in DMSO). The samples were incubated for 5 min at 37 °C before addition of newly thawn microsomes. The samples were mixed by gentle vortexing and incubated for 1 h at 37 °C, 300 rpm in a thermomixer. Samples were quenched by addition of ice-cold MeOH/MeCN (1:1) and centrifuged for 5 min at 10 000<i>g</i>. The supernantant was transferred to HPLC vials and stored in the freezer until analysis by HPLC. The metabolic stability was calculated based on the 0 min sample. The experiment was performed in triplicate.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00855" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00855" class="ext-link">10.1021/acs.jmedchem.8b00855</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic procedures, collection and crystallographic data for <b>14</b>, and high- and low-temperature <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>31</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates for crystal structure of <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular strings formula and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf">jm8b00855_si_001.pdf (1.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_002.pdb">jm8b00855_si_002.pdb (7.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_003.csv">jm8b00855_si_003.csv (3.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00855" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trond Ulven</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Drug Design and Pharmacology, University
of Copenhagen, Universitetsparken
2, DK-2100 Copenhagen, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8135-1755" title="Orcid link">http://orcid.org/0000-0002-8135-1755</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1f6b6a5f6c6a717b31746a317b74"><span class="__cf_email__" data-cfemail="2155546152544f450f4a540f454a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders
Højgaard Hansen</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugenia Sergeev</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular, Cell and Systems
Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Bolognini</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular, Cell and Systems
Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard R. Sprenger</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, University
of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3947-1606" title="Orcid link">http://orcid.org/0000-0002-3947-1606</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeppe Hvidtfeldt Ekberg</span> - <span class="hlFld-Affiliation affiliation">Novo
Nordisk Foundation Center for Basic Metabolic Research, Faculty of
Health and Medical Sciences, University
of Copenhagen, Blegdamsvej
3, 2200 Copenhagen, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christer S. Ejsing</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, University
of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine J. McKenzie</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5587-0626" title="Orcid link">http://orcid.org/0000-0001-5587-0626</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth Rexen Ulven</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics, Chemistry and Pharmacy, University
of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Drug Design and Pharmacology, University
of Copenhagen, Universitetsparken
2, DK-2100 Copenhagen, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1243-7587" title="Orcid link">http://orcid.org/0000-0003-1243-7587</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graeme Milligan</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular, Cell and Systems
Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">CCDC 1844850 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via <a href="http://www.ccdc.cam.ac.uk/data_request/cif" class="extLink">www.ccdc.cam.ac.uk/data_request/cif</a></p></div></li></ul></div><div class="ack" id="ACK-d7e6518-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Paul C. Stein for recording of high temperature <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>31</b>, Britt Grathwohl for assistance with in vitro stability studies, Rikke L. Jørgensen for help with synthesis, and Thue W. Schwartz for helpful discussions. This research was funded by the Danish Strategic Research Foundation (Grant 11-116196), the Biotechnology and Biological Sciences Research Council (Grant BB/L027887/1), and the University of Southern Denmark. E.R.U. is supported by a fellowship from the Lundbeck Foundation (Grant R181-2014-3247). We are grateful for funding from the Carlsberg Foundation Grant CF15-0675 for the X-ray diffractometer.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">BTFFH</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-bis(tetramethylene)fluoroformamidinium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">FaSSGF</td><td class="NLM_def"><p class="first last">fasted state simulated gastric fluid</p></td></tr><tr><td class="NLM_term">FFA1</td><td class="NLM_def"><p class="first last">free fatty acid receptor 1 (GPR40)</p></td></tr><tr><td class="NLM_term">FFA2</td><td class="NLM_def"><p class="first last">free fatty acid receptor 2 (GPR43)</p></td></tr><tr><td class="NLM_term">FFA3</td><td class="NLM_def"><p class="first last">free fatty acid receptor 3 (GPR41)</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">nr</td><td class="NLM_def"><p class="first last">no response</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">PYY</td><td class="NLM_def"><p class="first last">peptide tyrosine tyrosine</p></td></tr><tr><td class="NLM_term">SCFA</td><td class="NLM_def"><p class="first last">short-chain fatty acid.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotarsky, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olde, B.</span></span> <span> </span><span class="NLM_article-title">Identification of a free fatty acid receptor, FFA<sub>2</sub>R, expressed on leukocytes and activated by short-chain fatty acids</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1047</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00488-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2FS0006-291X%2803%2900488-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2003&pages=1047-1052&author=N.+E.+Nilssonauthor=K.+Kotarskyauthor=C.+Owmanauthor=B.+Olde&title=Identification+of+a+free+fatty+acid+receptor%2C+FFA2R%2C+expressed+on+leukocytes+and+activated+by+short-chain+fatty+acids&doi=10.1016%2FS0006-291X%2803%2900488-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900488-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900488-1%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DN.%2BE.%26aulast%3DKotarsky%26aufirst%3DK.%26aulast%3DOwman%26aufirst%3DC.%26aulast%3DOlde%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520a%2520free%2520fatty%2520acid%2520receptor%252C%2520FFA2R%252C%2520expressed%2520on%2520leukocytes%2520and%2520activated%2520by%2520short-chain%2520fatty%2520acids%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D303%26spage%3D1047%26epage%3D1052%26doi%3D10.1016%2FS0006-291X%2803%2900488-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsworthy, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilert, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tcheang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigglesworth, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strum, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steplewski, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignar, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foord, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, S. J.</span></span> <span> </span><span class="NLM_article-title">The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">11312</span>– <span class="NLM_lpage">11319</span>, <span class="refDoi"> DOI: 10.1074/jbc.M211609200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M211609200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=12496283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Kgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=11312-11319&author=A.+J.+Brownauthor=S.+M.+Goldsworthyauthor=A.+A.+Barnesauthor=M.+M.+Eilertauthor=L.+Tcheangauthor=D.+Danielsauthor=A.+I.+Muirauthor=M.+J.+Wigglesworthauthor=I.+Kinghornauthor=N.+J.+Fraserauthor=N.+B.+Pikeauthor=J.+C.+Strumauthor=K.+M.+Steplewskiauthor=P.+R.+Murdockauthor=J.+C.+Holderauthor=F.+H.+Marshallauthor=P.+G.+Szekeresauthor=S.+Wilsonauthor=D.+M.+Ignarauthor=S.+M.+Foordauthor=A.+Wiseauthor=S.+J.+Dowell&title=The+orphan+G+protein-coupled+receptors+GPR41+and+GPR43+are+activated+by+propionate+and+other+short+chain+carboxylic+acids&doi=10.1074%2Fjbc.M211609200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids</span></div><div class="casAuthors">Brown, Andrew J.; Goldsworthy, Susan M.; Barnes, Ashley A.; Eilert, Michelle M.; Tcheang, Lili; Daniels, Dion; Muir, Alison I.; Wigglesworth, Mark J.; Kinghorn, Ian; Fraser, Neil J.; Pike, Nicholas B.; Strum, Jay C.; Steplewski, Klaudia M.; Murdock, Paul R.; Holder, Julie C.; Marshall, Fiona H.; Szekeres, Philip G.; Wilson, Shelagh; Ignar, Diane M.; Foord, Steve M.; Wise, Alan; Dowell, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">11312-11319</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GPR41 and GPR43 are related members of a homologous family of orphan G protein-coupled receptors that are tandemly encoded at a single chromosomal locus in both humans and mice.  We identified the acetate anion as an agonist of human GPR43 during routine ligand bank screening in yeast.  This activity was confirmed after transient transfection of GPR43 into mammalian cells using Ca2+ mobilization and [35S]guanosine 5'-O-(3-thiotriphosphate) binding assays and by coexpression with GIRK G protein-regulated potassium channels in Xenopus laevis oocytes.  Other short chain carboxylic acid anions such as formate, propionate, butyrate, and pentanoate also had agonist activity.  GPR41 is related to GPR43 (52% similarity; 43% identity) and was activated by similar ligands but with differing specificity for carbon chain length, with pentanoate being the most potent agonist.  A third family member, GPR42, is most likely a recent gene duplication of GPR41 and may be a pseudogene.  GPR41 was expressed primarily in adipose tissue, whereas the highest levels of GPR43 were found in immune cells.  The identity of the cognate physiol. ligands for these receptors is not clear, although propionate is known to occur in vivo at high concns. under certain pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cv6I7xXrirVg90H21EOLACvtfcHk0ligC9RcIKlYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Kgsbc%253D&md5=9354164ddec16c6f18c99ce8e067bb1a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211609200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211609200%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DGoldsworthy%26aufirst%3DS.%2BM.%26aulast%3DBarnes%26aufirst%3DA.%2BA.%26aulast%3DEilert%26aufirst%3DM.%2BM.%26aulast%3DTcheang%26aufirst%3DL.%26aulast%3DDaniels%26aufirst%3DD.%26aulast%3DMuir%26aufirst%3DA.%2BI.%26aulast%3DWigglesworth%26aufirst%3DM.%2BJ.%26aulast%3DKinghorn%26aufirst%3DI.%26aulast%3DFraser%26aufirst%3DN.%2BJ.%26aulast%3DPike%26aufirst%3DN.%2BB.%26aulast%3DStrum%26aufirst%3DJ.%2BC.%26aulast%3DSteplewski%26aufirst%3DK.%2BM.%26aulast%3DMurdock%26aufirst%3DP.%2BR.%26aulast%3DHolder%26aufirst%3DJ.%2BC.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DSzekeres%26aufirst%3DP.%2BG.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DIgnar%26aufirst%3DD.%2BM.%26aulast%3DFoord%26aufirst%3DS.%2BM.%26aulast%3DWise%26aufirst%3DA.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520orphan%2520G%2520protein-coupled%2520receptors%2520GPR41%2520and%2520GPR43%2520are%2520activated%2520by%2520propionate%2520and%2520other%2520short%2520chain%2520carboxylic%2520acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D11312%26epage%3D11319%26doi%3D10.1074%2Fjbc.M211609200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Poul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springael, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decobecq, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brezillon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupriez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Detheux, M.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">25481</span>– <span class="NLM_lpage">25489</span>, <span class="refDoi"> DOI: 10.1074/jbc.M301403200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M301403200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=12711604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1CmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=25481-25489&author=E.+Le%0APoulauthor=C.+Loisonauthor=S.+Struyfauthor=J.+Y.+Springaelauthor=V.+Lannoyauthor=M.+E.+Decobecqauthor=S.+Brezillonauthor=V.+Dupriezauthor=G.+Vassartauthor=J.+Van+Dammeauthor=M.+Parmentierauthor=M.+Detheux&title=Functional+characterization+of+human+receptors+for+short+chain+fatty+acids+and+their+role+in+polymorphonuclear+cell+activation&doi=10.1074%2Fjbc.M301403200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation</span></div><div class="casAuthors">Le Poul, Emmanuel; Loison, Cecile; Struyf, Sofie; Springael, Jean-Yves; Lannoy, Vincent; Decobecq, Marie-Eve; Brezillon, Stephane; Dupriez, Vincent; Vassart, Gilbert; Van Damme, Jo; Parmentier, Marc; Detheux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">25481-25489</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Short chain fatty acids (SCFAs), including acetate, propionate, and butyrate, are produced at high concn. by bacteria in the gut and subsequently released in the bloodstream.  Basal acetate concns. in the blood (about 100 μM) can further increase to millimolar concns. following alc. intake.  It was known previously that SCFAs can activate leukocytes, particularly neutrophils.  In the present work, we have identified two previously orphan G protein-coupled receptors, GPR41 and GPR43, as receptors for SCFAs.  Propionate was the most potent agonist for both GPR41 and GPR43.  Acetate was more selective for GPR43, whereas butyrate and isobutyrate were more active on GPR41.  The two receptors were coupled to inositol 1,4,5-trisphosphate formation, intracellular Ca2+ release, ERK1/2 activation, and inhibition of cAMP accumulation.  They exhibited, however, a differential coupling to G proteins; GPR41 coupled exclusively though the Pertussis toxin-sensitive Gi/o family, whereas GPR43 displayed a dual coupling through Gi/o and Pertussis toxin-insensitive Gq protein families.  The broad expression profile of GPR41 in a no. of tissues does not allow us to infer clear hypotheses regarding its biol. functions.  In contrast, the highly selective expression of GPR43 in leukocytes, particularly polymorphonuclear cells, suggests a role in the recruitment of these cell populations toward sites of bacterial infection.  The pharmacol. of GPR43 matches indeed the effects of SCFAs on neutrophils, in terms of intracellular Ca2+ release and chemotaxis.  Such a neutrophil-specific SCFA receptor is potentially involved in the development of a variety of diseases characterized by either excessive or inefficient neutrophil recruitment and activation, such as inflammatory bowel diseases or alcoholism-assocd. immune depression.  GPR43 might therefore constitute a target allowing us to modulate immune responses in these pathol. situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ceIWikecmrVg90H21EOLACvtfcHk0ljpTYbmsgt-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1CmtbY%253D&md5=30e56b7bf671a607faa0dbea6f75d9dc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M301403200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M301403200%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DLoison%26aufirst%3DC.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DSpringael%26aufirst%3DJ.%2BY.%26aulast%3DLannoy%26aufirst%3DV.%26aulast%3DDecobecq%26aufirst%3DM.%2BE.%26aulast%3DBrezillon%26aufirst%3DS.%26aulast%3DDupriez%26aufirst%3DV.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DDetheux%26aufirst%3DM.%26atitle%3DFunctional%2520characterization%2520of%2520human%2520receptors%2520for%2520short%2520chain%2520fatty%2520acids%2520and%2520their%2520role%2520in%2520polymorphonuclear%2520cell%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D25481%26epage%3D25489%26doi%3D10.1074%2Fjbc.M301403200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011613-135945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1146%2Fannurev-pharmtox-011613-135945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=24160702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=407-434&author=S.+Offermanns&title=Free+fatty+acid+%28FFA%29+and+hydroxy+carboxylic+acid+%28HCA%29+receptors&doi=10.1146%2Fannurev-pharmtox-011613-135945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors</span></div><div class="casAuthors">Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">407-434</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Satd. and unsatd. free fatty acids (FFAs), as well as hydroxy carboxylic acids (HCAs) such as lactate and ketone bodies, are carriers of metabolic energy, precursors of biol. mediators, and components of biol. structures.  However, they are also able to exert cellular effects through G protein-coupled receptors named FFA1-FFA4 and HCA1-HCA3.  Work during the past decade has shown that these receptors are widely expressed in the human body and regulate the metabolic, endocrine, immune and other systems to maintain homeostasis under changing dietary conditions.  The development of genetic mouse models and the generation of synthetic ligands of individual FFA and HCA receptors have been instrumental in identifying cellular and biol. functions of these receptors.  These studies have produced strong evidence that several FFA and HCA receptors can be targets for the prevention and treatment of various diseases, including type 2 diabetes mellitus, obesity, and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRysSCQif5HrVg90H21EOLACvtfcHk0ljpTYbmsgt-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7g%253D&md5=0162fb7672c9245d581f54d8cb325f5a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011613-135945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011613-135945%26sid%3Dliteratum%253Aachs%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DFree%2520fatty%2520acid%2520%2528FFA%2529%2520and%2520hydroxy%2520carboxylic%2520acid%2520%2528HCA%2529%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D407%26epage%3D434%26doi%3D10.1146%2Fannurev-pharmtox-011613-135945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimpukade, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span> <span> </span><span class="NLM_article-title">Complex pharmacology of free fatty acid receptors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1ehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=67-110&author=G.+Milliganauthor=B.+Shimpukadeauthor=T.+Ulvenauthor=B.+D.+Hudson&title=Complex+pharmacology+of+free+fatty+acid+receptors&doi=10.1021%2Facs.chemrev.6b00056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Complex Pharmacology of Free Fatty Acid Receptors</span></div><div class="casAuthors">Milligan, Graeme; Shimpukade, Bharat; Ulven, Trond; Hudson, Brian D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-110</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are historically the most successful family of drug targets.  In recent times it has become clear that the pharmacol. of these receptors is far more complex than previously imagined.  Understanding of the pharmacol. regulation of GPCRs now extends beyond simple competitive agonism or antagonism by ligands interacting with the orthosteric binding site of the receptor to incorporate concepts of allosteric agonism, allosteric modulation, signaling bias, constitutive activity, and inverse agonism.  Herein, we consider how evolving concepts of GPCR pharmacol. have shaped understanding of the complex pharmacol. of receptors that recognize and are activated by nonesterified or "free" fatty acids (FFAs).  The FFA family of receptors is a recently deorphanized set of GPCRs, the members of which are now receiving substantial interest as novel targets for the treatment of metabolic and inflammatory diseases.  Further understanding of the complex pharmacol. of these receptors will be crit. to unlocking their ultimate therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdP6XCIBjo9bVg90H21EOLACvtfcHk0lj6efWu0tid-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1ehsr0%253D&md5=4bd71d657f4905bddb750d8ad4fdb9b4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00056%26sid%3Dliteratum%253Aachs%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26atitle%3DComplex%2520pharmacology%2520of%2520free%2520fatty%2520acid%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D67%26epage%3D110%26doi%3D10.1021%2Facs.chemrev.6b00056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishikawa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotoh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span> <span> </span><span class="NLM_article-title">Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">5092</span>– <span class="NLM_lpage">5099</span>, <span class="refDoi"> DOI: 10.1210/en.2005-0545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1210%2Fen.2005-0545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=16123168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ogur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=5092-5099&author=Y.+H.+Hongauthor=Y.+Nishimuraauthor=D.+Hishikawaauthor=H.+Tsuzukiauthor=H.+Miyaharaauthor=C.+Gotohauthor=K.+C.+Choiauthor=D.+D.+Fengauthor=C.+Chenauthor=H.+G.+Leeauthor=K.+Katohauthor=S.+G.+Rohauthor=S.+Sasaki&title=Acetate+and+propionate+short+chain+fatty+acids+stimulate+adipogenesis+via+GPCR43&doi=10.1210%2Fen.2005-0545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43</span></div><div class="casAuthors">Hong, Yeong-Hee; Nishimura, Yukihiko; Hishikawa, Daisuke; Tsuzuki, Hiroaki; Miyahara, Hisae; Gotoh, Chizu; Choi, Ki-Choon; Feng, Dan Dan; Chen, Chen; Lee, Hong-Gu; Katoh, Kazuo; Roh, Sang-Gun; Sasaki, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5092-5099</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">It has recently been discovered that G protein-coupled receptors (GPCR) 41 and 43 are characterized by having the short chain fatty acids acetate and propionate as their ligands.  The objective of this study was to investigate the involvement of GPCR41, GPCR43, and their ligands in the process of adipogenesis.  We measured the levels of GPCR41 and GPCR43 mRNA in both adipose and other tissues of the mouse.  GRP43 mRNA expression was higher in four types of adipose tissue than in other tissues, whereas GPCR41 mRNA was not detected in any adipose tissues.  A high level of GPCR43 expression was found in isolated adipocytes, but expression level was very low in stromal-vascular cells.  Expression of GPCR43 was up-regulated in adipose tissues of mice fed a high-fat diet compared with those fed a normal-fat diet.  GPCR43 mRNA could not be detected in confluent and undifferentiated 3T3-L1 adipocytes; however, the levels rose with time after the initiation of differentiation.  GPCR41 expression was not detected in confluent and differentiated adipocytes.  Acetate and propionate treatments increased lipids present as multiple droplets in 3T3-L1 adipocytes.  Propionate significantly elevated the level of GPCR43 expression during adipose differentiation, with up-regulation of PPAR-γ2.  Small interfering RNA mediated a redn. of GPCR43 mRNA in 3T3-L1 cells and blocked the process of adipocyte differentiation.  In addn., both acetate and propionate inhibited isoproterenol-induced lipolysis in a dose-dependent manner.  We conclude that acetate and propionate short chain fatty acids may have important physiol. roles in adipogenesis through GPCR43, but not through GPCR41.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZSBBqrlv-vLVg90H21EOLACvtfcHk0lj6efWu0tid-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ogur%252FL&md5=26c914beba3148a5007f27c19915d321</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fen.2005-0545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2005-0545%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%2BH.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DHishikawa%26aufirst%3DD.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DMiyahara%26aufirst%3DH.%26aulast%3DGotoh%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DK.%2BC.%26aulast%3DFeng%26aufirst%3DD.%2BD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DH.%2BG.%26aulast%3DKatoh%26aufirst%3DK.%26aulast%3DRoh%26aufirst%3DS.%2BG.%26aulast%3DSasaki%26aufirst%3DS.%26atitle%3DAcetate%2520and%2520propionate%2520short%2520chain%2520fatty%2520acids%2520stimulate%2520adipogenesis%2520via%2520GPCR43%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D5092%26epage%3D5099%26doi%3D10.1210%2Fen.2005-0545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furness, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwahara, A.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1007/s00441-005-0140-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2Fs00441-005-0140-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=16453106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFSgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2006&pages=353-360&author=S.+Karakiauthor=R.+Mitsuiauthor=H.+Hayashiauthor=I.+Katoauthor=H.+Sugiyaauthor=T.+Iwanagaauthor=J.+B.+Furnessauthor=A.+Kuwahara&title=Short-chain+fatty+acid+receptor%2C+GPR43%2C+is+expressed+by+enteroendocrine+cells+and+mucosal+mast+cells+in+rat+intestine&doi=10.1007%2Fs00441-005-0140-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine</span></div><div class="casAuthors">Karaki, Shin-ichiro; Mitsui, Retsu; Hayashi, Hisayoshi; Kato, Ikuo; Sugiya, Hiroshi; Iwanaga, Toshihiko; Furness, John B.; Kuwahara, Atsukazu</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-360</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, are the major anions in the large intestinal lumen.  They are produced from dietary fiber by bacterial fermn. and are known to have a variety of physiol. and pathophysiol. effects on the intestine.  In the present study, we investigated the expression of the SCFA receptor, GPR43, in the rat distal ileum and colon.  Expression of GPR43 was detected by reverse transcriptase/polymerase chain reaction (RT-PCR), Western blotting, and immunohistochem. mRNA for GPR43 was detected, by RT-PCR, in exts. of the whole wall and sepd. mucosa from the ileum and colon and from muscle plus submucosa from the ileum, but not from muscle plus submucosa prepns. from the colon.  We raised a rabbit antiserum against a synthesized fragment of rat GPR43; this was specific for rat GPR43.  GPR43 protein was detected by Western blot anal. in exts. of whole wall and sepd. mucosa, but not in muscle plus submucosa exts.  By immunohistochem., GPR43 immunoreactivity was localized to enteroendocrine cells expressing peptide YY (PYY), whereas 5-hydroxytryptamine (5-HT)-immunoreactive (IR) enteroendocrine cells were not immunoreactive for GPR43.  Mast cells of the lamina propria expressing 5-HT were also GPR43-IR.  The results of the present study suggest that the PYY-contg. enteroendocrine cells and 5-HT-contg. mucosal mast cells sense SCFAs via the GPR43 receptor.  This is consistent with physiol. data showing that SCFAs stimulate the release of PYY and 5-HT from the ileum and colon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP6Ve1VyCMErVg90H21EOLACvtfcHk0ljwJAOBq8wTSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFSgu7k%253D&md5=f950e424494291f04217ae0583c44d34</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00441-005-0140-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-005-0140-x%26sid%3Dliteratum%253Aachs%26aulast%3DKaraki%26aufirst%3DS.%26aulast%3DMitsui%26aufirst%3DR.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DSugiya%26aufirst%3DH.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DJ.%2BB.%26aulast%3DKuwahara%26aufirst%3DA.%26atitle%3DShort-chain%2520fatty%2520acid%2520receptor%252C%2520GPR43%252C%2520is%2520expressed%2520by%2520enteroendocrine%2520cells%2520and%2520mucosal%2520mast%2520cells%2520in%2520rat%2520intestine%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2006%26volume%3D324%26spage%3D353%26epage%3D360%26doi%3D10.1007%2Fs00441-005-0140-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivaprakasam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paschall, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolhe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sifuentes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijay-Kumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGaha, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e238</span>, <span class="refDoi"> DOI: 10.1038/oncsis.2016.38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Foncsis.2016.38" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e238&author=S.+Sivaprakasamauthor=A.+Guravauthor=A.+V.+Paschallauthor=G.+L.+Coeauthor=K.+Chaudharyauthor=Y.+Caiauthor=R.+Kolheauthor=P.+Martinauthor=D.+Browningauthor=L.+Huangauthor=H.+Shiauthor=H.+Sifuentesauthor=M.+Vijay-Kumarauthor=S.+A.+Thompsonauthor=D.+H.+Munnauthor=A.+Mellorauthor=T.+L.+McGahaauthor=P.+Shiaoauthor=C.+W.+Cutlerauthor=K.+Liuauthor=V.+Ganapathyauthor=H.+Liauthor=N.+Singh&title=An+essential+role+of+Ffar2+%28Gpr43%29+in+dietary+fibre-mediated+promotion+of+healthy+composition+of+gut+microbiota+and+suppression+of+intestinal+carcinogenesis&doi=10.1038%2Foncsis.2016.38"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2016.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2016.38%26sid%3Dliteratum%253Aachs%26aulast%3DSivaprakasam%26aufirst%3DS.%26aulast%3DGurav%26aufirst%3DA.%26aulast%3DPaschall%26aufirst%3DA.%2BV.%26aulast%3DCoe%26aufirst%3DG.%2BL.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DKolhe%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DBrowning%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSifuentes%26aufirst%3DH.%26aulast%3DVijay-Kumar%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DS.%2BA.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DMellor%26aufirst%3DA.%26aulast%3DMcGaha%26aufirst%3DT.%2BL.%26aulast%3DShiao%26aufirst%3DP.%26aulast%3DCutler%26aufirst%3DC.%2BW.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGanapathy%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DAn%2520essential%2520role%2520of%2520Ffar2%2520%2528Gpr43%2529%2520in%2520dietary%2520fibre-mediated%2520promotion%2520of%2520healthy%2520composition%2520of%2520gut%2520microbiota%2520and%2520suppression%2520of%2520intestinal%2520carcinogenesis%26jtitle%3DOncogenesis%26date%3D2016%26volume%3D5%26spage%3De238%26doi%3D10.1038%2Foncsis.2016.38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harig, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soergel, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komorowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. M.</span></span> <span> </span><span class="NLM_article-title">Treatment of diversion colitis with short-chain-fatty acid irrigation</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>320</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1056/NEJM198901053200105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1056%2FNEJM198901053200105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=2909876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADyaL1M%252Fot1GrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=1989&pages=23-28&author=J.+M.+Harigauthor=K.+H.+Soergelauthor=R.+A.+Komorowskiauthor=C.+M.+Wood&title=Treatment+of+diversion+colitis+with+short-chain-fatty+acid+irrigation&doi=10.1056%2FNEJM198901053200105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of diversion colitis with short-chain-fatty acid irrigation</span></div><div class="casAuthors">Harig J M; Soergel K H; Komorowski R A; Wood C M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A condition known as diversion colitis frequently develops in segments of the colorectum after surgical diversion of the fecal stream; it persists indefinitely unless the excluded segment is reanastomosed.  The disease is characterized by bleeding from inflamed colonic mucosa that mimics the bleeding of idiopathic inflammatory bowel disease, and it may culminate in stricture formation.  We hypothesized that this condition is caused by the absence of luminal short-chain fatty acids, the preferred metabolic substrates of colonic epithelium.  We studied four patients with diversion colitis, none of whom had evidence of Crohn's, idiopathic ulcerative, or infectious colitis.  The excluded segment of the rectosigmoid contained negligible concentrations of short-chain fatty acids.  When D-glucose was instilled, it did not undergo appreciable anaerobic fermentation.  Instillation of a solution containing short-chain fatty acids twice daily resulted in the disappearance of symptoms and the inflammatory changes observed at endoscopy, over a period of four to six weeks.  Remission has been maintained for up to 14 months (in one patient) by instillation daily to twice weekly.  Administering enemas containing isotonic saline, or omitting treatment for periods of two to four weeks during the regimen, by contrast, did not produce any improvement or rapid relapse of the colitis.  Histologic observation revealed a distinctive type of mucosal inflammation that resolved more slowly and less completely than the gross appearance of the inflamed mucosa.  From these preliminary studies we infer that diversion colitis may represent an inflammatory state resulting from a nutritional deficiency in the lumen of the colonic epithelium, which is effectively treated by local application of short-chain fatty acids, the missing nutrients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1jjefdfMZF-RS7coPn-RtfW6udTcc2eY1ra7dYiShabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252Fot1GrsA%253D%253D&md5=aebe98afd0625709d97d0e8c0df84263</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJM198901053200105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198901053200105%26sid%3Dliteratum%253Aachs%26aulast%3DHarig%26aufirst%3DJ.%2BM.%26aulast%3DSoergel%26aufirst%3DK.%2BH.%26aulast%3DKomorowski%26aufirst%3DR.%2BA.%26aulast%3DWood%26aufirst%3DC.%2BM.%26atitle%3DTreatment%2520of%2520diversion%2520colitis%2520with%2520short-chain-fatty%2520acid%2520irrigation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1989%26volume%3D320%26spage%3D23%26epage%3D28%26doi%3D10.1056%2FNEJM198901053200105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vernia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcheggiano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caprilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valpiani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoluzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torsoli, A.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acid topical treatment in distal ulcerative colitis</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2036.1995.tb00386.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1111%2Fj.1365-2036.1995.tb00386.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=7654893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADyaK2MzotlGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=309-313&author=P.+Verniaauthor=A.+Marcheggianoauthor=R.+Caprilliauthor=G.+Frieriauthor=G.+Corraoauthor=D.+Valpianiauthor=M.+C.+Di+Paoloauthor=P.+Paoluziauthor=A.+Torsoli&title=Short-chain+fatty+acid+topical+treatment+in+distal+ulcerative+colitis&doi=10.1111%2Fj.1365-2036.1995.tb00386.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acid topical treatment in distal ulcerative colitis</span></div><div class="casAuthors">Vernia P; Marcheggiano A; Caprilli R; Frieri G; Corrao G; Valpiani D; Di Paolo M C; Paoluzi P; Torsoli A</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-13</span>
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    </div><div class="casAbstract">BACKGROUND:  Some evidence indicates that short-chain fatty acid (SCFA) enemas are effective in the treatment of distal ulcerative colitis.  METHODS:  In a randomized, double-blind, placebo-controlled study, we tested the efficacy of a 6-week course of topical SCFA (100 mL, twice daily enemas of sodium acetate 80 mmol/L, sodium propionate 30 mmol/L and sodium butyrate 40 mmol/L) in 40 patients with mild to moderate distal colitis.  Clinical, endoscopic and histological data were collected at the beginning and end of the study.  RESULTS:  Fourteen patients on SCFA improved (overall score 11.3 +/- 2.0 vs. 7.4 +/- 3.5) as compared to five in the placebo group (overall score 10.0 +/- 1.9 vs. 8.9 +/- 2.5).  In the SCFA-treated group all parameters significantly improved except the number of bowel motions, whereas no significant changes were recorded in the control group.  A statistically significant difference between the two treatment regimens, however, was observed only for intestinal bleeding (P < 0.05), urgency (P < 0.02) and the patient self-evaluation score (P < 0.05).  This was probably due to the random inclusion of more patients with moderate disease into the SCFA-treated group, thus causing pretrial differences between the two groups.  CONCLUSION:  The present study confirms that irrigation with SCFA enemas is effective in distal colitis, and may represent an alternative therapeutic tool in the treatment of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkZb6cs3El-7GbPKh4T9eAfW6udTcc2eY1ra7dYiShabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzotlGhtg%253D%253D&md5=56655db6e038ae482dc5fbab555ff5e8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.1995.tb00386.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.1995.tb00386.x%26sid%3Dliteratum%253Aachs%26aulast%3DVernia%26aufirst%3DP.%26aulast%3DMarcheggiano%26aufirst%3DA.%26aulast%3DCaprilli%26aufirst%3DR.%26aulast%3DFrieri%26aufirst%3DG.%26aulast%3DCorrao%26aufirst%3DG.%26aulast%3DValpiani%26aufirst%3DD.%26aulast%3DDi%2BPaolo%26aufirst%3DM.%2BC.%26aulast%3DPaoluzi%26aufirst%3DP.%26aulast%3DTorsoli%26aufirst%3DA.%26atitle%3DShort-chain%2520fatty%2520acid%2520topical%2520treatment%2520in%2520distal%2520ulcerative%2520colitis%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D9%26spage%3D309%26epage%3D313%26doi%3D10.1111%2Fj.1365-2036.1995.tb00386.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maslowski, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilter, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolph, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, C. R.</span></span> <span> </span><span class="NLM_article-title">Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1038/nature08530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnature08530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=19865172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOjt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=1282-1286&author=K.+M.+Maslowskiauthor=A.+T.+Vieiraauthor=A.+Ngauthor=J.+Kranichauthor=F.+Sierroauthor=D.+Yuauthor=H.+C.+Schilterauthor=M.+S.+Rolphauthor=F.+Mackayauthor=D.+Artisauthor=R.+J.+Xavierauthor=M.+M.+Teixeiraauthor=C.+R.+Mackay&title=Regulation+of+inflammatory+responses+by+gut+microbiota+and+chemoattractant+receptor+GPR43&doi=10.1038%2Fnature08530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</span></div><div class="casAuthors">Maslowski, Kendle M.; Vieira, Angelica T.; Ng, Aylwin; Kranich, Jan; Sierro, Frederic; Yu, Di; Schilter, Heidi C.; Rolph, Michael S.; MacKay, Fabienne; Artis, David; Xavier, Ramnik; Teixeira, Mauro M.; MacKay, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7268</span>),
    <span class="NLM_cas:pages">1282-1286</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The immune system responds to pathogens by a variety of pattern recognition mols. such as the Toll-like receptors (TLRs), which promote recognition of dangerous foreign pathogens.  However, recent evidence indicates that normal intestinal microbiota might also pos. influence immune responses, and protect against the development of inflammatory diseases.  One of these elements may be short-chain fatty acids (SCFAs), which are produced by fermn. of dietary fiber by intestinal microbiota.  A feature of human ulcerative colitis and other colitic diseases is a change in 'healthy' microbiota such as Bifidobacterium and Bacteriodes, and a concurrent redn. in SCFAs.  Moreover, increased intake of fermentable dietary fiber, or SCFAs, seems to be clin. beneficial in the treatment of colitis.  SCFAs bind the G-protein-coupled receptor 43 (GPR43, also known as FFAR2), and here we show that SCFA-GPR43 interactions profoundly affect inflammatory responses.  Stimulation of GPR43 by SCFAs was necessary for the normal resoln. of certain inflammatory responses, because GPR43-deficient (Gpr43-/-) mice showed exacerbated or unresolving inflammation in models of colitis, arthritis and asthma.  This seemed to relate to increased prodn. of inflammatory mediators by Gpr43-/- immune cells, and increased immune cell recruitment.  Germ-free mice, which are devoid of bacteria and express little or no SCFAs, showed a similar dysregulation of certain inflammatory responses.  GPR43 binding of SCFAs potentially provides a mol. link between diet, gastrointestinal bacterial metab., and immune and inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGDIl1CGKdG7Vg90H21EOLACvtfcHk0ljKJ21EHQrW7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOjt7vI&md5=be0b507ab2c96e7cfc648eba40e0d205</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature08530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08530%26sid%3Dliteratum%253Aachs%26aulast%3DMaslowski%26aufirst%3DK.%2BM.%26aulast%3DVieira%26aufirst%3DA.%2BT.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DKranich%26aufirst%3DJ.%26aulast%3DSierro%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DSchilter%26aufirst%3DH.%2BC.%26aulast%3DRolph%26aufirst%3DM.%2BS.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DArtis%26aufirst%3DD.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DTeixeira%26aufirst%3DM.%2BM.%26aulast%3DMackay%26aufirst%3DC.%2BR.%26atitle%3DRegulation%2520of%2520inflammatory%2520responses%2520by%2520gut%2520microbiota%2520and%2520chemoattractant%2520receptor%2520GPR43%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D1282%26epage%3D1286%26doi%3D10.1038%2Fnature08530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Till, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raabe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalaris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folsch, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose-John, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenstiel, P.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptor 43 Is essential for neutrophil recruitment during intestinal inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">7514</span>– <span class="NLM_lpage">7522</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.4049%2Fjimmunol.0900063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=7514-7522&author=C.+Sinaauthor=O.+Gavrilovaauthor=M.+Forsterauthor=A.+Tillauthor=S.+Dererauthor=F.+Hildebrandauthor=B.+Raabeauthor=A.+Chalarisauthor=J.+Schellerauthor=A.+Rehmannauthor=A.+Frankeauthor=S.+Ottauthor=R.+Haslerauthor=S.+Nikolausauthor=U.+R.+Folschauthor=S.+Rose-Johnauthor=H.+P.+Jiangauthor=J.+Liauthor=S.+Schreiberauthor=P.+Rosenstiel&title=G+protein-coupled+receptor+43+Is+essential+for+neutrophil+recruitment+during+intestinal+inflammation&doi=10.4049%2Fjimmunol.0900063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900063%26sid%3Dliteratum%253Aachs%26aulast%3DSina%26aufirst%3DC.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DForster%26aufirst%3DM.%26aulast%3DTill%26aufirst%3DA.%26aulast%3DDerer%26aufirst%3DS.%26aulast%3DHildebrand%26aufirst%3DF.%26aulast%3DRaabe%26aufirst%3DB.%26aulast%3DChalaris%26aufirst%3DA.%26aulast%3DScheller%26aufirst%3DJ.%26aulast%3DRehmann%26aufirst%3DA.%26aulast%3DFranke%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DS.%26aulast%3DHasler%26aufirst%3DR.%26aulast%3DNikolaus%26aufirst%3DS.%26aulast%3DFolsch%26aufirst%3DU.%2BR.%26aulast%3DRose-John%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DRosenstiel%26aufirst%3DP.%26atitle%3DG%2520protein-coupled%2520receptor%252043%2520Is%2520essential%2520for%2520neutrophil%2520recruitment%2520during%2520intestinal%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D7514%26epage%3D7522%26doi%3D10.4049%2Fjimmunol.0900063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kaem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Aa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beetens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van’t Klooster, G.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1111/bcp.12900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1111%2Fbcp.12900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26852904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtValsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2016&pages=139-148&author=F.+Namourauthor=R.+Galienauthor=T.+Van+Kaemauthor=A.+Van+der+Aaauthor=F.+Vanhoutteauthor=J.+Beetensauthor=G.+Van%E2%80%99t+Klooster&title=Safety%2C+pharmacokinetics+and+pharmacodynamics+of+GLPG0974%2C+a+potent+and+selective+FFA2+antagonist%2C+in+healthy+male+subjects&doi=10.1111%2Fbcp.12900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects</span></div><div class="casAuthors">Namour, Florence; Galien, Rene; Van Kaem, Tim; Van der Aa, Annegret; Vanhoutte, Frederic; Beetens, Johan; van't Klooster, Gerben</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Free fatty acids (FFA) can act as direct signalling mols. through activation of several membrane-bound G-protein coupled receptors.  The FFA2 receptor (known as GPR43) is activated by short chain fatty acids (SCFA) such as acetate and has been shown to play a major role in SCFA-induced neutrophil activation and migration and to contribute in the development and control of inflammation.  GLPG0974 is a potent and selective antagonist of the human FFA2.  The main objectives of the two phase 1 trials were to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of GLPG0974.  Methods : Two consecutive randomized, double-blind, placebo-controlled, single center trials in healthy subjects were performed.  In the first, GLPG0974 was administered as single doses up to 250 mg and in the second, multiple daily doses up to 400 mg for 14 days were evaluated.  Non-compartmental anal. was used to det. GLPG0974 pharmacokinetics while target engagement was investigated through the inhibition of neutrophils in acetate-simulated whole blood samples using surface expression of CD11b activated epitope as a marker of neutrophil activation.  Results : The investigation of safety/tolerability and pharmacokinetics in the early development phase showed that GLPG0974 was safe and well tolerated up to a daily dose of 400 mg.  GLPG0974 showed good and dose proportional exposure up to 400 mg daily as well as a substantial and sustained inhibition of acetate-stimulated neutrophil activation.  Conclusion : Based on these results, a proof-of-concept study was initiated to evaluate the safety, tolerability and efficacy of GLPG0974 in patients with mild to moderate ulcerative colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF0JlJeJAnoLVg90H21EOLACvtfcHk0ljayjENO1hwDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtValsbrK&md5=c108c375a07b233111b639b05bd99174</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12900%26sid%3Dliteratum%253Aachs%26aulast%3DNamour%26aufirst%3DF.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3DVan%2BKaem%26aufirst%3DT.%26aulast%3DVan%2Bder%2BAa%26aufirst%3DA.%26aulast%3DVanhoutte%26aufirst%3DF.%26aulast%3DBeetens%26aufirst%3DJ.%26aulast%3DVan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520GLPG0974%252C%2520a%2520potent%2520and%2520selective%2520FFA2%2520antagonist%252C%2520in%2520healthy%2520male%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2016%26volume%3D82%26spage%3D139%26epage%3D148%26doi%3D10.1111%2Fbcp.12900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaline, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornstein, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, P. E.</span></span> <span> </span><span class="NLM_article-title">The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products</span>. <i>Horm. Metab. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1055/s-2007-985811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1055%2Fs-2007-985811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=17846978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Kqs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=687-693&author=K.+Kalineauthor=S.+R.+Bornsteinauthor=A.+Bergmannauthor=H.+Haunerauthor=P.+E.+Schwarz&title=The+importance+and+effect+of+dietary+fiber+in+diabetes+prevention+with+particular+consideration+of+whole+grain+products&doi=10.1055%2Fs-2007-985811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products</span></div><div class="casAuthors">Kaline, K.; Bornstein, S. R.; Bergmann, A.; Hauner, H.; Schwarz, P. E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">687-693</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  The state of prediabetes is characterized by increased insulin resistance and decreased pancreatic islet β-cell function.  This prestage of type 2 diabetes mellitus can be identified by impaired glucose tolerance and/or impaired fasting blood sugar levels.  Apart from body wt. loss and increased phys. activity, the development of type 2 diabetes mellitus can also be prevented by dietary changes.  Low-fat diets with dietary fiber intakes of >30g/day are an effective preventive approach.  High-fiber diets have many pos. effects on the phys. health status.  In addn. to pos. effects in the gastrointestinal tract, they have obvious potential to support body wt. decrease and to improve disturbances of carbohydrate and fat metab.  Insol. dietary fibers as found in whole grain cereal products are esp. effective in the prevention of type 2 diabetes mellitus.  High intakes of fruits and vegetables and pulses also have health-promoting properties.  High-fiber diets also help in the prevention of obesity and coronary heart diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Etiz3NgzTrVg90H21EOLACvtfcHk0ljayjENO1hwDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Kqs7bL&md5=e9327f901506b7663ec37b35efe38980</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-985811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-985811%26sid%3Dliteratum%253Aachs%26aulast%3DKaline%26aufirst%3DK.%26aulast%3DBornstein%26aufirst%3DS.%2BR.%26aulast%3DBergmann%26aufirst%3DA.%26aulast%3DHauner%26aufirst%3DH.%26aulast%3DSchwarz%26aufirst%3DP.%2BE.%26atitle%3DThe%2520importance%2520and%2520effect%2520of%2520dietary%2520fiber%2520in%2520diabetes%2520prevention%2520with%2520particular%2520consideration%2520of%2520whole%2520grain%2520products%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2007%26volume%3D39%26spage%3D687%26epage%3D693%26doi%3D10.1055%2Fs-2007-985811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarshini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicksteed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alquier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poitout, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancebo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirmira, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layden, B. T.</span></span> <span> </span><span class="NLM_article-title">An acetate-specific GPCR, FFAR2, regulates insulin secretion</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1210/me.2015-1007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1210%2Fme.2015-1007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26075576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFykurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1055-1066&author=M.+Priyadarshiniauthor=S.+R.+Villaauthor=M.+Fullerauthor=B.+Wicksteedauthor=C.+R.+Mackayauthor=T.+Alquierauthor=V.+Poitoutauthor=H.+Manceboauthor=R.+G.+Mirmiraauthor=A.+Gilchristauthor=B.+T.+Layden&title=An+acetate-specific+GPCR%2C+FFAR2%2C+regulates+insulin+secretion&doi=10.1210%2Fme.2015-1007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An acetate-specific GPCR, FFAR2, regulates insulin secretion</span></div><div class="casAuthors">Priyadarshini, Medha; Villa, Stephanie R.; Fuller, Miles; Wicksteed, Barton; MacKay, Charles R.; Alquier, Thierry; Poitout, Vincent; Mancebo, Helena; Mirmira, Raghavendra G.; Gilchrist, Annette; Layden, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1055-1066</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">G protein-coupled receptors have been well described to contribute to the regulation of glucose-stimulated insulin secretion (GSIS).  The short-chain fatty acid-sensing G protein-coupled receptor, free fatty acid receptor 2 (FFAR2), is expressed in pancreatic β-cells, and in rodents, its expression is altered during insulin resistance.  Thus, we explored the role of FFAR2 in regulating GSIS.  First, assessing the phenotype of wild-type and Ffar2-/- mice in vivo, we obsd. no differences with regard to glucose homeostasis on normal or high-fat diet, with a marginally significant defect in insulin secretion in Ffar2(-/-) mice during hyperglycemic clamps.  In ex vivo insulin secretion studies, we obsd. diminished GSIS from Ffar2(-/-) islets relative to wild-type islets under high-glucose conditions.  Further, in the presence of acetate, the primary endogenous ligand for FFAR2, we obsd. FFAR2-dependent potentiation of GSIS, whereas FFAR2-specific agonists resulted in either potentiation or inhibition of GSIS, which we found to result from selective signaling through either Gαq/11 or Gαi/o, resp.  Lastly, in ex vivo insulin secretion studies of human islets, we obsd. that acetate and FFAR2 agonists elicited different signaling properties at human FFAR2 than at mouse FFAR2.  Taken together, our studies reveal that FFAR2 signaling occurs by divergent G protein pathways that can selectively potentiate or inhibit GSIS in mouse islets.  Further, we have identified important differences in the response of mouse and human FFAR2 to selective agonists, and we suggest that these differences warrant consideration in the continued investigation of FFAR2 as a novel type 2 diabetes target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxtSgaizuzC7Vg90H21EOLACvtfcHk0ljqUs5C8IP0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFykurjI&md5=015fd8df68e924fea4bc301a3ef33fa5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fme.2015-1007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2015-1007%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarshini%26aufirst%3DM.%26aulast%3DVilla%26aufirst%3DS.%2BR.%26aulast%3DFuller%26aufirst%3DM.%26aulast%3DWicksteed%26aufirst%3DB.%26aulast%3DMackay%26aufirst%3DC.%2BR.%26aulast%3DAlquier%26aufirst%3DT.%26aulast%3DPoitout%26aufirst%3DV.%26aulast%3DMancebo%26aufirst%3DH.%26aulast%3DMirmira%26aufirst%3DR.%2BG.%26aulast%3DGilchrist%26aufirst%3DA.%26aulast%3DLayden%26aufirst%3DB.%2BT.%26atitle%3DAn%2520acetate-specific%2520GPCR%252C%2520FFAR2%252C%2520regulates%2520insulin%2520secretion%26jtitle%3DMol.%2520Endocrinol.%26date%3D2015%26volume%3D29%26spage%3D1055%26epage%3D1066%26doi%3D10.1210%2Fme.2015-1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tolhurst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diakogiannaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.2337/db11-1019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.2337%2Fdb11-1019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22190648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=364-371&author=G.+Tolhurstauthor=H.+Heffronauthor=Y.+S.+Lamauthor=H.+E.+Parkerauthor=A.+M.+Habibauthor=E.+Diakogiannakiauthor=J.+Cameronauthor=J.+Grosseauthor=F.+Reimannauthor=F.+M.+Gribble&title=Short-chain+fatty+acids+stimulate+glucagon-like+peptide-1+secretion+via+the+G-protein-coupled+receptor+FFAR2&doi=10.2337%2Fdb11-1019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2</span></div><div class="casAuthors">Tolhurst, Gwen; Heffron, Helen; Lam, Yu Shan; Parker, Helen E.; Habib, Abdella M.; Diakogiannaki, Eleftheria; Cameron, Jennifer; Grosse, Johannes; Reimann, Frank; Gribble, Fiona M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">364-371</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened.  One postulated link is bacterial fermn. of "indigestible" prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite.  We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro.  Quant. PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1-secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture.  Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance.  These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJRcchnF-BrrVg90H21EOLACvtfcHk0ljqUs5C8IP0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOlt7Y%253D&md5=fa3f45e6f2dd3b88b217700febe3248f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2337%2Fdb11-1019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb11-1019%26sid%3Dliteratum%253Aachs%26aulast%3DTolhurst%26aufirst%3DG.%26aulast%3DHeffron%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DY.%2BS.%26aulast%3DParker%26aufirst%3DH.%2BE.%26aulast%3DHabib%26aufirst%3DA.%2BM.%26aulast%3DDiakogiannaki%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DGrosse%26aufirst%3DJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26atitle%3DShort-chain%2520fatty%2520acids%2520stimulate%2520glucagon-like%2520peptide-1%2520secretion%2520via%2520the%2520G-protein-coupled%2520receptor%2520FFAR2%26jtitle%3DDiabetes%26date%3D2012%26volume%3D61%26spage%3D364%26epage%3D371%26doi%3D10.2337%2Fdb11-1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Psichas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeth, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bewick, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanyaloglu, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghatei, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, G.</span></span> <span> </span><span class="NLM_article-title">The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1038/ijo.2014.153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fijo.2014.153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFylsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=424-429&author=A.+Psichasauthor=M.+L.+Sleethauthor=K.+G.+Murphyauthor=L.+Brooksauthor=G.+A.+Bewickauthor=A.+C.+Hanyalogluauthor=M.+A.+Ghateiauthor=S.+R.+Bloomauthor=G.+Frost&title=The+short+chain+fatty+acid+propionate+stimulates+GLP-1+and+PYY+secretion+via+free+fatty+acid+receptor+2+in+rodents&doi=10.1038%2Fijo.2014.153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents</span></div><div class="casAuthors">Psichas, A.; Sleeth, M. L.; Murphy, K. G.; Brooks, L.; Bewick, G. A.; Hanyaloglu, A. C.; Ghatei, M. A.; Bloom, S. R.; Frost, G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Obesity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">424-429</span>CODEN:
                <span class="NLM_cas:coden">IJOBDP</span>;
        ISSN:<span class="NLM_cas:issn">0307-0565</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and Objectives: The gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) acutely suppress appetite.  The short chain fatty acid (SCFA) receptor, free fatty acid receptor 2 (FFA2) is present on colonic enteroendocrine L cells, and a role has been suggested for SCFAs in appetite regulation.  Here, we characterize the in vitro and in vivo effects of colonic propionate on PYY and GLP-1 release in rodents, and investigate the role of FFA2 in mediating these effects using FFA2 knockout mice.  Methods: We used Wistar rats, C57BL6 mice and free fatty acid receptor 2 knockout (FFA-/-) mice on a C57BL6 background to explore the impact of the SCFA propionate on PYY and GLP-1 release.  Isolated colonic crypt cultures were used to assess the effects of propionate on gut hormone release in vitro.  We subsequently developed an in vivo technique to assess gut hormone release into the portal vein following colonic infusion of propionate.  Results: Propionate stimulated the secretion of both PYY and GLP-1 from wild-type primary murine colonic crypt cultures.  This effect was significantly attenuated in cultures from FFA2-/- mice.  Intra-colonic infusion of propionate elevated PYY and GLP-1 levels in jugular vein plasma in rats and in portal vein plasma in both rats and mice.  However, propionate did not significantly stimulate gut hormone release in FFA2-/- mice.  Conclusions: Intra-colonic administration of propionate stimulates the concurrent release of both GLP-1 and PYY in rats and mice.  These data demonstrate that FFA2 deficiency impairs SCFA-induced gut hormone secretion both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxcy4oI0mDMbVg90H21EOLACvtfcHk0ljqUs5C8IP0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFylsbvM&md5=b2fe1a55e9dce70ead589666dd9a8366</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fijo.2014.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fijo.2014.153%26sid%3Dliteratum%253Aachs%26aulast%3DPsichas%26aufirst%3DA.%26aulast%3DSleeth%26aufirst%3DM.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BG.%26aulast%3DBrooks%26aufirst%3DL.%26aulast%3DBewick%26aufirst%3DG.%2BA.%26aulast%3DHanyaloglu%26aufirst%3DA.%2BC.%26aulast%3DGhatei%26aufirst%3DM.%2BA.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26aulast%3DFrost%26aufirst%3DG.%26atitle%3DThe%2520short%2520chain%2520fatty%2520acid%2520propionate%2520stimulates%2520GLP-1%2520and%2520PYY%2520secretion%2520via%2520free%2520fatty%2520acid%2520receptor%25202%2520in%2520rodents%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2015%26volume%3D39%26spage%3D424%26epage%3D429%26doi%3D10.1038%2Fijo.2014.153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grone, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunaru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1038/nm.3779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnm.3779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25581519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=173-177&author=C.+Tangauthor=K.+Ahmedauthor=A.+Gilleauthor=S.+Luauthor=H.+J.+Groneauthor=S.+Tunaruauthor=S.+Offermanns&title=Loss+of+FFA2+and+FFA3+increases+insulin+secretion+and+improves+glucose+tolerance+in+type+2+diabetes&doi=10.1038%2Fnm.3779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes</span></div><div class="casAuthors">Tang, Cong; Ahmed, Kashan; Gille, Andreas; Lu, Shun; Groene, Hermann-Josef; Tunaru, Sorin; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-177</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type 2 diabetes is a major health problem worldwide, and one of its key features is the inability of elevated glucose to stimulate the release of sufficient amts. of insulin from pancreatic beta cells to maintain normal blood glucose levels.  New therapeutic strategies to improve beta cell function are therefore believed to be beneficial.  Here we demonstrate that the short-chain fatty acid receptors FFA2 (encoded by FFAR2) and FFA3 (encoded by FFAR3) are expressed in mouse and human pancreatic beta cells and mediate an inhibition of insulin secretion by coupling to Gi-type G proteins.  We also provide evidence that mice with dietary-induced obesity and type 2 diabetes, as compared to non-obese control mice, have increased local formation by pancreatic islets of acetate, an endogenous agonist of FFA2 and FFA3, as well as increased systemic levels.  This elevation may contribute to the insufficient capacity of beta cells to respond to hyperglycemia in obese states.  Indeed, we found that genetic deletion of both receptors, either on the whole-body level or specifically in pancreatic beta cells, leads to greater insulin secretion and a profound improvement of glucose tolerance when mice are on a high-fat diet compared to controls.  On the other hand, deletion of Ffar2 and Ffar3 in intestinal cells did not alter glucose tolerance in diabetic animals, suggesting these receptors act in a cell-autonomous manner in beta cells to regulate insulin secretion.  In summary, under diabetic conditions elevated acetate acts on FFA2 and FFA3 to inhibit proper glucose-stimulated insulin secretion, and we expect antagonists of FFA2 and FFA3 to improve insulin secretion in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0-6dBfVkjLVg90H21EOLACvtfcHk0lhM2AwFrht_AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslKkuw%253D%253D&md5=c7eeb8baf0013e07eba31bb918228f64</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnm.3779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3779%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DC.%26aulast%3DAhmed%26aufirst%3DK.%26aulast%3DGille%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DGrone%26aufirst%3DH.%2BJ.%26aulast%3DTunaru%26aufirst%3DS.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DLoss%2520of%2520FFA2%2520and%2520FFA3%2520increases%2520insulin%2520secretion%2520and%2520improves%2520glucose%2520tolerance%2520in%2520type%25202%2520diabetes%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D173%26epage%3D177%26doi%3D10.1038%2Fnm.3779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terasawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashihara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyauchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span> <span> </span><span class="NLM_article-title">The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1829</span>, <span class="refDoi"> DOI: 10.1038/ncomms2852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fncomms2852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=23652017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC3snhslWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1829&author=I.+Kimuraauthor=K.+Ozawaauthor=D.+Inoueauthor=T.+Imamuraauthor=K.+Kimuraauthor=T.+Maedaauthor=K.+Terasawaauthor=D.+Kashiharaauthor=K.+Hiranoauthor=T.+Taniauthor=T.+Takahashiauthor=S.+Miyauchiauthor=G.+Shioiauthor=H.+Inoueauthor=G.+Tsujimoto&title=The+gut+microbiota+suppresses+insulin-mediated+fat+accumulation+via+the+short-chain+fatty+acid+receptor+GPR43&doi=10.1038%2Fncomms2852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43</span></div><div class="casAuthors">Kimura Ikuo; Ozawa Kentaro; Inoue Daisuke; Imamura Takeshi; Kimura Kumi; Maeda Takeshi; Terasawa Kazuya; Kashihara Daiji; Hirano Kanako; Tani Taeko; Takahashi Tomoyuki; Miyauchi Satoshi; Shioi Go; Inoue Hiroshi; Tsujimoto Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1829</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The gut microbiota affects nutrient acquisition and energy regulation of the host, and can influence the development of obesity, insulin resistance, and diabetes.  During feeding, gut microbes produce short-chain fatty acids, which are important energy sources for the host.  Here we show that the short-chain fatty acid receptor GPR43 links the metabolic activity of the gut microbiota with host body energy homoeostasis.  We demonstrate that GPR43-deficient mice are obese on a normal diet, whereas mice overexpressing GPR43 specifically in adipose tissue remain lean even when fed a high-fat diet.  Raised under germ-free conditions or after treatment with antibiotics, both types of mice have a normal phenotype.  We further show that short-chain fatty acid-mediated activation of GPR43 suppresses insulin signalling in adipocytes, which inhibits fat accumulation in adipose tissue and promotes the metabolism of unincorporated lipids and glucose in other tissues.  These findings establish GPR43 as a sensor for excessive dietary energy, thereby controlling body energy utilization while maintaining metabolic homoeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTm37Yh3ajtm3WEEzDrymxmfW6udTcc2eamzdovdg2EmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snhslWrsw%253D%253D&md5=89775d6210dbd1163103f5f7f986b870</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncomms2852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2852%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DOzawa%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DD.%26aulast%3DImamura%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DTerasawa%26aufirst%3DK.%26aulast%3DKashihara%26aufirst%3DD.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DTani%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DMiyauchi%26aufirst%3DS.%26aulast%3DShioi%26aufirst%3DG.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DThe%2520gut%2520microbiota%2520suppresses%2520insulin-mediated%2520fat%2520accumulation%2520via%2520the%2520short-chain%2520fatty%2520acid%2520receptor%2520GPR43%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1829%26doi%3D10.1038%2Fncomms2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">111</span>, <span class="refDoi"> DOI: 10.3389/fendo.2012.00111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.3389%2Ffendo.2012.00111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=23060857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fks1Oquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=111&author=T.+Ulven&title=Short-chain+free+fatty+acid+receptors+FFA2%2FGPR43+and+FFA3%2FGPR41+as+new+potential+therapeutic+targets&doi=10.3389%2Ffendo.2012.00111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets</span></div><div class="casAuthors">Ulven Trond</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The deorphanization of the free fatty acid (FFA) receptors FFA1 (GPR40), FFA2 (GPR43), FFA3 (GPR41), GPR84, and GPR120 has made clear that the body is capable of recognizing and responding directly to nonesterified fatty acid of virtually any chain length.  Colonic fermentation of dietary fiber produces high concentrations of the short-chain fatty acids (SCFAs) acetate, propionate and butyrate, a process which is important to health.  The phylogenetically related 7-transmembrane (7TM) receptors free fatty acid receptor 2 (FFA2) and FFA3 are activated by these SCFAs, and several lines of evidence indicate that FFA2 and FFA3 mediate beneficial effects associated with a fiber-rich diet, and that they may be of interest as targets for treatment of inflammatory and metabolic diseases.  FFA2 is highly expressed on immune cells, in particular neutrophils, and several studies suggest that the receptor plays a role in diseases involving a dysfunctional neutrophil response, such as inflammatory bowel disease (IBD).  Both FFA2 and FFA3 have been implicated in metabolic diseases such as type 2 diabetes and in regulation of appetite.  More research is however required to clarify the potential of the receptors as drug targets and establish if activation or inhibition would be the preferred mode of action.  The availability of potent and selective receptor modulators is a prerequisite for these studies.  The few modulators of FFA2 or FFA3 that have been published hitherto in the peer-reviewed literature in general have properties that make them less than ideal as such tools, but published patent applications indicate that better tool compounds might soon become available which should enable studies critical to validate the receptors as new drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBT-ohvJN31zW1zwg2yUK5fW6udTcc2eamzdovdg2EmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fks1Oquw%253D%253D&md5=eeeab4914cd52398c8df549b2757efec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2012.00111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2012.00111%26sid%3Dliteratum%253Aachs%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DShort-chain%2520free%2520fatty%2520acid%2520receptors%2520FFA2%252FGPR43%2520and%2520FFA3%252FGPR41%2520as%2520new%2520potential%2520therapeutic%2520targets%26jtitle%3DFront.%2520Endocrinol.%26date%3D2012%26volume%3D3%26spage%3D111%26doi%3D10.3389%2Ffendo.2012.00111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coope, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, H.</span></span> <span> </span><span class="NLM_article-title">Selective FFA2 agonism appears to act via intestinal PYY to reduce transit and food intake but does not improve glucose tolerance in mouse models</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">3763</span>– <span class="NLM_lpage">3771</span>, <span class="refDoi"> DOI: 10.2337/db15-0481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.2337%2Fdb15-0481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=3763-3771&author=S.+Forbesauthor=S.+Staffordauthor=G.+Coopeauthor=H.+Heffronauthor=K.+Realauthor=R.+Newmanauthor=R.+Davenportauthor=M.+Barnesauthor=J.+Grosseauthor=H.+Cox&title=Selective+FFA2+agonism+appears+to+act+via+intestinal+PYY+to+reduce+transit+and+food+intake+but+does+not+improve+glucose+tolerance+in+mouse+models&doi=10.2337%2Fdb15-0481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2337%2Fdb15-0481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-0481%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DS.%26aulast%3DStafford%26aufirst%3DS.%26aulast%3DCoope%26aufirst%3DG.%26aulast%3DHeffron%26aufirst%3DH.%26aulast%3DReal%26aufirst%3DK.%26aulast%3DNewman%26aufirst%3DR.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DBarnes%26aufirst%3DM.%26aulast%3DGrosse%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DH.%26atitle%3DSelective%2520FFA2%2520agonism%2520appears%2520to%2520act%2520via%2520intestinal%2520PYY%2520to%2520reduce%2520transit%2520and%2520food%2520intake%2520but%2520does%2520not%2520improve%2520glucose%2520tolerance%2520in%2520mouse%2520models%26jtitle%3DDiabetes%26date%3D2015%26volume%3D64%26spage%3D3763%26epage%3D3771%26doi%3D10.2337%2Fdb15-0481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">FFA2 and FFA3 in metabolic regulation</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1007/164_2016_50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F164_2016_50" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2016&pages=205-220&author=C.+Tangauthor=S.+Offermanns&title=FFA2+and+FFA3+in+metabolic+regulation&doi=10.1007%2F164_2016_50"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F164_2016_50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_50%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DC.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DFFA2%2520and%2520FFA3%2520in%2520metabolic%2520regulation%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2016%26volume%3D236%26spage%3D205%26epage%3D220%26doi%3D10.1007%2F164_2016_50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarshini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicksteed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiltz, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layden, B. T.</span></span> <span> </span><span class="NLM_article-title">SCFA receptors in pancreatic beta cells: novel diabetes targets?</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2016.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2Fj.tem.2016.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=27091493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=653-664&author=M.+Priyadarshiniauthor=B.+Wicksteedauthor=G.+E.+Schiltzauthor=A.+Gilchristauthor=B.+T.+Layden&title=SCFA+receptors+in+pancreatic+beta+cells%3A+novel+diabetes+targets%3F&doi=10.1016%2Fj.tem.2016.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?</span></div><div class="casAuthors">Priyadarshini, Medha; Wicksteed, Barton; Schiltz, Gary E.; Gilchrist, Annette; Layden, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">653-664</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nutrient sensing receptors are key metabolic mediators of responses to dietary and endogenously derived nutrients.  These receptors are largely G-protein-coupled receptors (GPCRs) and many are gaining significant interest as drug targets with a potential therapeutic role in metabolic diseases.  A distinct subclass of nutrient sensing GPCRs, two short chain fatty acid (SCFA) receptors (FFA2 and FFA3) are uniquely responsive to gut microbiota derived nutrients (such as acetate, propionate, and butyrate).  Pharmacol., mol., and genetic studies have investigated their role in organismal glucose metab. and recently in pancreatic β cell biol.  Here, we summarize the present knowledge on the role of these receptors as metabolic sensors in β cell function and physiol., revealing new therapeutic opportunities for type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqFrI_ojw7QbVg90H21EOLACvtfcHk0lghUrCn0PS-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOnsL4%253D&md5=456fe4a194982d0baaef397a13f44cc7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2016.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2016.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarshini%26aufirst%3DM.%26aulast%3DWicksteed%26aufirst%3DB.%26aulast%3DSchiltz%26aufirst%3DG.%2BE.%26aulast%3DGilchrist%26aufirst%3DA.%26aulast%3DLayden%26aufirst%3DB.%2BT.%26atitle%3DSCFA%2520receptors%2520in%2520pancreatic%2520beta%2520cells%253A%2520novel%2520diabetes%2520targets%253F%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D27%26spage%3D653%26epage%3D664%26doi%3D10.1016%2Fj.tem.2016.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span> <span> </span><span class="NLM_article-title">Ligands at the free fatty acid receptors 2/3 (GPR43/GPR41)</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1007/164_2016_49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F164_2016_49" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2016&pages=17-32&author=G.+Milliganauthor=D.+Bologniniauthor=E.+Sergeev&title=Ligands+at+the+free+fatty+acid+receptors+2%2F3+%28GPR43%2FGPR41%29&doi=10.1007%2F164_2016_49"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2F164_2016_49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_49%26sid%3Dliteratum%253Aachs%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DSergeev%26aufirst%3DE.%26atitle%3DLigands%2520at%2520the%2520free%2520fatty%2520acid%2520receptors%25202%252F3%2520%2528GPR43%252FGPR41%2529%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2016%26volume%3D236%26spage%3D17%26epage%3D32%26doi%3D10.1007%2F164_2016_49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suckow, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briscoe, C. P.</span></span> <span> </span><span class="NLM_article-title">Key questions for translation of FFA receptors: From pharmacology to medicines</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1007/164_2016_45</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F164_2016_45" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2016&pages=101-131&author=A.+T.+Suckowauthor=C.+P.+Briscoe&title=Key+questions+for+translation+of+FFA+receptors%3A+From+pharmacology+to+medicines&doi=10.1007%2F164_2016_45"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2F164_2016_45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_45%26sid%3Dliteratum%253Aachs%26aulast%3DSuckow%26aufirst%3DA.%2BT.%26aulast%3DBriscoe%26aufirst%3DC.%2BP.%26atitle%3DKey%2520questions%2520for%2520translation%2520of%2520FFA%2520receptors%253A%2520From%2520pharmacology%2520to%2520medicines%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2016%26volume%3D236%26spage%3D101%26epage%3D131%26doi%3D10.1007%2F164_2016_45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwandner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiszmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeckel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1124/mol.108.049536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1124%2Fmol.108.049536" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1599-1609&author=T.+Leeauthor=R.+Schwandnerauthor=G.+Swaminathauthor=J.+Weiszmannauthor=M.+Cardozoauthor=J.+Greenbergauthor=P.+Jaeckelauthor=H.+F.+Geauthor=Y.+C.+Wangauthor=X.+Y.+Jiaoauthor=J.+Liuauthor=F.+Kayserauthor=H.+Tianauthor=Y.+Li&title=Identification+and+functional+characterization+of+allosteric+agonists+for+the+G+protein-coupled+receptor+FFA2&doi=10.1124%2Fmol.108.049536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049536%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DSchwandner%26aufirst%3DR.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DWeiszmann%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DGreenberg%26aufirst%3DJ.%26aulast%3DJaeckel%26aufirst%3DP.%26aulast%3DGe%26aufirst%3DH.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DIdentification%2520and%2520functional%2520characterization%2520of%2520allosteric%2520agonists%2520for%2520the%2520G%2520protein-coupled%2520receptor%2520FFA2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1599%26epage%3D1609%26doi%3D10.1124%2Fmol.108.049536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiszmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwandner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2Fj.bmcl.2009.11.112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=493-498&author=Y.+C.+Wangauthor=X.+Y.+Jiaoauthor=F.+Kayserauthor=J.+W.+Liuauthor=Z.+Y.+Wangauthor=M.+Wanskaauthor=J.+Greenbergauthor=J.+Weiszmannauthor=H.+F.+Geauthor=H.+Tianauthor=S.+Wongauthor=R.+Schwandnerauthor=T.+Leeauthor=Y.+Li&title=The+first+synthetic+agonists+of+FFA2%3A+Discovery+and+SAR+of+phenylacetamides+as+allosteric+modulators&doi=10.1016%2Fj.bmcl.2009.11.112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.112%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DWanska%26aufirst%3DM.%26aulast%3DGreenberg%26aufirst%3DJ.%26aulast%3DWeiszmann%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DH.%2BF.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DSchwandner%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DThe%2520first%2520synthetic%2520agonists%2520of%2520FFA2%253A%2520Discovery%2520and%2520SAR%2520of%2520phenylacetamides%2520as%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D493%26epage%3D498%26doi%3D10.1016%2Fj.bmcl.2009.11.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trankle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Extracellular loop 2 of the Free Fatty Acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1124/mol.110.070789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1124%2Fmol.110.070789" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=163-173&author=N.+J.+Smithauthor=R.+J.+Wardauthor=L.+A.+Stoddartauthor=B.+D.+Hudsonauthor=E.+Kostenisauthor=T.+Ulvenauthor=J.+C.+Morrisauthor=C.+Trankleauthor=I.+G.+Tikhonovaauthor=D.+R.+Adamsauthor=G.+Milligan&title=Extracellular+loop+2+of+the+Free+Fatty+Acid+receptor+2+mediates+allosterism+of+a+phenylacetamide+ago-allosteric+modulator&doi=10.1124%2Fmol.110.070789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.070789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.070789%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DN.%2BJ.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DTrankle%26aufirst%3DC.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DExtracellular%2520loop%25202%2520of%2520the%2520Free%2520Fatty%2520Acid%2520receptor%25202%2520mediates%2520allosterism%2520of%2520a%2520phenylacetamide%2520ago-allosteric%2520modulator%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D163%26epage%3D173%26doi%3D10.1124%2Fmol.110.070789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H.</span>; <span class="NLM_string-name">Brantis, C. E.</span>; <span class="NLM_string-name">Dutheuil, G.</span>; <span class="NLM_string-name">Zoute, L.</span>; <span class="NLM_string-name">Schils, D.</span>; <span class="NLM_string-name">Bernard, J.</span></span> <span> </span><span class="NLM_article-title">Compounds, Pharmaceutical Composition and Methods for Use in Treating Metabolic Disorders</span>. <span class="NLM_patent">WO2010066682A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+Hoveyda&author=C.+E.+Brantis&author=G.+Dutheuil&author=L.+Zoute&author=D.+Schils&author=J.+Bernard&title=Compounds%2C+Pharmaceutical+Composition+and+Methods+for+Use+in+Treating+Metabolic+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%26atitle%3DCompounds%252C%2520Pharmaceutical%2520Composition%2520and%2520Methods%2520for%2520Use%2520in%2520Treating%2520Metabolic%2520Disorders%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Due-Hansen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">17296</span>– <span class="NLM_lpage">17312</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.455337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M113.455337" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=17296-17312&author=B.%0AD.+Hudsonauthor=M.+E.+Due-Hansenauthor=E.+Christiansenauthor=A.+M.+Hansenauthor=A.+E.+Mackenzieauthor=H.+Murdochauthor=S.+K.+Pandeyauthor=R.+J.+Wardauthor=R.+Marquezauthor=I.+G.+Tikhonovaauthor=T.+Ulvenauthor=G.+Milligan&title=Defining+the+molecular+basis+for+the+first+potent+and+selective+orthosteric+agonists+of+the+FFA2+free+fatty+acid+receptor&doi=10.1074%2Fjbc.M113.455337"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.455337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.455337%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DHansen%26aufirst%3DA.%2BM.%26aulast%3DMackenzie%26aufirst%3DA.%2BE.%26aulast%3DMurdoch%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DMarquez%26aufirst%3DR.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DDefining%2520the%2520molecular%2520basis%2520for%2520the%2520first%2520potent%2520and%2520selective%2520orthosteric%2520agonists%2520of%2520the%2520FFA2%2520free%2520fatty%2520acid%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D17296%26epage%3D17312%26doi%3D10.1074%2Fjbc.M113.455337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H.</span>; <span class="NLM_string-name">Schils, D.</span>; <span class="NLM_string-name">Zoute, L.</span>; <span class="NLM_string-name">Parcq, J.</span>; <span class="NLM_string-name">Bernard, J.</span>; <span class="NLM_string-name">Fraser, G.</span></span> <span> </span><span class="NLM_article-title">Compounds, Pharmaceutical Composition and Methods for Use in Treating Inflammatory Diseases</span>. <span class="NLM_patent">WO2015078949A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Hoveyda&author=D.+Schils&author=L.+Zoute&author=J.+Parcq&author=J.+Bernard&author=G.+Fraser&title=Compounds%2C+Pharmaceutical+Composition+and+Methods+for+Use+in+Treating+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%26atitle%3DCompounds%252C%2520Pharmaceutical%2520Composition%2520and%2520Methods%2520for%2520Use%2520in%2520Treating%2520Inflammatory%2520Diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13741</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-14096-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fs41598-017-14096-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=29061999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC1M7js1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=13741&author=E.+Sergeevauthor=A.+H.+Hansenauthor=D.+Bologniniauthor=K.+Kawakamiauthor=T.+Kishiauthor=J.+Aokiauthor=T.+Ulvenauthor=A.+Inoueauthor=B.+D.+Hudsonauthor=G.+Milligan&title=A+single+extracellular+amino+acid+in+Free+Fatty+Acid+Receptor+2+defines+antagonist+species+selectivity+and+G+protein+selection+bias&doi=10.1038%2Fs41598-017-14096-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias</span></div><div class="casAuthors">Sergeev Eugenia; Bolognini Daniele; Hudson Brian D; Milligan Graeme; Hansen Anders Hojgaard; Ulven Trond; Kawakami Kouki; Kishi Takayuki; Aoki Junken; Inoue Asuka; Aoki Junken; Inoue Asuka</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13741</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Free Fatty Acid Receptor 2 is a GPCR activated by short chain fatty acids produced in high levels in the lower gut by microbial fermentation of non-digestible carbohydrates.  A major challenge in studying this receptor is that the mouse ortholog does not have significant affinity for antagonists that are able to block the human receptor.  Docking of exemplar antagonists from two chemical series to homology models of both human and mouse Free Fatty Acid Receptor 2 suggested that a single lysine - arginine variation at the extracellular face of the receptor might provide the basis for antagonist selectivity and mutational swap studies confirmed this hypothesis.  Extending these studies to agonist function indicated that although the lysine - arginine variation between human and mouse orthologs had limited effect on G protein-mediated signal transduction, removal of positive charge from this residue produced a signalling-biased variant of Free Fatty Acid Receptor 2 in which Gi-mediated signalling by both short chain fatty acids and synthetic agonists was maintained whilst there was marked loss of agonist potency for signalling via Gq/11 and G12/13 G proteins.  A single residue at the extracellular face of the receptor thus plays key roles in both agonist and antagonist function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9zxYb5ouxkH6CEoQgWY10fW6udTcc2ebC-9AbJXC6yLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7js1yqtg%253D%253D&md5=0a47510edb50136be64524ab4667eb17</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-14096-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-14096-3%26sid%3Dliteratum%253Aachs%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DA%2520single%2520extracellular%2520amino%2520acid%2520in%2520Free%2520Fatty%2520Acid%2520Receptor%25202%2520defines%2520antagonist%2520species%2520selectivity%2520and%2520G%2520protein%2520selection%2520bias%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D13741%26doi%3D10.1038%2Fs41598-017-14096-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0li7y-n61FYLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0li7y-n61FYLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandrell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span> <span> </span><span class="NLM_article-title">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nrd4609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnrd4609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26091267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=475-486&author=M.+J.+Waringauthor=J.+Arrowsmithauthor=A.+R.+Leachauthor=P.+D.+Leesonauthor=S.+Mandrellauthor=R.+M.+Owenauthor=G.+Pairaudeauauthor=W.+D.+Pennieauthor=S.+D.+Pickettauthor=J.+Wangauthor=O.+Wallaceauthor=A.+Weir&title=An+analysis+of+the+attrition+of+drug+candidates+from+four+major+pharmaceutical+companies&doi=10.1038%2Fnrd4609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span></div><div class="casAuthors">Waring, Michael J.; Arrowsmith, John; Leach, Andrew R.; Leeson, Paul D.; Mandrell, Sam; Owen, Robert M.; Pairaudeau, Garry; Pennie, William D.; Pickett, Stephen D.; Wang, Jibo; Wallace, Owen; Weir, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development.  Attempts to reduce the no. of efficacy- and safety-related failures by analyzing possible links to the physicochem. properties of small-mol. drug candidates have been inconclusive because of the limited size of data sets from individual companies.  Here, we describe the compilation and anal. of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer.  The anal. reaffirms that control of physicochem. properties during compd. optimization is beneficial in identifying compds. of candidate drug quality and indicates for the first time a link between the physicochem. properties of compds. and clin. failure due to safety issues.  The results also suggest that further control of physicochem. properties is unlikely to have a significant effect on attrition rates and that addnl. work is required to address safety-related failures.  Further cross-company collaborations will be crucial to future progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsLfBWrLC3ZLVg90H21EOLACvtfcHk0li7y-n61FYLaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM&md5=1fdc374d32816b1e91438152299dd1b1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd4609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4609%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DMandrell%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPennie%26aufirst%3DW.%2BD.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWeir%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520attrition%2520of%2520drug%2520candidates%2520from%2520four%2520major%2520pharmaceutical%2520companies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D475%26epage%3D486%26doi%3D10.1038%2Fnrd4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Due-Hansen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">A protocol for amide bond formation with electron deficient amines and sterically hindered substrates</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1039/C5OB02129D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1039%2FC5OB02129D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26586516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyrsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=430-433&author=M.+E.+Due-Hansenauthor=S.+K.+Pandeyauthor=E.+Christiansenauthor=R.+Andersenauthor=S.+V.+Hansenauthor=T.+Ulven&title=A+protocol+for+amide+bond+formation+with+electron+deficient+amines+and+sterically+hindered+substrates&doi=10.1039%2FC5OB02129D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A protocol for amide bond formation with electron deficient amines and sterically hindered substrates</span></div><div class="casAuthors">Due-Hansen, Maria E.; Pandey, Sunil K.; Christiansen, Elisabeth; Andersen, Rikke; Hansen, Steffen V. F.; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-433</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A protocol for amide coupling by in situ formation of acyl fluorides and reaction with amines at elevated temp. has been developed and found to be efficient for coupling of sterically hindered substrates and electron deficient amines where std. methods failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-aOU75NuGLVg90H21EOLACvtfcHk0lgpPcUtdjzUiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyrsLnE&md5=4ece43260172b15c7fe5fffe08e58466</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC5OB02129D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB02129D%26sid%3Dliteratum%253Aachs%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DAndersen%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DS.%2BV.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DA%2520protocol%2520for%2520amide%2520bond%2520formation%2520with%2520electron%2520deficient%2520amines%2520and%2520sterically%2520hindered%2520substrates%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D430%26epage%3D433%26doi%3D10.1039%2FC5OB02129D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. D.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.4155/fmc.11.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.4155%2Ffmc.11.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=21806380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFeisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1181-1197&author=A.+K.+Ghoshauthor=D.+D.+Anderson&title=Tetrahydrofuran%2C+tetrahydropyran%2C+triazoles+and+related+heterocyclic+derivatives+as+HIV+protease+inhibitors&doi=10.4155%2Ffmc.11.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors</span></div><div class="casAuthors">Ghosh, Arun K.; Anderson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1181-1197</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  HIV/AIDS remains a formidable disease with millions of individuals inflicted worldwide.  Although treatment regimens have improved considerably, drug resistance brought on by viral mutation continues to erode their effectiveness.  Intense research efforts are currently underway in search of new and improved therapies.  This review is concerned with the design of novel HIV-1 protease inhibitors that incorporate heterocyclic scaffolds and which have been reported within the recent literature (2005--2010).  Various examples in this review showcase the essential role heterocycles play as scaffolds and bioisosteres in HIV-1 protease inhibitor drug development.  This review will hopefully stimulate the widespread application of these heterocycles in the design of other therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRpKhwnPK7LVg90H21EOLACvtfcHk0lgpPcUtdjzUiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFeisbw%253D&md5=c5c7ac273b57adae7b8c18cabaee2c49</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.68%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DAnderson%26aufirst%3DD.%2BD.%26atitle%3DTetrahydrofuran%252C%2520tetrahydropyran%252C%2520triazoles%2520and%2520related%2520heterocyclic%2520derivatives%2520as%2520HIV%2520protease%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1181%26epage%3D1197%26doi%3D10.4155%2Ffmc.11.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinho
e Melo, T. M. V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, C. I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha Gonsalves, A. M. d. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paixão, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beja, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of tricyclic isoindoles and thiazolo[3,2-c][1,3]benzoxazines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3949</span>– <span class="NLM_lpage">3955</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2004.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2Fj.tet.2004.03.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=3949-3955&author=T.+M.+V.+D.+Pinho%0Ae+Meloauthor=C.+I.+A.+Santosauthor=A.+M.+d.+A.+Rocha+Gonsalvesauthor=J.+A.+Paix%C3%A3oauthor=A.+M.+Beja&title=Synthesis+of+tricyclic+isoindoles+and+thiazolo%5B3%2C2-c%5D%5B1%2C3%5Dbenzoxazines&doi=10.1016%2Fj.tet.2004.03.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DPinho%2Be%2BMelo%26aufirst%3DT.%2BM.%2BV.%2BD.%26aulast%3DSantos%26aufirst%3DC.%2BI.%2BA.%26aulast%3DRocha%2BGonsalves%26aufirst%3DA.%2BM.%2Bd.%2BA.%26aulast%3DPaix%25C3%25A3o%26aufirst%3DJ.%2BA.%26aulast%3DBeja%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520of%2520tricyclic%2520isoindoles%2520and%2520thiazolo%255B3%252C2-c%255D%255B1%252C3%255Dbenzoxazines%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D3949%26epage%3D3955%26doi%3D10.1016%2Fj.tet.2004.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinho
e Melo, T. M. V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, C. S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha Gonsalves, A. M. d. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paixão, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beja, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos
Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alte da Veiga, L.</span></span> <span> </span><span class="NLM_article-title">Cycloaddition reactions of 3-aryl-5-phenyl-5H,7H-thiazolo[3,4-c]oxazol-4-ium-1-olates</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5093</span>– <span class="NLM_lpage">5102</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(02)00463-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2FS0040-4020%2802%2900463-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5093-5102&author=T.+M.+V.+D.+Pinho%0Ae+Meloauthor=C.+S.+B.+Gomesauthor=A.+M.+d.+A.+Rocha+Gonsalvesauthor=J.+A.+Paix%C3%A3oauthor=A.+M.+Bejaauthor=M.+Ramos%0ASilvaauthor=L.+Alte+da+Veiga&title=Cycloaddition+reactions+of+3-aryl-5-phenyl-5H%2C7H-thiazolo%5B3%2C4-c%5Doxazol-4-ium-1-olates&doi=10.1016%2FS0040-4020%2802%2900463-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900463-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900463-5%26sid%3Dliteratum%253Aachs%26aulast%3DPinho%2Be%2BMelo%26aufirst%3DT.%2BM.%2BV.%2BD.%26aulast%3DGomes%26aufirst%3DC.%2BS.%2BB.%26aulast%3DRocha%2BGonsalves%26aufirst%3DA.%2BM.%2Bd.%2BA.%26aulast%3DPaix%25C3%25A3o%26aufirst%3DJ.%2BA.%26aulast%3DBeja%26aufirst%3DA.%2BM.%26aulast%3DRamos%2BSilva%26aufirst%3DM.%26aulast%3DAlte%2Bda%2BVeiga%26aufirst%3DL.%26atitle%3DCycloaddition%2520reactions%2520of%25203-aryl-5-phenyl-5H%252C7H-thiazolo%255B3%252C4-c%255Doxazol-4-ium-1-olates%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5093%26epage%3D5102%26doi%3D10.1016%2FS0040-4020%2802%2900463-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4951</span>– <span class="NLM_lpage">4965</span>, <span class="refDoi"> DOI: 10.1096/fj.12-213314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1096%2Ffj.12-213314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22919070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCgtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=4951-4965&author=B.+D.+Hudsonauthor=E.+Christiansenauthor=I.+G.+Tikhonovaauthor=M.+Grundmannauthor=E.+Kostenisauthor=D.+R.+Adamsauthor=T.+Ulvenauthor=G.+Milligan&title=Chemically+engineering+ligand+selectivity+at+the+free+fatty+acid+receptor+2+based+on+pharmacological+variation+between+species+orthologs&doi=10.1096%2Ffj.12-213314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs</span></div><div class="casAuthors">Hudson, Brian D.; Christiansen, Elisabeth; Tikhonova, Irina G.; Grundmann, Manuel; Kostenis, Evi; Adams, David R.; Ulven, Trond; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4951-4965, 10.1096/fj.12-213314</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">When it is difficult to develop selective ligands within a family of related G-protein-coupled receptors (GPCRs), chem. engineered receptors activated solely by synthetic ligands (RASSLs) are useful alternatives for probing receptor function.  In the present work, we explored whether a RASSL of the free fatty acid receptor 2 (FFA2) could be developed on the basis of pharmacol. variation between species orhologs.  For this, bovine FFA2 was characterized, revealing distinct ligand selectivity compared with human FFA2.  Homol. modeling and mutational anal. demonstrated a single mutation in human FFA2 of C4.57G resulted in a human FFA2 receptor with ligand selectivity similar to the bovine receptor.  This was exploited to generate human FFA2-RASSL by the addn. of a second mutation at a known orthosteric ligand interaction site, H6.55Q.  The resulting FFA2-RASSL displayed a >100-fold loss of activity to endogenous ligands, while responding to the distinct ligand sorbic acid with pEC50 values for inhibition of cAMP, 5.83 ± 0.11; Ca2+ mobilization, 4.63 ± 0.05; ERK phosphorylation, 5.61 ± 0.06; and dynamic mass redistribution, 5.35 ± 0.06.  This FFA2-RASSL will be useful in future studies on this receptor and demonstrates that exploitation of pharmacol. variation between species orthologs is a powerful method to generate novel chem. engineered GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8PNDJQs2ArVg90H21EOLACvtfcHk0lgpPcUtdjzUiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCgtrnO&md5=60bc83a1b4768bb4d3641de4362cd65c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-213314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-213314%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DChemically%2520engineering%2520ligand%2520selectivity%2520at%2520the%2520free%2520fatty%2520acid%2520receptor%25202%2520based%2520on%2520pharmacological%2520variation%2520between%2520species%2520orthologs%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D4951%26epage%3D4965%26doi%3D10.1096%2Ffj.12-213314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.687939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M115.687939" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=303-317&author=E.+Sergeevauthor=A.+H.+Hansenauthor=S.+K.+Pandeyauthor=A.+E.+MacKenzieauthor=B.+D.+Hudsonauthor=T.+Ulvenauthor=G.+Milligan&title=Non-equivalence+of+key+positively+charged+residues+of+the+free+fatty+acid+2+receptor+in+the+recognition+and+function+of+agonist+versus+antagonist+ligands&doi=10.1074%2Fjbc.M115.687939"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.687939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.687939%26sid%3Dliteratum%253Aachs%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DMacKenzie%26aufirst%3DA.%2BE.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DNon-equivalence%2520of%2520key%2520positively%2520charged%2520residues%2520of%2520the%2520free%2520fatty%2520acid%25202%2520receptor%2520in%2520the%2520recognition%2520and%2520function%2520of%2520agonist%2520versus%2520antagonist%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D303%26epage%3D317%26doi%3D10.1074%2Fjbc.M115.687939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martensson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdfeldt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhrbom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bylund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hojgaard Hansen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span> <span> </span><span class="NLM_article-title">The neutrophil response induced by an agonist for free fatty acid receptor 2 (GPR43) Is primed by tumor necrosis factor alpha and by receptor uncoupling from the cytoskeleton but attenuated by tissue recruitment</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2595</span>, <span class="refDoi"> DOI: 10.1128/MCB.00161-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1128%2FMCB.00161-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=27503855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ovVKntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=2583-2595&author=L.+Bjorkmanauthor=J.+Martenssonauthor=M.+Wintherauthor=M.+Gablauthor=A.+Holdfeldtauthor=M.+Uhrbomauthor=J.+Bylundauthor=A.+Hojgaard+Hansenauthor=S.+K.+Pandeyauthor=T.+Ulvenauthor=H.+Forsmanauthor=C.+Dahlgren&title=The+neutrophil+response+induced+by+an+agonist+for+free+fatty+acid+receptor+2+%28GPR43%29+Is+primed+by+tumor+necrosis+factor+alpha+and+by+receptor+uncoupling+from+the+cytoskeleton+but+attenuated+by+tissue+recruitment&doi=10.1128%2FMCB.00161-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The Neutrophil Response Induced by an Agonist for Free Fatty Acid Receptor 2 (GPR43) Is Primed by Tumor Necrosis Factor Alpha and by Receptor Uncoupling from the Cytoskeleton but Attenuated by Tissue Recruitment</span></div><div class="casAuthors">Bjorkman Lena; Martensson Jonas; Winther Malene; Gabl Michael; Holdfeldt Andre; Uhrbom Martin; Forsman Huamei; Dahlgren Claes; Bylund Johan; Hojgaard Hansen Anders; Pandey Sunil K; Ulven Trond</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and cellular biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2583-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ligands with improved potency and selectivity for free fatty acid receptor 2 (FFA2R) have become available, and we here characterize the neutrophil responses induced by one such agonist (Cmp1) and one antagonist (CATPB).  Cmp1 triggered an increase in the cytosolic concentration of Ca(2+), and the neutrophils were then desensitized to Cmp1 and to acetate, a naturally occurring FFA2R agonist.  The antagonist CATPB selectively inhibited responses induced by Cmp1 or acetate.  The activated FFA2R induced superoxide anion secretion at a low level in naive blood neutrophils.  This response was largely increased by tumor necrosis factor alpha (TNF-α) in a process associated with a recruitment of easily mobilizable granules, but neutrophils recruited to an aseptic inflammation in vivo were nonresponding.  Superoxide production induced by Cmp1 was increased in latrunculin A-treated neutrophils, but no reactivation of desensitized FFA2R was induced by this drug, suggesting that the cytoskeleton is not directly involved in terminating the response.  The functional and regulatory differences between the receptors that recognize short-chain fatty acids and formylated peptides, respectively, imply different roles of these receptors in the orchestration of inflammation and confirm the usefulness of a selective FFA2R agonist and antagonist as tools for the exploration of the precise role of the FFA2R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5J7LL994RMlw2ofyr07jXfW6udTcc2ebIryiJzkb0h7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ovVKntw%253D%253D&md5=659fa2c5ec3199f270dbdd6273ee4e01</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.00161-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00161-16%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkman%26aufirst%3DL.%26aulast%3DMartensson%26aufirst%3DJ.%26aulast%3DWinther%26aufirst%3DM.%26aulast%3DGabl%26aufirst%3DM.%26aulast%3DHoldfeldt%26aufirst%3DA.%26aulast%3DUhrbom%26aufirst%3DM.%26aulast%3DBylund%26aufirst%3DJ.%26aulast%3DHojgaard%2BHansen%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DForsman%26aufirst%3DH.%26aulast%3DDahlgren%26aufirst%3DC.%26atitle%3DThe%2520neutrophil%2520response%2520induced%2520by%2520an%2520agonist%2520for%2520free%2520fatty%2520acid%2520receptor%25202%2520%2528GPR43%2529%2520Is%2520primed%2520by%2520tumor%2520necrosis%2520factor%2520alpha%2520and%2520by%2520receptor%2520uncoupling%2520from%2520the%2520cytoskeleton%2520but%2520attenuated%2520by%2520tissue%2520recruitment%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2016%26volume%3D36%26spage%3D2583%26epage%3D2595%26doi%3D10.1128%2FMCB.00161-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vermeire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojecký, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoflícek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinisch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kaem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beetens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, F.</span></span> <span> </span><span class="NLM_article-title">GLPG0974, an FFA2 antagonist, in ulcerative colitis: efficacy and safety in a multicenter proof-of-concept study</span>. <i>J. Crohn’s Colitis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S39</span>, <span class="refDoi"> DOI: 10.1093/ecco-jcc/jju027.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1093%2Fecco-jcc%2Fjju027.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=S39&issue=Suppl.+1&author=S.+Vermeireauthor=V.+Kojeck%C3%BDauthor=V.+Knofl%C3%ADcekauthor=W.+Reinischauthor=T.+Van+Kaemauthor=F.+Namourauthor=J.+Beetensauthor=F.+Vanhoutte&title=GLPG0974%2C+an+FFA2+antagonist%2C+in+ulcerative+colitis%3A+efficacy+and+safety+in+a+multicenter+proof-of-concept+study&doi=10.1093%2Fecco-jcc%2Fjju027.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fecco-jcc%2Fjju027.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fecco-jcc%252Fjju027.058%26sid%3Dliteratum%253Aachs%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DKojeck%25C3%25BD%26aufirst%3DV.%26aulast%3DKnofl%25C3%25ADcek%26aufirst%3DV.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DVan%2BKaem%26aufirst%3DT.%26aulast%3DNamour%26aufirst%3DF.%26aulast%3DBeetens%26aufirst%3DJ.%26aulast%3DVanhoutte%26aufirst%3DF.%26atitle%3DGLPG0974%252C%2520an%2520FFA2%2520antagonist%252C%2520in%2520ulcerative%2520colitis%253A%2520efficacy%2520and%2520safety%2520in%2520a%2520multicenter%2520proof-of-concept%2520study%26jtitle%3DJ.%2520Crohn%25E2%2580%2599s%2520Colitis%26date%3D2015%26volume%3D9%26issue%3DSuppl.%25201%26spage%3DS39%26doi%3D10.1093%2Fecco-jcc%2Fjju027.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolaczkowska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubes, P.</span></span> <span> </span><span class="NLM_article-title">Neutrophil recruitment and function in health and inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1038/nri3399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnri3399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=23435331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFygtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=159-175&author=E.+Kolaczkowskaauthor=P.+Kubes&title=Neutrophil+recruitment+and+function+in+health+and+inflammation&doi=10.1038%2Fnri3399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil recruitment and function in health and inflammation</span></div><div class="casAuthors">Kolaczkowska, Elzbieta; Kubes, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-175</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neutrophils have traditionally been thought of as simple foot soldiers of the innate immune system with a restricted set of pro-inflammatory functions.  More recently, it has become apparent that neutrophils are, in fact, complex cells capable of a vast array of specialized functions.  Although neutrophils are undoubtedly major effectors of acute inflammation, several lines of evidence indicate that they also contribute to chronic inflammatory conditions and adaptive immune responses.  Here, we discuss the key features of the life of a neutrophil, from its release from bone marrow to its death.  We discuss the possible existence of different neutrophil subsets and their putative anti-inflammatory roles.  We focus on how neutrophils are recruited to infected or injured tissues and describe differences in neutrophil recruitment between different tissues.  Finally, we explain the mechanisms that are used by neutrophils to promote protective or pathol. immune responses at different sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjXqyTwlRLmbVg90H21EOLACvtfcHk0lgCJCO3y9-_VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFygtbo%253D&md5=78d8d2753727fbddde0b6262fb8323bf</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnri3399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3399%26sid%3Dliteratum%253Aachs%26aulast%3DKolaczkowska%26aufirst%3DE.%26aulast%3DKubes%26aufirst%3DP.%26atitle%3DNeutrophil%2520recruitment%2520and%2520function%2520in%2520health%2520and%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26spage%3D159%26epage%3D175%26doi%3D10.1038%2Fnri3399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pizzonero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lemos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delerive, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopiejewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">L’Ebraly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancois, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavazais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manioc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelles, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polancec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quenehen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandeghinste, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saniere, L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: From hit to clinic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10044</span>– <span class="NLM_lpage">10057</span>, <span class="refDoi"> DOI: 10.1021/jm5012885</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012885" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10044-10057&author=M.+Pizzoneroauthor=S.+Dupontauthor=M.+Babelauthor=S.+Beaumontauthor=N.+Bienvenuauthor=R.+Blanqueauthor=L.+Cherelauthor=T.+Christopheauthor=B.+Crescenziauthor=E.+De+Lemosauthor=P.+Deleriveauthor=P.+Deprezauthor=S.+De+Vosauthor=F.+Djataauthor=S.+Fletcherauthor=S.+Kopiejewskiauthor=C.+L%E2%80%99Ebralyauthor=J.+M.+Lefrancoisauthor=S.+Lavazaisauthor=M.+Maniocauthor=L.+Nellesauthor=L.+Osteauthor=D.+Polancecauthor=V.+Quenehenauthor=F.+Soulasauthor=N.+Triballeauauthor=E.+M.+van+der+Aarauthor=N.+Vandeghinsteauthor=E.+Wakselmanauthor=R.+Brysauthor=L.+Saniere&title=Discovery+and+optimization+of+an+azetidine+chemical+series+as+a+free+fatty+acid+receptor+2+%28FFA2%29+antagonist%3A+From+hit+to+clinic&doi=10.1021%2Fjm5012885"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm5012885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012885%26sid%3Dliteratum%253Aachs%26aulast%3DPizzonero%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DBabel%26aufirst%3DM.%26aulast%3DBeaumont%26aufirst%3DS.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDe%2BLemos%26aufirst%3DE.%26aulast%3DDelerive%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DP.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DDjata%26aufirst%3DF.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DKopiejewski%26aufirst%3DS.%26aulast%3DL%25E2%2580%2599Ebraly%26aufirst%3DC.%26aulast%3DLefrancois%26aufirst%3DJ.%2BM.%26aulast%3DLavazais%26aufirst%3DS.%26aulast%3DManioc%26aufirst%3DM.%26aulast%3DNelles%26aufirst%3DL.%26aulast%3DOste%26aufirst%3DL.%26aulast%3DPolancec%26aufirst%3DD.%26aulast%3DQuenehen%26aufirst%3DV.%26aulast%3DSoulas%26aufirst%3DF.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%2BM.%26aulast%3DVandeghinste%26aufirst%3DN.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DSaniere%26aufirst%3DL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520an%2520azetidine%2520chemical%2520series%2520as%2520a%2520free%2520fatty%2520acid%2520receptor%25202%2520%2528FFA2%2529%2520antagonist%253A%2520From%2520hit%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10044%26epage%3D10057%26doi%3D10.1021%2Fjm5012885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinolo, M. A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoulakis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlooly-Y, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curi, R.</span></span> <span> </span><span class="NLM_article-title">SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e21205</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0021205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1371%2Fjournal.pone.0021205" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e21205&author=M.+A.+R.+Vinoloauthor=G.+J.+Fergusonauthor=S.+Kulkarniauthor=G.+Damoulakisauthor=K.+Andersonauthor=M.+Bohlooly-Yauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=R.+Curi&title=SCFAs+induce+mouse+neutrophil+chemotaxis+through+the+GPR43+receptor&doi=10.1371%2Fjournal.pone.0021205"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0021205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0021205%26sid%3Dliteratum%253Aachs%26aulast%3DVinolo%26aufirst%3DM.%2BA.%2BR.%26aulast%3DFerguson%26aufirst%3DG.%2BJ.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DDamoulakis%26aufirst%3DG.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DBohlooly-Y%26aufirst%3DM.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DCuri%26aufirst%3DR.%26atitle%3DSCFAs%2520induce%2520mouse%2520neutrophil%2520chemotaxis%2520through%2520the%2520GPR43%2520receptor%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De21205%26doi%3D10.1371%2Fjournal.pone.0021205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. R.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease</span>. <i>Scand. J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">sup216</span>),  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.3109/00365529609094568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.3109%2F00365529609094568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADyaK28XivFaktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1996&pages=132-148&issue=sup216&author=P.+B.+Mortensenauthor=M.+R.+Clausen&title=Short-chain+fatty+acids+in+the+human+colon%3A+relation+to+gastrointestinal+health+and+disease&doi=10.3109%2F00365529609094568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease</span></div><div class="casAuthors">Mortensen, P. Broebech; Clausen, M. Rye</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Gastroenterology, Supplement</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">216</span>),
    <span class="NLM_cas:pages">132-148</span>CODEN:
                <span class="NLM_cas:coden">SJGSB8</span>;
        ISSN:<span class="NLM_cas:issn">0085-5928</span>.
    
            (<span class="NLM_cas:orgname">Scandinavian University Press</span>)
        </div><div class="casAbstract">A review with 50 refs.  Fermn., the process whereby anaerobic bacteria break down carbohydrates to short-chain (C2-C6) fatty acids (SCAFs), is an important function of the large bowel.  SCFAs constitute approx. two-thirds of the colonic anion concn. (70-130 mmol/l), mainly as acetate, propionate, and butyrate.  Gastroenterologists have, in spite of these facts, addressed this scientific field surprisingly late, in contrast to veterinarians, for whom the fermentative prodn. of SCFAs has been acknowledged as a principal mechanism of intestinal digestion in plant-eating animals for decades.  Interest in the effects of SCFA prodn. on the human organism has been growing rapidly in the last 10 yr, because gastrointestinal functions and beneficial effects are assocd. with these acids.  SCFAs are of major importance in the understanding of the physiol. function of dietary fiber and their possible role for colonic neoplasia.  SCFA prodn. and absorption are closely related to the nourishment of the colonic mucosa and sodium and water absorption, and mechanisms of diarrhea.  Patients with severe malabsorption compensate by the fermn. of otherwise osmotic active saccharides to SCFAs, which are readily absorbed and used as energy fuels in the organism.  SCFA prodn. from dietary carbohydrates is a mechanism whereby considerable amts. of calories can be salvaged in short-bowel patients with remaining colonic function if dietary treatment is adjusted.  SCFA enemas are a new and promising treatment modality for patients with ulcerative colitis.  The effect has been attributed to the oxidn. of SCFAs in the colonocytes.  An impressive no. of papers have described the effects of butyrate on various cell functions, the significance of which is still unknown.  Up until now, attention has been related esp. to cancer prophylaxis and treatment.  Diminished prodn. of SCFAs appears to be involved in antibiotic-assocd. diarrhea, diversion colitis, and possibly in pouchitis.  The interaction between bacterial fermn., ammonia metab., and bacterial growth and protein synthesis appears to be the main mechanism of action of lactulose treatment in hepatic coma.  Pathol. and extremely high rates of saccharide fermn. explain the severe deterioration in patients with D-lactate acidosis.  Hence, this scientific field has come late to clin. working gastroenterologists, but as work is progressing the prodn. of SCFAs in the large bowel becomes involved in several well-known intestinal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8A0DXrNPRlLVg90H21EOLACvtfcHk0ljR79nTJrT6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFaktr8%253D&md5=46fda9626415b54b0276aa0b30e04a45</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3109%2F00365529609094568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00365529609094568%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DP.%2BB.%26aulast%3DClausen%26aufirst%3DM.%2BR.%26atitle%3DShort-chain%2520fatty%2520acids%2520in%2520the%2520human%2520colon%253A%2520relation%2520to%2520gastrointestinal%2520health%2520and%2520disease%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D1996%26volume%3D31%26issue%3Dsup216%26spage%3D132%26epage%3D148%26doi%3D10.3109%2F00365529609094568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiszmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baribault, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">4519</span>– <span class="NLM_lpage">4526</span>, <span class="refDoi"> DOI: 10.1210/en.2008-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1210%2Fen.2008-0059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=4519-4526&author=H.+Geauthor=X.+Liauthor=J.+Weiszmannauthor=P.+Wangauthor=H.+Baribaultauthor=J.+L.+Chenauthor=H.+Tianauthor=Y.+Li&title=Activation+of+G+protein-coupled+receptor+43+in+adipocytes+leads+to+inhibition+of+lipolysis+and+suppression+of+plasma+free+fatty+acids&doi=10.1210%2Fen.2008-0059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1210%2Fen.2008-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2008-0059%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWeiszmann%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DBaribault%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DActivation%2520of%2520G%2520protein-coupled%2520receptor%252043%2520in%2520adipocytes%2520leads%2520to%2520inhibition%2520of%2520lipolysis%2520and%2520suppression%2520of%2520plasma%2520free%2520fatty%2520acids%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D4519%26epage%3D4526%26doi%3D10.1210%2Fen.2008-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhQYK-6I88vdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span> <i>CrysAlis PRO 1.171.39.12b</i>; <span class="NLM_publisher-name">Rigaku
Oxford Diffraction</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CrysAlis+PRO+1.171.39.12b%3B+Rigaku%0AOxford+Diffraction%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCrysAlis%2520PRO%25201.171.39.12b%26pub%3DRigaku%250AOxford%2520Diffraction%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubschle, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich, B.</span></span> <span> </span><span class="NLM_article-title">ShelXle: a Qt graphical user interface for SHELXL</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1107/S0021889811043202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1107%2FS0021889811043202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22477785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC2sbovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1281-1284&author=C.+B.+Hubschleauthor=G.+M.+Sheldrickauthor=B.+Dittrich&title=ShelXle%3A+a+Qt+graphical+user+interface+for+SHELXL&doi=10.1107%2FS0021889811043202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">ShelXle: a Qt graphical user interface for SHELXL</span></div><div class="casAuthors">Hubschle Christian B; Sheldrick George M; Dittrich Birger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of applied crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">Pt 6</span>),
    <span class="NLM_cas:pages">1281-1284</span>
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">ShelXle is a graphical user interface for SHELXL [Sheldrick, G.  M. (2008).  Acta Cryst.  A64, 112-122], currently the most widely used program for small-molecule structure refinement.  It combines an editor with syntax highlighting for the SHELXL-associated .ins (input) and .res (output) files with an interactive graphical display for visualization of a three-dimensional structure including the electron density (F(o)) and difference density (F(o)-F(c)) maps.  Special features of ShelXle include intuitive atom (re-)naming, a strongly coupled editor, structure visualization in various mono and stereo modes, and a novel way of displaying disorder extending over special positions.  ShelXle is completely compatible with all features of SHELXL and is written entirely in C++ using the Qt4 and FFTW libraries.  It is available at no cost for Windows, Linux and Mac-OS X and as source code.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrmOUws2S_g0EgZCMqtRBifW6udTcc2ea97uUG-aBxtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbovFKktw%253D%253D&md5=9f345940dd39778a2e921e7020ebff8f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0021889811043202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889811043202%26sid%3Dliteratum%253Aachs%26aulast%3DHubschle%26aufirst%3DC.%2BB.%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26aulast%3DDittrich%26aufirst%3DB.%26atitle%3DShelXle%253A%2520a%2520Qt%2520graphical%2520user%2520interface%2520for%2520SHELXL%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2011%26volume%3D44%26spage%3D1281%26epage%3D1284%26doi%3D10.1107%2FS0021889811043202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G.</span></span> <span> </span><span class="NLM_article-title">SHELXT - Integrated space-group and crystal-structure determination</span>. <i>Acta Crystallogr., Sect. A: Found. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+Sheldrick&title=SHELXT+-+Integrated+space-group+and+crystal-structure+determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0lhQYK-6I88vdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%26atitle%3DSHELXT%2520-%2520Integrated%2520space-group%2520and%2520crystal-structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+structure+refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lh7JJtaoZFldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520structure%2520refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirozane, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kefala, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruswitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span> <span> </span><span class="NLM_article-title">High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1038/nature13494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnature13494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25043059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=124-127&author=A.+Srivastavaauthor=J.+Yanoauthor=Y.+Hirozaneauthor=G.+Kefalaauthor=F.+Gruswitzauthor=G.+Snellauthor=W.+Laneauthor=A.+Ivetacauthor=K.+Aertgeertsauthor=J.+Nguyenauthor=A.+Jenningsauthor=K.+Okada&title=High-resolution+structure+of+the+human+GPR40+receptor+bound+to+allosteric+agonist+TAK-875&doi=10.1038%2Fnature13494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875</span></div><div class="casAuthors">Srivastava, Ankita; Yano, Jason; Hirozane, Yoshihiko; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy; Okada, Kengo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7516</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human GPR40 receptor (hGPR40), also known as free fatty-acid receptor 1 (FFAR1), is a G-protein-coupled receptor that binds long-chain free fatty acids to enhance glucose-dependent insulin secretion.  Novel treatments for type-2 diabetes mellitus are therefore possible by targeting hGPR40 with partial or full agonists.  TAK-875, or fasiglifam, is an orally available, potent and selective partial agonist of hGPR40 receptor, which reached phase III clin. trials for the potential treatment of type-2 diabetes mellitus.  Data from clin. studies indicate that TAK-875, which is an ago-allosteric modulator of hGPR40 (ref. 3), demonstrates improved glycemic control and low hypoglycemic risk in diabetic patients.  Here the authors report the crystal structure of hGPR40 receptor bound to TAK-875 at 2.3 Å resoln.  The co-complex structure reveals a unique binding mode of TAK-875 and suggests that entry to the non-canonical binding pocket most probably occurs via the lipid bilayer.  The at. details of the extensive charge network in the ligand binding pocket reveal addnl. interactions not identified in previous studies and contribute to a clear understanding of TAK-875 binding to the receptor.  The hGPR40-TAK-875 structure also provides insights into the plausible binding of multiple ligands to the receptor, which has been obsd. in radioligand binding and Ca2+ influx assay studies.  Comparison of the transmembrane helix architecture with other G-protein-coupled receptors suggests that the crystd. TAK-875-bound hGPR40 complex is in an inactive-like state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9EJ42g7iaLVg90H21EOLACvtfcHk0lh7JJtaoZFldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhurvK&md5=06e38fa105ab0783715a541bc2008311</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature13494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13494%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DHirozane%26aufirst%3DY.%26aulast%3DKefala%26aufirst%3DG.%26aulast%3DGruswitz%26aufirst%3DF.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DHigh-resolution%2520structure%2520of%2520the%2520human%2520GPR40%2520receptor%2520bound%2520to%2520allosteric%2520agonist%2520TAK-875%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D124%26epage%3D127%26doi%3D10.1038%2Fnature13494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallicchio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, R. M.</span></span> <span> </span><span class="NLM_article-title">Integrated modeling program, applied chemical theory (IMPACT)</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1780</span>, <span class="refDoi"> DOI: 10.1002/jcc.20292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1002%2Fjcc.20292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=16211539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1752-1780&author=J.+L.+Banksauthor=H.+S.+Beardauthor=Y.+Caoauthor=A.+E.+Choauthor=W.+Dammauthor=R.+Faridauthor=A.+K.+Feltsauthor=T.+A.+Halgrenauthor=D.+T.+Mainzauthor=J.+R.+Mapleauthor=R.+Murphyauthor=D.+M.+Philippauthor=M.+P.+Repaskyauthor=L.+Y.+Zhangauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=E.+Gallicchioauthor=R.+M.+Levy&title=Integrated+modeling+program%2C+applied+chemical+theory+%28IMPACT%29&doi=10.1002%2Fjcc.20292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated modeling program, applied chemical theory (IMPACT)</span></div><div class="casAuthors">Banks, Jay L.; Beard, Hege S.; Cao, Yixiang; Cho, Art E.; Damm, Wolfgang; Farid, Ramy; Felts, Anthony K.; Halgren, Thomas A.; Mainz, Daniel T.; Maple, Jon R.; Murphy, Robert; Philipp, Dean M.; Repasky, Matthew P.; Zhang, Linda Y.; Berne, Bruce J.; Friesner, Richard A.; Gallicchio, Emilio; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1752-1780</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  We provide an overview of the IMPACT mol. mechanics program with an emphasis on recent developments and a description of its current functionality.  With respect to core mol. mechanics technologies we include a status report for the fixed charge and polarizable force fields that can be used with the program and illustrate how the force fields, when used together with new atom typing and parameter assignment modules, have greatly expanded the coverage of org. compds. and medicinally relevant ligands.  As we discuss in this review, explicit solvent simulations have been used to guide our design of implicit solvent models based on the generalized Born framework and a novel nonpolar estimator that have recently been incorporated into the program.  With IMPACT it is possible to use several different advanced conformational sampling algorithms based on combining features of mol. dynamics and Monte Carlo simulations.  The program includes two specialized mol. mechanics modules: Glide, a high-throughput docking program, and QSite, a mixed quantum mechanics/mol. mechanics module.  These modules employ the IMPACT infrastructure as a starting point for the construction of the protein model and assignment of mol. mechanics parameters, but have then been developed to meet specialized objectives with respect to sampling and the energy function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZX2FzcGWGM7Vg90H21EOLACvtfcHk0lh7JJtaoZFldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI&md5=0094f15727c7fb77a0fae16ccf8292f0</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20292%26sid%3Dliteratum%253Aachs%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BK.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DIntegrated%2520modeling%2520program%252C%2520applied%2520chemical%2520theory%2520%2528IMPACT%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1752%26epage%3D1780%26doi%3D10.1002%2Fjcc.20292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimpukade, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">20345</span>– <span class="NLM_lpage">20358</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.561449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M114.561449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=24860101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=20345-20358&author=B.+D.+Hudsonauthor=B.+Shimpukadeauthor=G.+Milliganauthor=T.+Ulven&title=The+molecular+basis+of+ligand+interaction+at+free+fatty+acid+receptor+4+%28FFA4%2FGPR120%29&doi=10.1074%2Fjbc.M114.561449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)</span></div><div class="casAuthors">Hudson, Brian D.; Shimpukade, Bharat; Milligan, Graeme; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">20345-20358</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The long-chain fatty acid receptor FFA4 (previously GPR120) is receiving substantial interest as a novel target for the treatment of metabolic and inflammatory disease.  This study examines for the first time the detailed mode of binding of both long-chain fatty acid and synthetic agonist ligands at FFA4 by integrating mol. modeling, receptor mutagenesis, and ligand structure-activity relationship approaches in an iterative format.  In doing so, residues required for binding of fatty acid and synthetic agonists to FFA4 have been identified.  This has allowed for the refinement of a well validated model of the mode of ligand-FFA4 interaction that will be invaluable in the identification of novel ligands and the future development of this receptor as a therapeutic target.  The model reliably predicted the effects of substituent variations on agonist potency, and it was also able to predict the qual. effect of binding site mutations in the majority of cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWoimY0slQW7Vg90H21EOLACvtfcHk0liEsHRqKpBY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7zN&md5=d59c40e7f5ffd13e5a50f114a347e041</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.561449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.561449%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DThe%2520molecular%2520basis%2520of%2520ligand%2520interaction%2520at%2520free%2520fatty%2520acid%2520receptor%25204%2520%2528FFA4%252FGPR120%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D20345%26epage%3D20358%26doi%3D10.1074%2Fjbc.M114.561449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caltabiano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCallum, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicklin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawcett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1124%2Fmol.113.089482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=24113750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtV2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=91-104&author=A.+E.+MacKenzieauthor=G.+Caltabianoauthor=T.+C.+Kentauthor=L.+Jenkinsauthor=J.+E.+McCallumauthor=B.+D.+Hudsonauthor=S.+A.+Nicklinauthor=L.+Fawcettauthor=R.+Markwickauthor=S.+J.+Charltonauthor=G.+Milligan&title=The+antiallergic+mast+cell+stabilizers+lodoxamide+and+bufrolin+as+the+first+high+and+equipotent+agonists+of+human+and+rat+GPR35&doi=10.1124%2Fmol.113.089482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35</span></div><div class="casAuthors">MacKenzie, Amanda E.; Caltabiano, Gianluigi; Kent, Toby C.; Jenkins, Laura; McCallum, Jennifer E.; Hudson, Brian D.; Nicklin, Stuart A.; Fawcett, Lindsay; Markwick, Rachel; Charlton, Steven J.; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-104, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lack of high potency agonists has restricted anal. of the G protein-coupled receptor GPR35.  Moreover, marked variation in potency and/or affinity of current ligands between human and rodent orthologs of GPR35 has limited their productive use in rodent models of physiol.  Based on the reported modest potency of the antiasthma and antiallergic ligands cromolyn disodium and nedocromil sodium, we identified the related compds. lodoxamide and bufrolin as high potency agonists of human GPR35.  Unlike previously identified high potency agonists that are highly selective for human GPR35, both lodoxamide and bufrolin displayed equiv. potency at rat GPR35.  Further synthetic antiallergic ligands, either sharing features of the std. surrogate agonist zaprinast, or with lodoxamide and bufrolin, were also shown to display agonism at either human or rat GPR35.  Because both lodoxamide and bufrolin are sym. di-acids, their potential mode of binding was explored via mutagenesis based on swapping between the rat and human ortholog nonconserved arginine residues within proximity of a key conserved arginine at position 3.36.  Computational modeling and ligand docking predicted the contributions of different arginine residues, other than at 3.36, in human GPR35 for these two ligands and were consistent with selective loss of potency of either bufrolin or lodoxamide at distinct arginine mutants.  The computational models also suggested that bufrolin and lodoxamide would display reduced potency at a low-frequency human GPR35 single nucleotide polymorphism.  This prediction was confirmed exptl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6HODMUQaxXLVg90H21EOLACvtfcHk0liEsHRqKpBY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtV2msrg%253D&md5=9b04b63eca46f1ec3ef97c302e138bda</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089482%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DA.%2BE.%26aulast%3DCaltabiano%26aufirst%3DG.%26aulast%3DKent%26aufirst%3DT.%2BC.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DMcCallum%26aufirst%3DJ.%2BE.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DNicklin%26aufirst%3DS.%2BA.%26aulast%3DFawcett%26aufirst%3DL.%26aulast%3DMarkwick%26aufirst%3DR.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DThe%2520antiallergic%2520mast%2520cell%2520stabilizers%2520lodoxamide%2520and%2520bufrolin%2520as%2520the%2520first%2520high%2520and%2520equipotent%2520agonists%2520of%2520human%2520and%2520rat%2520GPR35%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D91%26epage%3D104%26doi%3D10.1124%2Fmol.113.089482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Curto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Using the Flp-In T-Rex system to regulate GPCR expression</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>746</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1007/978-1-61779-126-0_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F978-1-61779-126-0_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=21607850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvVakt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=746&publication_year=2011&pages=21-37&author=R.+J.+Wardauthor=E.+Alvarez-Curtoauthor=G.+Milligan&title=Using+the+Flp-In+T-Rex+system+to+regulate+GPCR+expression&doi=10.1007%2F978-1-61779-126-0_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Flp-In T-Rex system to regulate GPCR expression</span></div><div class="casAuthors">Ward, Richard J.; Alvarez-Curto, Elisa; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">746</span>
        (<span class="NLM_cas:issue">Receptor Signal Transduction Protocols</span>),
    <span class="NLM_cas:pages">21-37</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The development of a cell-based system that allows the integration of a gene of interest (GOI), such as a G protein-coupled receptor (GPCR), into a specific site on the genome, has made the generation of mammalian cell lines able to express such proteins easy and efficient.  Flp-In stable cell lines are isogenic and hence protein expression is const. across a population of cells.  A useful addn. to the Flp-In system (Flp-In T-Rex) allows this expression to be controlled by the addn. of a small mol. inducer to the cell culture medium.  Stable cell lines generated as described here can be used to great advantage in the study of receptor pharmacol. signalling and oligomerisation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3ej4RV6KcvbVg90H21EOLACvtfcHk0liEsHRqKpBY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvVakt78%253D&md5=3190b03c0663c4d6d17f4366dff6b155</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-126-0_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-126-0_2%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Curto%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DUsing%2520the%2520Flp-In%2520T-Rex%2520system%2520to%2520regulate%2520GPCR%2520expression%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D746%26spage%3D21%26epage%3D37%26doi%3D10.1007%2F978-1-61779-126-0_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersson, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konig, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurowska-Stolarska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">18915</span>– <span class="NLM_lpage">18931</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.736157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M116.736157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=27385588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGgurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=18915-18931&author=D.+Bologniniauthor=C.+E.+Mossauthor=K.+Nilssonauthor=A.+U.+Peterssonauthor=I.+Donnellyauthor=E.+Sergeevauthor=G.+M.+Konigauthor=E.+Kostenisauthor=M.+Kurowska-Stolarskaauthor=A.+Millerauthor=N.+Dekkerauthor=A.+B.+Tobinauthor=G.+Milligan&title=A+novel+allosteric+activator+of+free+fatty+acid+2+receptor+displays+unique+Gi-functional+bias&doi=10.1074%2Fjbc.M116.736157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias</span></div><div class="casAuthors">Bolognini, Daniele; Moss, Catherine E.; Nilsson, Karolina; Petersson, Annika U.; Donnelly, Iona; Sergeev, Eugenia; Konig, Gabriele M.; Kostenis, Evi; Kurowska-Stolarska, Mariola; Miller, Ashley; Dekker, Niek; Tobin, Andrew B.; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">18915-18931</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The short chain fatty acid receptor FFA2 is able to stimulate signaling via both Gi- and Gq/G11-promoted pathways.  These pathways are believed to control distinct physiol. end points but FFA2 receptor ligands appropriate to test this hypothesis have been lacking.  Herein, we characterize AZ1729, a novel FFA2 regulator that acts as a direct allosteric agonist and as a pos. allosteric modulator, increasing the activity of the endogenously produced short chain fatty acid propionate in Gi-mediated pathways, but not at those transduced by Gq/G11.  Using AZ1729 in combination with direct inhibitors of Gi and Gq/G11 family G proteins demonstrated that although both arms contribute to propionate-mediated regulation of phospho-ERK1/2 MAP kinase signaling in FFA2-expressing 293 cells, the Gq/G11-mediated pathway is predominant.  We extend these studies by employing AZ1729 to dissect physiol. FFA2 signaling pathways.  The capacity of AZ1729 to act at FFA2 receptors to inhibit β-adrenoreceptor agonist-promoted lipolysis in primary mouse adipocytes and to promote chemotaxis of isolated human neutrophils confirmed these as FFA2 processes mediated by Gi signaling, whereas, in concert with blockade by the Gq/G11 inhibitor FR900359, the inability of AZ1729 to mimic or regulate propionate-mediated release of GLP-1 from mouse colonic prepns. defined this physiol. response as an end point transduced via activation of Gq/G11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6ZUDPWavu7Vg90H21EOLACvtfcHk0liEsHRqKpBY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGgurjJ&md5=b06b876cff3073786d297734496afe8f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.736157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.736157%26sid%3Dliteratum%253Aachs%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DMoss%26aufirst%3DC.%2BE.%26aulast%3DNilsson%26aufirst%3DK.%26aulast%3DPetersson%26aufirst%3DA.%2BU.%26aulast%3DDonnelly%26aufirst%3DI.%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DKonig%26aufirst%3DG.%2BM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKurowska-Stolarska%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DDekker%26aufirst%3DN.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DA%2520novel%2520allosteric%2520activator%2520of%2520free%2520fatty%2520acid%25202%2520receptor%2520displays%2520unique%2520Gi-functional%2520bias%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D18915%26epage%3D18931%26doi%3D10.1074%2Fjbc.M116.736157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. R.</span></span> <span> </span><span class="NLM_article-title">In vitro drug metabolism using liver microsomes</span>. <i>Curr. Protoc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7.8.1</span>– <span class="NLM_lpage">7.8.11</span>, <span class="refDoi"> DOI: 10.1002/0471141755.ph0708s23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1002%2F0471141755.ph0708s23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7.8.1-7.8.11&author=J.+R.+Hill&title=In+vitro+drug+metabolism+using+liver+microsomes&doi=10.1002%2F0471141755.ph0708s23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2F0471141755.ph0708s23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471141755.ph0708s23%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BR.%26atitle%3DIn%2520vitro%2520drug%2520metabolism%2520using%2520liver%2520microsomes%26jtitle%3DCurr.%2520Protoc.%2520Pharmacol.%26date%3D2003%26volume%3D23%26spage%3D7.8.1%26epage%3D7.8.11%26doi%3D10.1002%2F0471141755.ph0708s23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radhika Amaradhi, Avijit Banik, Shabber Mohammed, Vidyavathi Patro, Asheebo Rojas, Wenyi Wang, Damoder Reddy Motati, Ray Dingledine, <span class="NLM_string-name hlFld-ContribAuthor">Thota Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1032-1050. <a href="https://doi.org/10.1021/acs.jmedchem.9b01218" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01218%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252BWater%252BSoluble%25252C%252BBrain-Permeable%252BEP2%252BReceptor%252BAntagonist%252Bfor%252BUse%252Bin%252BCentral%252BNervous%252BSystem%252BDisease%252BModels%26aulast%3DAmaradhi%26aufirst%3DRadhika%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14082019%26date%3D16012020%26date%3D06012020%26volume%3D63%26issue%3D3%26spage%3D1032%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Daniella  Carretta</span>, <span class="hlFld-ContribAuthor ">John  Quiroga</span>, <span class="hlFld-ContribAuthor ">Rodrigo  López</span>, <span class="hlFld-ContribAuthor ">María Angélica  Hidalgo</span>, <span class="hlFld-ContribAuthor ">Rafael Agustín  Burgos</span>. </span><span class="cited-content_cbyCitation_article-title">Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphys.2021.662739" title="DOI URL">https://doi.org/10.3389/fphys.2021.662739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2021.662739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2021.662739%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DParticipation%252Bof%252BShort-Chain%252BFatty%252BAcids%252Band%252BTheir%252BReceptors%252Bin%252BGut%252BInflammation%252Band%252BColon%252BCancer%26aulast%3DCarretta%26aufirst%3DMar%25C3%25ADa%2BDaniella%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Graeme  Milligan</span>, <span class="hlFld-ContribAuthor ">Natasja  Barki</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>. </span><span class="cited-content_cbyCitation_article-title">Chemogenetic Approaches to Explore the Functions of Free Fatty Acid Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (3)
                                     , 191-202. <a href="https://doi.org/10.1016/j.tips.2020.12.003" title="DOI URL">https://doi.org/10.1016/j.tips.2020.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DChemogenetic%252BApproaches%252Bto%252BExplore%252Bthe%252BFunctions%252Bof%252BFree%252BFatty%252BAcid%252BReceptor%252B2%26aulast%3DMilligan%26aufirst%3DGraeme%26date%3D2021%26volume%3D42%26issue%3D3%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Ghislain</span>, <span class="hlFld-ContribAuthor ">Vincent  Poitout</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Endocrinology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (3)
                                     , 162-175. <a href="https://doi.org/10.1038/s41574-020-00459-w" title="DOI URL">https://doi.org/10.1038/s41574-020-00459-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41574-020-00459-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41574-020-00459-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Endocrinology%26atitle%3DTargeting%252Blipid%252BGPCRs%252Bto%252Btreat%252Btype%2525C2%2525A02%252Bdiabetes%252Bmellitus%252B%2525E2%252580%252594%252Bprogress%252Band%252Bchallenges%26aulast%3DGhislain%26aufirst%3DJulien%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D3%26spage%3D162%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Estela  Lorza-Gil</span>, <span class="hlFld-ContribAuthor ">Gabriele  Kaiser</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Rexen Ulven</span>, <span class="hlFld-ContribAuthor ">Gabriele M.  König</span>, <span class="hlFld-ContribAuthor ">Felicia  Gerst</span>, <span class="hlFld-ContribAuthor ">Morgana Barroso  Oquendo</span>, <span class="hlFld-ContribAuthor ">Andreas L.  Birkenfeld</span>, <span class="hlFld-ContribAuthor ">Hans-Ulrich  Häring</span>, <span class="hlFld-ContribAuthor ">Evi  Kostenis</span>, <span class="hlFld-ContribAuthor ">Trond  Ulven</span>, <span class="hlFld-ContribAuthor ">Susanne  Ullrich</span>. </span><span class="cited-content_cbyCitation_article-title">FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-73467-5" title="DOI URL">https://doi.org/10.1038/s41598-020-73467-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-73467-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-73467-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFFA2-%25252C%252Bbut%252Bnot%252BFFA3-agonists%252Binhibit%252BGSIS%252Bof%252Bhuman%252Bpseudoislets%25253A%252Ba%252Bcomparative%252Bstudy%252Bwith%252Bmouse%252Bislets%252Band%252Brat%252BINS-1E%252Bcells%26aulast%3DLorza-Gil%26aufirst%3DEstela%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James I.  Fells</span>, <span class="hlFld-ContribAuthor ">Xi  Ai</span>, <span class="hlFld-ContribAuthor ">Adam  Weinglass</span>, <span class="hlFld-ContribAuthor ">Wen  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Lei</span>, <span class="hlFld-ContribAuthor ">Michael  Finley</span>, <span class="hlFld-ContribAuthor ">Hamid R.  Hoveyda</span>, <span class="hlFld-ContribAuthor ">Graeme L.  Fraser</span>, <span class="hlFld-ContribAuthor ">Michelle  Machacek</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of free fatty acid receptor 2 agonists using virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127460. <a href="https://doi.org/10.1016/j.bmcl.2020.127460" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127460%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bfree%252Bfatty%252Bacid%252Breceptor%252B2%252Bagonists%252Busing%252Bvirtual%252Bscreening%26aulast%3DFells%26aufirst%3DJames%2BI.%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathy-Ann  Secker</span>, <span class="hlFld-ContribAuthor ">Lukas  Bruns</span>, <span class="hlFld-ContribAuthor ">Hildegard  Keppeler</span>, <span class="hlFld-ContribAuthor ">Johan  Jeong</span>, <span class="hlFld-ContribAuthor ">Thomas  Hentrich</span>, <span class="hlFld-ContribAuthor ">Julia M.  Schulze-Hentrich</span>, <span class="hlFld-ContribAuthor ">Barbara  Mankel</span>, <span class="hlFld-ContribAuthor ">Falko  Fend</span>, <span class="hlFld-ContribAuthor ">Dominik  Schneidawind</span>, <span class="hlFld-ContribAuthor ">Corina  Schneidawind</span>. </span><span class="cited-content_cbyCitation_article-title">Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1487. <a href="https://doi.org/10.3390/cancers12061487" title="DOI URL">https://doi.org/10.3390/cancers12061487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061487%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DOnly%252BHematopoietic%252BStem%252Band%252BProgenitor%252BCells%252Bfrom%252BCord%252BBlood%252BAre%252BSusceptible%252Bto%252BMalignant%252BTransformation%252Bby%252BMLL-AF4%252BTranslocations%26aulast%3DSecker%26aufirst%3DKathy-Ann%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Baaske</span>, <span class="hlFld-ContribAuthor ">Franziska  Masur</span>, <span class="hlFld-ContribAuthor ">Franziska  Dengler</span>, <span class="hlFld-ContribAuthor ">Reiko  Rackwitz</span>, <span class="hlFld-ContribAuthor ">Bastian  Kaiser</span>, <span class="hlFld-ContribAuthor ">Helga  Pfannkuche</span>, <span class="hlFld-ContribAuthor ">Gotthold  Gäbel</span>. </span><span class="cited-content_cbyCitation_article-title">Possible influence of free fatty acid receptors on pH regulation in the ruminal epithelium of sheep. </span><span class="cited-content_cbyCitation_journal-name">Journal of Animal Physiology and Animal Nutrition</span><span> <strong>2020,</strong> <em>104 </em>
                                    (3)
                                     , 776-789. <a href="https://doi.org/10.1111/jpn.13308" title="DOI URL">https://doi.org/10.1111/jpn.13308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jpn.13308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjpn.13308%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Animal%2520Physiology%2520and%2520Animal%2520Nutrition%26atitle%3DPossible%252Binfluence%252Bof%252Bfree%252Bfatty%252Bacid%252Breceptors%252Bon%252BpH%252Bregulation%252Bin%252Bthe%252Bruminal%252Bepithelium%252Bof%252Bsheep%26aulast%3DBaaske%26aufirst%3DLisa%26date%3D2020%26date%3D2020%26volume%3D104%26issue%3D3%26spage%3D776%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentin  Sencio</span>, <span class="hlFld-ContribAuthor ">Adeline  Barthelemy</span>, <span class="hlFld-ContribAuthor ">Luciana P.  Tavares</span>, <span class="hlFld-ContribAuthor ">Marina G.  Machado</span>, <span class="hlFld-ContribAuthor ">Daphnée  Soulard</span>, <span class="hlFld-ContribAuthor ">Céline  Cuinat</span>, <span class="hlFld-ContribAuthor ">Celso Martins  Queiroz-Junior</span>, <span class="hlFld-ContribAuthor ">Marie-Louise  Noordine</span>, <span class="hlFld-ContribAuthor ">Sophie  Salomé-Desnoulez</span>, <span class="hlFld-ContribAuthor ">Lucie  Deryuter</span>, <span class="hlFld-ContribAuthor ">Benoit  Foligné</span>, <span class="hlFld-ContribAuthor ">Céline  Wahl</span>, <span class="hlFld-ContribAuthor ">Benoit  Frisch</span>, <span class="hlFld-ContribAuthor ">Angelica T.  Vieira</span>, <span class="hlFld-ContribAuthor ">Christophe  Paget</span>, <span class="hlFld-ContribAuthor ">Graeme  Milligan</span>, <span class="hlFld-ContribAuthor ">Trond  Ulven</span>, <span class="hlFld-ContribAuthor ">Isabelle  Wolowczuk</span>, <span class="hlFld-ContribAuthor ">Christelle  Faveeuw</span>, <span class="hlFld-ContribAuthor ">Ronan  Le Goffic</span>, <span class="hlFld-ContribAuthor ">Muriel  Thomas</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Ferreira</span>, <span class="hlFld-ContribAuthor ">Mauro M.  Teixeira</span>, <span class="hlFld-ContribAuthor ">François  Trottein</span>. </span><span class="cited-content_cbyCitation_article-title">Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2020,</strong> <em>30 </em>
                                    (9)
                                     , 2934-2947.e6. <a href="https://doi.org/10.1016/j.celrep.2020.02.013" title="DOI URL">https://doi.org/10.1016/j.celrep.2020.02.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2020.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2020.02.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DGut%252BDysbiosis%252Bduring%252BInfluenza%252BContributes%252Bto%252BPulmonary%252BPneumococcal%252BSuperinfection%252Bthrough%252BAltered%252BShort-Chain%252BFatty%252BAcid%252BProduction%26aulast%3DSencio%26aufirst%3DValentin%26date%3D2020%26volume%3D30%26issue%3D9%26spage%3D2934%26epage%3D2947.e6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuya  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Akinobu  Akatsuka</span>, <span class="hlFld-ContribAuthor ">Shingo  Dan</span>, <span class="hlFld-ContribAuthor ">Hiroki  Iwasaki</span>, <span class="hlFld-ContribAuthor ">Masayuki  Yamashita</span>, <span class="hlFld-ContribAuthor ">Naoto  Kojima</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and cancer cell growth inhibition effects of acetogenin analogs bearing ethylene glycol units for enhancing the water solubility. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (13)
                                     , 131058. <a href="https://doi.org/10.1016/j.tet.2020.131058" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131058%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Band%252Bcancer%252Bcell%252Bgrowth%252Binhibition%252Beffects%252Bof%252Bacetogenin%252Banalogs%252Bbearing%252Bethylene%252Bglycol%252Bunits%252Bfor%252Benhancing%252Bthe%252Bwater%252Bsolubility%26aulast%3DMatsumoto%26aufirst%3DTakuya%26date%3D2020%26volume%3D76%26issue%3D13%26spage%3D131058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Bartoszek</span>, <span class="hlFld-ContribAuthor ">Ee Von  Moo</span>, <span class="hlFld-ContribAuthor ">Agata  Binienda</span>, <span class="hlFld-ContribAuthor ">Adam  Fabisiak</span>, <span class="hlFld-ContribAuthor ">Julia B.  Krajewska</span>, <span class="hlFld-ContribAuthor ">Paula  Mosińska</span>, <span class="hlFld-ContribAuthor ">Karolina  Niewinna</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Tarasiuk</span>, <span class="hlFld-ContribAuthor ">Kirill  Martemyanov</span>, <span class="hlFld-ContribAuthor ">Maciej  Salaga</span>, <span class="hlFld-ContribAuthor ">Jakub  Fichna</span>. </span><span class="cited-content_cbyCitation_article-title">Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104604. <a href="https://doi.org/10.1016/j.phrs.2019.104604" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104604%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DFree%252BFatty%252BAcid%252BReceptors%252Bas%252Bnew%252Bpotential%252Btherapeutic%252Btarget%252Bin%252Binflammatory%252Bbowel%252Bdiseases%26aulast%3DBartoszek%26aufirst%3DAdrian%26date%3D2020%26volume%3D152%26spage%3D104604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. FFA2 Modulators<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>clogP values are calculated using ChemBioDraw v16.0.1.4. pIC<sub>50</sub> for <b>1</b> and pEC<sub>50</sub> for <b>2</b> and <b>3</b> are previously reported.<a onclick="showRef(event, 'ref28 ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref30 ref32">(28,30,32)</a></p></p></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolidines <b>4</b> and <b>37</b> from <span class="smallcaps smallerCapital">l</span>-Pyroglutamic Acid<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, rt, 70%; (b) Boc<sub>2</sub>O, DMAP, DCM, rt, 4 h, 98%; (c) (i) 1-iodo-2-chlorobenzene, <i>n</i>-BuLi, THF, 20 min at −78 °C → rt; (ii) sat. aq NH<sub>4</sub>Cl, 67%; (d) TFA, DCM, rt, 98%; (e) NaBH<sub>3</sub>CN, AcOH (cat.), MeOH, rt, 71% (<i>cis</i>/<i>trans</i> 2:1, 49%/22%); (f) carboxylic acid, BTFFH, DIPEA, DCM, 80 °C, 8 h, 75%; (g) LiOH (aq), THF, rt, 42–93%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of (2<i>R</i>,4<i>R</i>)-<i>N</i>-Acylthiazolidine-4-carboxylic Acids from (<i>R</i>)-Cys-OMe<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>O/EtOH 1:1, KHCO<sub>3</sub>, rt, 4–24 h, 63–81%; (b) benzoyl chlorides, Et<sub>3</sub>N, −10 °C → rt, THF, 1–14 h, 21–83%; (c) LiI, EtOAc, 80 °C, 24–92%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Biaryl Analogues via Coupling Reactions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ArB(OH)<sub>2</sub> or ArBPin, Pd(PPh<sub>3</sub>)<sub>4</sub>, MeOH, toluene, 6–27 h, 20–86%; or ArCCH, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, 4 h, rt, 76%; (b) LiI, EtOAc, 80 °C, 37–78%.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Perspective view of <b>14</b> drawn with 50% probability ellipsoids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lowest energy pose of <b>31</b> (gray) docked into hFFA2 (gold) with strongly interacting residues shown (cyan) and hydrogen bonds highlighted (yellow stipples). (A) Receptor as ribbon viewed from the angle of helix 4 and 5. (B) Same pose with receptor as surface viewed from the angle of helix 3 and 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ability of propionate (C3) and <b>31</b> to induce neutrophil migration relative to the highly potent chemotactic factor fMLP (<i>n</i> = 4–6): (∗) <i>p</i> < 0.05, (∗∗∗) <i>p</i> < 0.01; one-way ANOVA followed by Dunnett post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/medium/jm-2018-00855n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of isoproterenol-induced lipolysis by propionate (pEC<sub>50</sub> = 3.6 ± 0.4) and <b>31</b> (pEC<sub>50</sub> = 5.3 ± 0.6) in murine adipocytes (<i>n</i> = 3–4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00855/20181101/images/large/jm-2018-00855n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00855&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotarsky, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olde, B.</span></span> <span> </span><span class="NLM_article-title">Identification of a free fatty acid receptor, FFA<sub>2</sub>R, expressed on leukocytes and activated by short-chain fatty acids</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1047</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00488-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2FS0006-291X%2803%2900488-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2003&pages=1047-1052&author=N.+E.+Nilssonauthor=K.+Kotarskyauthor=C.+Owmanauthor=B.+Olde&title=Identification+of+a+free+fatty+acid+receptor%2C+FFA2R%2C+expressed+on+leukocytes+and+activated+by+short-chain+fatty+acids&doi=10.1016%2FS0006-291X%2803%2900488-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900488-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900488-1%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DN.%2BE.%26aulast%3DKotarsky%26aufirst%3DK.%26aulast%3DOwman%26aufirst%3DC.%26aulast%3DOlde%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520a%2520free%2520fatty%2520acid%2520receptor%252C%2520FFA2R%252C%2520expressed%2520on%2520leukocytes%2520and%2520activated%2520by%2520short-chain%2520fatty%2520acids%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D303%26spage%3D1047%26epage%3D1052%26doi%3D10.1016%2FS0006-291X%2803%2900488-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsworthy, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilert, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tcheang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigglesworth, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strum, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steplewski, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignar, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foord, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, S. J.</span></span> <span> </span><span class="NLM_article-title">The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">11312</span>– <span class="NLM_lpage">11319</span>, <span class="refDoi"> DOI: 10.1074/jbc.M211609200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M211609200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=12496283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Kgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=11312-11319&author=A.+J.+Brownauthor=S.+M.+Goldsworthyauthor=A.+A.+Barnesauthor=M.+M.+Eilertauthor=L.+Tcheangauthor=D.+Danielsauthor=A.+I.+Muirauthor=M.+J.+Wigglesworthauthor=I.+Kinghornauthor=N.+J.+Fraserauthor=N.+B.+Pikeauthor=J.+C.+Strumauthor=K.+M.+Steplewskiauthor=P.+R.+Murdockauthor=J.+C.+Holderauthor=F.+H.+Marshallauthor=P.+G.+Szekeresauthor=S.+Wilsonauthor=D.+M.+Ignarauthor=S.+M.+Foordauthor=A.+Wiseauthor=S.+J.+Dowell&title=The+orphan+G+protein-coupled+receptors+GPR41+and+GPR43+are+activated+by+propionate+and+other+short+chain+carboxylic+acids&doi=10.1074%2Fjbc.M211609200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids</span></div><div class="casAuthors">Brown, Andrew J.; Goldsworthy, Susan M.; Barnes, Ashley A.; Eilert, Michelle M.; Tcheang, Lili; Daniels, Dion; Muir, Alison I.; Wigglesworth, Mark J.; Kinghorn, Ian; Fraser, Neil J.; Pike, Nicholas B.; Strum, Jay C.; Steplewski, Klaudia M.; Murdock, Paul R.; Holder, Julie C.; Marshall, Fiona H.; Szekeres, Philip G.; Wilson, Shelagh; Ignar, Diane M.; Foord, Steve M.; Wise, Alan; Dowell, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">11312-11319</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GPR41 and GPR43 are related members of a homologous family of orphan G protein-coupled receptors that are tandemly encoded at a single chromosomal locus in both humans and mice.  We identified the acetate anion as an agonist of human GPR43 during routine ligand bank screening in yeast.  This activity was confirmed after transient transfection of GPR43 into mammalian cells using Ca2+ mobilization and [35S]guanosine 5'-O-(3-thiotriphosphate) binding assays and by coexpression with GIRK G protein-regulated potassium channels in Xenopus laevis oocytes.  Other short chain carboxylic acid anions such as formate, propionate, butyrate, and pentanoate also had agonist activity.  GPR41 is related to GPR43 (52% similarity; 43% identity) and was activated by similar ligands but with differing specificity for carbon chain length, with pentanoate being the most potent agonist.  A third family member, GPR42, is most likely a recent gene duplication of GPR41 and may be a pseudogene.  GPR41 was expressed primarily in adipose tissue, whereas the highest levels of GPR43 were found in immune cells.  The identity of the cognate physiol. ligands for these receptors is not clear, although propionate is known to occur in vivo at high concns. under certain pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cv6I7xXrirVg90H21EOLACvtfcHk0lgqvRAn94mSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Kgsbc%253D&md5=9354164ddec16c6f18c99ce8e067bb1a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211609200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211609200%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DGoldsworthy%26aufirst%3DS.%2BM.%26aulast%3DBarnes%26aufirst%3DA.%2BA.%26aulast%3DEilert%26aufirst%3DM.%2BM.%26aulast%3DTcheang%26aufirst%3DL.%26aulast%3DDaniels%26aufirst%3DD.%26aulast%3DMuir%26aufirst%3DA.%2BI.%26aulast%3DWigglesworth%26aufirst%3DM.%2BJ.%26aulast%3DKinghorn%26aufirst%3DI.%26aulast%3DFraser%26aufirst%3DN.%2BJ.%26aulast%3DPike%26aufirst%3DN.%2BB.%26aulast%3DStrum%26aufirst%3DJ.%2BC.%26aulast%3DSteplewski%26aufirst%3DK.%2BM.%26aulast%3DMurdock%26aufirst%3DP.%2BR.%26aulast%3DHolder%26aufirst%3DJ.%2BC.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DSzekeres%26aufirst%3DP.%2BG.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DIgnar%26aufirst%3DD.%2BM.%26aulast%3DFoord%26aufirst%3DS.%2BM.%26aulast%3DWise%26aufirst%3DA.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520orphan%2520G%2520protein-coupled%2520receptors%2520GPR41%2520and%2520GPR43%2520are%2520activated%2520by%2520propionate%2520and%2520other%2520short%2520chain%2520carboxylic%2520acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D11312%26epage%3D11319%26doi%3D10.1074%2Fjbc.M211609200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Poul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springael, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decobecq, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brezillon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupriez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Detheux, M.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">25481</span>– <span class="NLM_lpage">25489</span>, <span class="refDoi"> DOI: 10.1074/jbc.M301403200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M301403200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=12711604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1CmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=25481-25489&author=E.+Le%0APoulauthor=C.+Loisonauthor=S.+Struyfauthor=J.+Y.+Springaelauthor=V.+Lannoyauthor=M.+E.+Decobecqauthor=S.+Brezillonauthor=V.+Dupriezauthor=G.+Vassartauthor=J.+Van+Dammeauthor=M.+Parmentierauthor=M.+Detheux&title=Functional+characterization+of+human+receptors+for+short+chain+fatty+acids+and+their+role+in+polymorphonuclear+cell+activation&doi=10.1074%2Fjbc.M301403200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation</span></div><div class="casAuthors">Le Poul, Emmanuel; Loison, Cecile; Struyf, Sofie; Springael, Jean-Yves; Lannoy, Vincent; Decobecq, Marie-Eve; Brezillon, Stephane; Dupriez, Vincent; Vassart, Gilbert; Van Damme, Jo; Parmentier, Marc; Detheux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">25481-25489</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Short chain fatty acids (SCFAs), including acetate, propionate, and butyrate, are produced at high concn. by bacteria in the gut and subsequently released in the bloodstream.  Basal acetate concns. in the blood (about 100 μM) can further increase to millimolar concns. following alc. intake.  It was known previously that SCFAs can activate leukocytes, particularly neutrophils.  In the present work, we have identified two previously orphan G protein-coupled receptors, GPR41 and GPR43, as receptors for SCFAs.  Propionate was the most potent agonist for both GPR41 and GPR43.  Acetate was more selective for GPR43, whereas butyrate and isobutyrate were more active on GPR41.  The two receptors were coupled to inositol 1,4,5-trisphosphate formation, intracellular Ca2+ release, ERK1/2 activation, and inhibition of cAMP accumulation.  They exhibited, however, a differential coupling to G proteins; GPR41 coupled exclusively though the Pertussis toxin-sensitive Gi/o family, whereas GPR43 displayed a dual coupling through Gi/o and Pertussis toxin-insensitive Gq protein families.  The broad expression profile of GPR41 in a no. of tissues does not allow us to infer clear hypotheses regarding its biol. functions.  In contrast, the highly selective expression of GPR43 in leukocytes, particularly polymorphonuclear cells, suggests a role in the recruitment of these cell populations toward sites of bacterial infection.  The pharmacol. of GPR43 matches indeed the effects of SCFAs on neutrophils, in terms of intracellular Ca2+ release and chemotaxis.  Such a neutrophil-specific SCFA receptor is potentially involved in the development of a variety of diseases characterized by either excessive or inefficient neutrophil recruitment and activation, such as inflammatory bowel diseases or alcoholism-assocd. immune depression.  GPR43 might therefore constitute a target allowing us to modulate immune responses in these pathol. situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ceIWikecmrVg90H21EOLACvtfcHk0lgqvRAn94mSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1CmtbY%253D&md5=30e56b7bf671a607faa0dbea6f75d9dc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M301403200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M301403200%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DLoison%26aufirst%3DC.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DSpringael%26aufirst%3DJ.%2BY.%26aulast%3DLannoy%26aufirst%3DV.%26aulast%3DDecobecq%26aufirst%3DM.%2BE.%26aulast%3DBrezillon%26aufirst%3DS.%26aulast%3DDupriez%26aufirst%3DV.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DDetheux%26aufirst%3DM.%26atitle%3DFunctional%2520characterization%2520of%2520human%2520receptors%2520for%2520short%2520chain%2520fatty%2520acids%2520and%2520their%2520role%2520in%2520polymorphonuclear%2520cell%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D25481%26epage%3D25489%26doi%3D10.1074%2Fjbc.M301403200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011613-135945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1146%2Fannurev-pharmtox-011613-135945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=24160702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=407-434&author=S.+Offermanns&title=Free+fatty+acid+%28FFA%29+and+hydroxy+carboxylic+acid+%28HCA%29+receptors&doi=10.1146%2Fannurev-pharmtox-011613-135945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors</span></div><div class="casAuthors">Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">407-434</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Satd. and unsatd. free fatty acids (FFAs), as well as hydroxy carboxylic acids (HCAs) such as lactate and ketone bodies, are carriers of metabolic energy, precursors of biol. mediators, and components of biol. structures.  However, they are also able to exert cellular effects through G protein-coupled receptors named FFA1-FFA4 and HCA1-HCA3.  Work during the past decade has shown that these receptors are widely expressed in the human body and regulate the metabolic, endocrine, immune and other systems to maintain homeostasis under changing dietary conditions.  The development of genetic mouse models and the generation of synthetic ligands of individual FFA and HCA receptors have been instrumental in identifying cellular and biol. functions of these receptors.  These studies have produced strong evidence that several FFA and HCA receptors can be targets for the prevention and treatment of various diseases, including type 2 diabetes mellitus, obesity, and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRysSCQif5HrVg90H21EOLACvtfcHk0lgqvRAn94mSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7g%253D&md5=0162fb7672c9245d581f54d8cb325f5a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011613-135945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011613-135945%26sid%3Dliteratum%253Aachs%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DFree%2520fatty%2520acid%2520%2528FFA%2529%2520and%2520hydroxy%2520carboxylic%2520acid%2520%2528HCA%2529%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D407%26epage%3D434%26doi%3D10.1146%2Fannurev-pharmtox-011613-135945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimpukade, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span> <span> </span><span class="NLM_article-title">Complex pharmacology of free fatty acid receptors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1ehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=67-110&author=G.+Milliganauthor=B.+Shimpukadeauthor=T.+Ulvenauthor=B.+D.+Hudson&title=Complex+pharmacology+of+free+fatty+acid+receptors&doi=10.1021%2Facs.chemrev.6b00056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Complex Pharmacology of Free Fatty Acid Receptors</span></div><div class="casAuthors">Milligan, Graeme; Shimpukade, Bharat; Ulven, Trond; Hudson, Brian D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-110</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are historically the most successful family of drug targets.  In recent times it has become clear that the pharmacol. of these receptors is far more complex than previously imagined.  Understanding of the pharmacol. regulation of GPCRs now extends beyond simple competitive agonism or antagonism by ligands interacting with the orthosteric binding site of the receptor to incorporate concepts of allosteric agonism, allosteric modulation, signaling bias, constitutive activity, and inverse agonism.  Herein, we consider how evolving concepts of GPCR pharmacol. have shaped understanding of the complex pharmacol. of receptors that recognize and are activated by nonesterified or "free" fatty acids (FFAs).  The FFA family of receptors is a recently deorphanized set of GPCRs, the members of which are now receiving substantial interest as novel targets for the treatment of metabolic and inflammatory diseases.  Further understanding of the complex pharmacol. of these receptors will be crit. to unlocking their ultimate therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdP6XCIBjo9bVg90H21EOLACvtfcHk0lht2Xb6dEdYRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1ehsr0%253D&md5=4bd71d657f4905bddb750d8ad4fdb9b4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00056%26sid%3Dliteratum%253Aachs%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26atitle%3DComplex%2520pharmacology%2520of%2520free%2520fatty%2520acid%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D67%26epage%3D110%26doi%3D10.1021%2Facs.chemrev.6b00056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishikawa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotoh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span> <span> </span><span class="NLM_article-title">Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">5092</span>– <span class="NLM_lpage">5099</span>, <span class="refDoi"> DOI: 10.1210/en.2005-0545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1210%2Fen.2005-0545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=16123168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ogur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=5092-5099&author=Y.+H.+Hongauthor=Y.+Nishimuraauthor=D.+Hishikawaauthor=H.+Tsuzukiauthor=H.+Miyaharaauthor=C.+Gotohauthor=K.+C.+Choiauthor=D.+D.+Fengauthor=C.+Chenauthor=H.+G.+Leeauthor=K.+Katohauthor=S.+G.+Rohauthor=S.+Sasaki&title=Acetate+and+propionate+short+chain+fatty+acids+stimulate+adipogenesis+via+GPCR43&doi=10.1210%2Fen.2005-0545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43</span></div><div class="casAuthors">Hong, Yeong-Hee; Nishimura, Yukihiko; Hishikawa, Daisuke; Tsuzuki, Hiroaki; Miyahara, Hisae; Gotoh, Chizu; Choi, Ki-Choon; Feng, Dan Dan; Chen, Chen; Lee, Hong-Gu; Katoh, Kazuo; Roh, Sang-Gun; Sasaki, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5092-5099</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">It has recently been discovered that G protein-coupled receptors (GPCR) 41 and 43 are characterized by having the short chain fatty acids acetate and propionate as their ligands.  The objective of this study was to investigate the involvement of GPCR41, GPCR43, and their ligands in the process of adipogenesis.  We measured the levels of GPCR41 and GPCR43 mRNA in both adipose and other tissues of the mouse.  GRP43 mRNA expression was higher in four types of adipose tissue than in other tissues, whereas GPCR41 mRNA was not detected in any adipose tissues.  A high level of GPCR43 expression was found in isolated adipocytes, but expression level was very low in stromal-vascular cells.  Expression of GPCR43 was up-regulated in adipose tissues of mice fed a high-fat diet compared with those fed a normal-fat diet.  GPCR43 mRNA could not be detected in confluent and undifferentiated 3T3-L1 adipocytes; however, the levels rose with time after the initiation of differentiation.  GPCR41 expression was not detected in confluent and differentiated adipocytes.  Acetate and propionate treatments increased lipids present as multiple droplets in 3T3-L1 adipocytes.  Propionate significantly elevated the level of GPCR43 expression during adipose differentiation, with up-regulation of PPAR-γ2.  Small interfering RNA mediated a redn. of GPCR43 mRNA in 3T3-L1 cells and blocked the process of adipocyte differentiation.  In addn., both acetate and propionate inhibited isoproterenol-induced lipolysis in a dose-dependent manner.  We conclude that acetate and propionate short chain fatty acids may have important physiol. roles in adipogenesis through GPCR43, but not through GPCR41.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZSBBqrlv-vLVg90H21EOLACvtfcHk0lhPqFVrNZbgaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ogur%252FL&md5=26c914beba3148a5007f27c19915d321</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fen.2005-0545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2005-0545%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%2BH.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DHishikawa%26aufirst%3DD.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DMiyahara%26aufirst%3DH.%26aulast%3DGotoh%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DK.%2BC.%26aulast%3DFeng%26aufirst%3DD.%2BD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DH.%2BG.%26aulast%3DKatoh%26aufirst%3DK.%26aulast%3DRoh%26aufirst%3DS.%2BG.%26aulast%3DSasaki%26aufirst%3DS.%26atitle%3DAcetate%2520and%2520propionate%2520short%2520chain%2520fatty%2520acids%2520stimulate%2520adipogenesis%2520via%2520GPCR43%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D5092%26epage%3D5099%26doi%3D10.1210%2Fen.2005-0545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furness, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwahara, A.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1007/s00441-005-0140-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2Fs00441-005-0140-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=16453106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFSgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2006&pages=353-360&author=S.+Karakiauthor=R.+Mitsuiauthor=H.+Hayashiauthor=I.+Katoauthor=H.+Sugiyaauthor=T.+Iwanagaauthor=J.+B.+Furnessauthor=A.+Kuwahara&title=Short-chain+fatty+acid+receptor%2C+GPR43%2C+is+expressed+by+enteroendocrine+cells+and+mucosal+mast+cells+in+rat+intestine&doi=10.1007%2Fs00441-005-0140-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine</span></div><div class="casAuthors">Karaki, Shin-ichiro; Mitsui, Retsu; Hayashi, Hisayoshi; Kato, Ikuo; Sugiya, Hiroshi; Iwanaga, Toshihiko; Furness, John B.; Kuwahara, Atsukazu</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-360</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, are the major anions in the large intestinal lumen.  They are produced from dietary fiber by bacterial fermn. and are known to have a variety of physiol. and pathophysiol. effects on the intestine.  In the present study, we investigated the expression of the SCFA receptor, GPR43, in the rat distal ileum and colon.  Expression of GPR43 was detected by reverse transcriptase/polymerase chain reaction (RT-PCR), Western blotting, and immunohistochem. mRNA for GPR43 was detected, by RT-PCR, in exts. of the whole wall and sepd. mucosa from the ileum and colon and from muscle plus submucosa from the ileum, but not from muscle plus submucosa prepns. from the colon.  We raised a rabbit antiserum against a synthesized fragment of rat GPR43; this was specific for rat GPR43.  GPR43 protein was detected by Western blot anal. in exts. of whole wall and sepd. mucosa, but not in muscle plus submucosa exts.  By immunohistochem., GPR43 immunoreactivity was localized to enteroendocrine cells expressing peptide YY (PYY), whereas 5-hydroxytryptamine (5-HT)-immunoreactive (IR) enteroendocrine cells were not immunoreactive for GPR43.  Mast cells of the lamina propria expressing 5-HT were also GPR43-IR.  The results of the present study suggest that the PYY-contg. enteroendocrine cells and 5-HT-contg. mucosal mast cells sense SCFAs via the GPR43 receptor.  This is consistent with physiol. data showing that SCFAs stimulate the release of PYY and 5-HT from the ileum and colon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP6Ve1VyCMErVg90H21EOLACvtfcHk0lhPqFVrNZbgaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFSgu7k%253D&md5=f950e424494291f04217ae0583c44d34</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00441-005-0140-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-005-0140-x%26sid%3Dliteratum%253Aachs%26aulast%3DKaraki%26aufirst%3DS.%26aulast%3DMitsui%26aufirst%3DR.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DSugiya%26aufirst%3DH.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DJ.%2BB.%26aulast%3DKuwahara%26aufirst%3DA.%26atitle%3DShort-chain%2520fatty%2520acid%2520receptor%252C%2520GPR43%252C%2520is%2520expressed%2520by%2520enteroendocrine%2520cells%2520and%2520mucosal%2520mast%2520cells%2520in%2520rat%2520intestine%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2006%26volume%3D324%26spage%3D353%26epage%3D360%26doi%3D10.1007%2Fs00441-005-0140-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivaprakasam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paschall, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolhe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sifuentes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijay-Kumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGaha, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e238</span>, <span class="refDoi"> DOI: 10.1038/oncsis.2016.38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Foncsis.2016.38" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e238&author=S.+Sivaprakasamauthor=A.+Guravauthor=A.+V.+Paschallauthor=G.+L.+Coeauthor=K.+Chaudharyauthor=Y.+Caiauthor=R.+Kolheauthor=P.+Martinauthor=D.+Browningauthor=L.+Huangauthor=H.+Shiauthor=H.+Sifuentesauthor=M.+Vijay-Kumarauthor=S.+A.+Thompsonauthor=D.+H.+Munnauthor=A.+Mellorauthor=T.+L.+McGahaauthor=P.+Shiaoauthor=C.+W.+Cutlerauthor=K.+Liuauthor=V.+Ganapathyauthor=H.+Liauthor=N.+Singh&title=An+essential+role+of+Ffar2+%28Gpr43%29+in+dietary+fibre-mediated+promotion+of+healthy+composition+of+gut+microbiota+and+suppression+of+intestinal+carcinogenesis&doi=10.1038%2Foncsis.2016.38"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2016.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2016.38%26sid%3Dliteratum%253Aachs%26aulast%3DSivaprakasam%26aufirst%3DS.%26aulast%3DGurav%26aufirst%3DA.%26aulast%3DPaschall%26aufirst%3DA.%2BV.%26aulast%3DCoe%26aufirst%3DG.%2BL.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DKolhe%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DBrowning%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSifuentes%26aufirst%3DH.%26aulast%3DVijay-Kumar%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DS.%2BA.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DMellor%26aufirst%3DA.%26aulast%3DMcGaha%26aufirst%3DT.%2BL.%26aulast%3DShiao%26aufirst%3DP.%26aulast%3DCutler%26aufirst%3DC.%2BW.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGanapathy%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DAn%2520essential%2520role%2520of%2520Ffar2%2520%2528Gpr43%2529%2520in%2520dietary%2520fibre-mediated%2520promotion%2520of%2520healthy%2520composition%2520of%2520gut%2520microbiota%2520and%2520suppression%2520of%2520intestinal%2520carcinogenesis%26jtitle%3DOncogenesis%26date%3D2016%26volume%3D5%26spage%3De238%26doi%3D10.1038%2Foncsis.2016.38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harig, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soergel, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komorowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. M.</span></span> <span> </span><span class="NLM_article-title">Treatment of diversion colitis with short-chain-fatty acid irrigation</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>320</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1056/NEJM198901053200105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1056%2FNEJM198901053200105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=2909876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADyaL1M%252Fot1GrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=1989&pages=23-28&author=J.+M.+Harigauthor=K.+H.+Soergelauthor=R.+A.+Komorowskiauthor=C.+M.+Wood&title=Treatment+of+diversion+colitis+with+short-chain-fatty+acid+irrigation&doi=10.1056%2FNEJM198901053200105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of diversion colitis with short-chain-fatty acid irrigation</span></div><div class="casAuthors">Harig J M; Soergel K H; Komorowski R A; Wood C M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A condition known as diversion colitis frequently develops in segments of the colorectum after surgical diversion of the fecal stream; it persists indefinitely unless the excluded segment is reanastomosed.  The disease is characterized by bleeding from inflamed colonic mucosa that mimics the bleeding of idiopathic inflammatory bowel disease, and it may culminate in stricture formation.  We hypothesized that this condition is caused by the absence of luminal short-chain fatty acids, the preferred metabolic substrates of colonic epithelium.  We studied four patients with diversion colitis, none of whom had evidence of Crohn's, idiopathic ulcerative, or infectious colitis.  The excluded segment of the rectosigmoid contained negligible concentrations of short-chain fatty acids.  When D-glucose was instilled, it did not undergo appreciable anaerobic fermentation.  Instillation of a solution containing short-chain fatty acids twice daily resulted in the disappearance of symptoms and the inflammatory changes observed at endoscopy, over a period of four to six weeks.  Remission has been maintained for up to 14 months (in one patient) by instillation daily to twice weekly.  Administering enemas containing isotonic saline, or omitting treatment for periods of two to four weeks during the regimen, by contrast, did not produce any improvement or rapid relapse of the colitis.  Histologic observation revealed a distinctive type of mucosal inflammation that resolved more slowly and less completely than the gross appearance of the inflamed mucosa.  From these preliminary studies we infer that diversion colitis may represent an inflammatory state resulting from a nutritional deficiency in the lumen of the colonic epithelium, which is effectively treated by local application of short-chain fatty acids, the missing nutrients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1jjefdfMZF-RS7coPn-RtfW6udTcc2ebJpvcAeqLPRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252Fot1GrsA%253D%253D&md5=aebe98afd0625709d97d0e8c0df84263</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJM198901053200105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198901053200105%26sid%3Dliteratum%253Aachs%26aulast%3DHarig%26aufirst%3DJ.%2BM.%26aulast%3DSoergel%26aufirst%3DK.%2BH.%26aulast%3DKomorowski%26aufirst%3DR.%2BA.%26aulast%3DWood%26aufirst%3DC.%2BM.%26atitle%3DTreatment%2520of%2520diversion%2520colitis%2520with%2520short-chain-fatty%2520acid%2520irrigation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1989%26volume%3D320%26spage%3D23%26epage%3D28%26doi%3D10.1056%2FNEJM198901053200105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vernia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcheggiano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caprilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valpiani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoluzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torsoli, A.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acid topical treatment in distal ulcerative colitis</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2036.1995.tb00386.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1111%2Fj.1365-2036.1995.tb00386.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=7654893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADyaK2MzotlGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=309-313&author=P.+Verniaauthor=A.+Marcheggianoauthor=R.+Caprilliauthor=G.+Frieriauthor=G.+Corraoauthor=D.+Valpianiauthor=M.+C.+Di+Paoloauthor=P.+Paoluziauthor=A.+Torsoli&title=Short-chain+fatty+acid+topical+treatment+in+distal+ulcerative+colitis&doi=10.1111%2Fj.1365-2036.1995.tb00386.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acid topical treatment in distal ulcerative colitis</span></div><div class="casAuthors">Vernia P; Marcheggiano A; Caprilli R; Frieri G; Corrao G; Valpiani D; Di Paolo M C; Paoluzi P; Torsoli A</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-13</span>
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    </div><div class="casAbstract">BACKGROUND:  Some evidence indicates that short-chain fatty acid (SCFA) enemas are effective in the treatment of distal ulcerative colitis.  METHODS:  In a randomized, double-blind, placebo-controlled study, we tested the efficacy of a 6-week course of topical SCFA (100 mL, twice daily enemas of sodium acetate 80 mmol/L, sodium propionate 30 mmol/L and sodium butyrate 40 mmol/L) in 40 patients with mild to moderate distal colitis.  Clinical, endoscopic and histological data were collected at the beginning and end of the study.  RESULTS:  Fourteen patients on SCFA improved (overall score 11.3 +/- 2.0 vs. 7.4 +/- 3.5) as compared to five in the placebo group (overall score 10.0 +/- 1.9 vs. 8.9 +/- 2.5).  In the SCFA-treated group all parameters significantly improved except the number of bowel motions, whereas no significant changes were recorded in the control group.  A statistically significant difference between the two treatment regimens, however, was observed only for intestinal bleeding (P < 0.05), urgency (P < 0.02) and the patient self-evaluation score (P < 0.05).  This was probably due to the random inclusion of more patients with moderate disease into the SCFA-treated group, thus causing pretrial differences between the two groups.  CONCLUSION:  The present study confirms that irrigation with SCFA enemas is effective in distal colitis, and may represent an alternative therapeutic tool in the treatment of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkZb6cs3El-7GbPKh4T9eAfW6udTcc2ebJpvcAeqLPRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzotlGhtg%253D%253D&md5=56655db6e038ae482dc5fbab555ff5e8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.1995.tb00386.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.1995.tb00386.x%26sid%3Dliteratum%253Aachs%26aulast%3DVernia%26aufirst%3DP.%26aulast%3DMarcheggiano%26aufirst%3DA.%26aulast%3DCaprilli%26aufirst%3DR.%26aulast%3DFrieri%26aufirst%3DG.%26aulast%3DCorrao%26aufirst%3DG.%26aulast%3DValpiani%26aufirst%3DD.%26aulast%3DDi%2BPaolo%26aufirst%3DM.%2BC.%26aulast%3DPaoluzi%26aufirst%3DP.%26aulast%3DTorsoli%26aufirst%3DA.%26atitle%3DShort-chain%2520fatty%2520acid%2520topical%2520treatment%2520in%2520distal%2520ulcerative%2520colitis%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D9%26spage%3D309%26epage%3D313%26doi%3D10.1111%2Fj.1365-2036.1995.tb00386.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maslowski, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilter, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolph, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, C. R.</span></span> <span> </span><span class="NLM_article-title">Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1038/nature08530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnature08530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=19865172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOjt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=1282-1286&author=K.+M.+Maslowskiauthor=A.+T.+Vieiraauthor=A.+Ngauthor=J.+Kranichauthor=F.+Sierroauthor=D.+Yuauthor=H.+C.+Schilterauthor=M.+S.+Rolphauthor=F.+Mackayauthor=D.+Artisauthor=R.+J.+Xavierauthor=M.+M.+Teixeiraauthor=C.+R.+Mackay&title=Regulation+of+inflammatory+responses+by+gut+microbiota+and+chemoattractant+receptor+GPR43&doi=10.1038%2Fnature08530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</span></div><div class="casAuthors">Maslowski, Kendle M.; Vieira, Angelica T.; Ng, Aylwin; Kranich, Jan; Sierro, Frederic; Yu, Di; Schilter, Heidi C.; Rolph, Michael S.; MacKay, Fabienne; Artis, David; Xavier, Ramnik; Teixeira, Mauro M.; MacKay, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7268</span>),
    <span class="NLM_cas:pages">1282-1286</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The immune system responds to pathogens by a variety of pattern recognition mols. such as the Toll-like receptors (TLRs), which promote recognition of dangerous foreign pathogens.  However, recent evidence indicates that normal intestinal microbiota might also pos. influence immune responses, and protect against the development of inflammatory diseases.  One of these elements may be short-chain fatty acids (SCFAs), which are produced by fermn. of dietary fiber by intestinal microbiota.  A feature of human ulcerative colitis and other colitic diseases is a change in 'healthy' microbiota such as Bifidobacterium and Bacteriodes, and a concurrent redn. in SCFAs.  Moreover, increased intake of fermentable dietary fiber, or SCFAs, seems to be clin. beneficial in the treatment of colitis.  SCFAs bind the G-protein-coupled receptor 43 (GPR43, also known as FFAR2), and here we show that SCFA-GPR43 interactions profoundly affect inflammatory responses.  Stimulation of GPR43 by SCFAs was necessary for the normal resoln. of certain inflammatory responses, because GPR43-deficient (Gpr43-/-) mice showed exacerbated or unresolving inflammation in models of colitis, arthritis and asthma.  This seemed to relate to increased prodn. of inflammatory mediators by Gpr43-/- immune cells, and increased immune cell recruitment.  Germ-free mice, which are devoid of bacteria and express little or no SCFAs, showed a similar dysregulation of certain inflammatory responses.  GPR43 binding of SCFAs potentially provides a mol. link between diet, gastrointestinal bacterial metab., and immune and inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGDIl1CGKdG7Vg90H21EOLACvtfcHk0lgshsISQIZXTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOjt7vI&md5=be0b507ab2c96e7cfc648eba40e0d205</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature08530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08530%26sid%3Dliteratum%253Aachs%26aulast%3DMaslowski%26aufirst%3DK.%2BM.%26aulast%3DVieira%26aufirst%3DA.%2BT.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DKranich%26aufirst%3DJ.%26aulast%3DSierro%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DSchilter%26aufirst%3DH.%2BC.%26aulast%3DRolph%26aufirst%3DM.%2BS.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DArtis%26aufirst%3DD.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DTeixeira%26aufirst%3DM.%2BM.%26aulast%3DMackay%26aufirst%3DC.%2BR.%26atitle%3DRegulation%2520of%2520inflammatory%2520responses%2520by%2520gut%2520microbiota%2520and%2520chemoattractant%2520receptor%2520GPR43%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D1282%26epage%3D1286%26doi%3D10.1038%2Fnature08530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Till, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raabe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalaris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folsch, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose-John, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenstiel, P.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptor 43 Is essential for neutrophil recruitment during intestinal inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">7514</span>– <span class="NLM_lpage">7522</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.4049%2Fjimmunol.0900063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=7514-7522&author=C.+Sinaauthor=O.+Gavrilovaauthor=M.+Forsterauthor=A.+Tillauthor=S.+Dererauthor=F.+Hildebrandauthor=B.+Raabeauthor=A.+Chalarisauthor=J.+Schellerauthor=A.+Rehmannauthor=A.+Frankeauthor=S.+Ottauthor=R.+Haslerauthor=S.+Nikolausauthor=U.+R.+Folschauthor=S.+Rose-Johnauthor=H.+P.+Jiangauthor=J.+Liauthor=S.+Schreiberauthor=P.+Rosenstiel&title=G+protein-coupled+receptor+43+Is+essential+for+neutrophil+recruitment+during+intestinal+inflammation&doi=10.4049%2Fjimmunol.0900063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900063%26sid%3Dliteratum%253Aachs%26aulast%3DSina%26aufirst%3DC.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DForster%26aufirst%3DM.%26aulast%3DTill%26aufirst%3DA.%26aulast%3DDerer%26aufirst%3DS.%26aulast%3DHildebrand%26aufirst%3DF.%26aulast%3DRaabe%26aufirst%3DB.%26aulast%3DChalaris%26aufirst%3DA.%26aulast%3DScheller%26aufirst%3DJ.%26aulast%3DRehmann%26aufirst%3DA.%26aulast%3DFranke%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DS.%26aulast%3DHasler%26aufirst%3DR.%26aulast%3DNikolaus%26aufirst%3DS.%26aulast%3DFolsch%26aufirst%3DU.%2BR.%26aulast%3DRose-John%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DRosenstiel%26aufirst%3DP.%26atitle%3DG%2520protein-coupled%2520receptor%252043%2520Is%2520essential%2520for%2520neutrophil%2520recruitment%2520during%2520intestinal%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D7514%26epage%3D7522%26doi%3D10.4049%2Fjimmunol.0900063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kaem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Aa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beetens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van’t Klooster, G.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1111/bcp.12900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1111%2Fbcp.12900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26852904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtValsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2016&pages=139-148&author=F.+Namourauthor=R.+Galienauthor=T.+Van+Kaemauthor=A.+Van+der+Aaauthor=F.+Vanhoutteauthor=J.+Beetensauthor=G.+Van%E2%80%99t+Klooster&title=Safety%2C+pharmacokinetics+and+pharmacodynamics+of+GLPG0974%2C+a+potent+and+selective+FFA2+antagonist%2C+in+healthy+male+subjects&doi=10.1111%2Fbcp.12900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects</span></div><div class="casAuthors">Namour, Florence; Galien, Rene; Van Kaem, Tim; Van der Aa, Annegret; Vanhoutte, Frederic; Beetens, Johan; van't Klooster, Gerben</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Free fatty acids (FFA) can act as direct signalling mols. through activation of several membrane-bound G-protein coupled receptors.  The FFA2 receptor (known as GPR43) is activated by short chain fatty acids (SCFA) such as acetate and has been shown to play a major role in SCFA-induced neutrophil activation and migration and to contribute in the development and control of inflammation.  GLPG0974 is a potent and selective antagonist of the human FFA2.  The main objectives of the two phase 1 trials were to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of GLPG0974.  Methods : Two consecutive randomized, double-blind, placebo-controlled, single center trials in healthy subjects were performed.  In the first, GLPG0974 was administered as single doses up to 250 mg and in the second, multiple daily doses up to 400 mg for 14 days were evaluated.  Non-compartmental anal. was used to det. GLPG0974 pharmacokinetics while target engagement was investigated through the inhibition of neutrophils in acetate-simulated whole blood samples using surface expression of CD11b activated epitope as a marker of neutrophil activation.  Results : The investigation of safety/tolerability and pharmacokinetics in the early development phase showed that GLPG0974 was safe and well tolerated up to a daily dose of 400 mg.  GLPG0974 showed good and dose proportional exposure up to 400 mg daily as well as a substantial and sustained inhibition of acetate-stimulated neutrophil activation.  Conclusion : Based on these results, a proof-of-concept study was initiated to evaluate the safety, tolerability and efficacy of GLPG0974 in patients with mild to moderate ulcerative colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF0JlJeJAnoLVg90H21EOLACvtfcHk0lhSnSKR_d68eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtValsbrK&md5=c108c375a07b233111b639b05bd99174</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12900%26sid%3Dliteratum%253Aachs%26aulast%3DNamour%26aufirst%3DF.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3DVan%2BKaem%26aufirst%3DT.%26aulast%3DVan%2Bder%2BAa%26aufirst%3DA.%26aulast%3DVanhoutte%26aufirst%3DF.%26aulast%3DBeetens%26aufirst%3DJ.%26aulast%3DVan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520GLPG0974%252C%2520a%2520potent%2520and%2520selective%2520FFA2%2520antagonist%252C%2520in%2520healthy%2520male%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2016%26volume%3D82%26spage%3D139%26epage%3D148%26doi%3D10.1111%2Fbcp.12900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaline, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornstein, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, P. E.</span></span> <span> </span><span class="NLM_article-title">The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products</span>. <i>Horm. Metab. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1055/s-2007-985811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1055%2Fs-2007-985811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=17846978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Kqs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=687-693&author=K.+Kalineauthor=S.+R.+Bornsteinauthor=A.+Bergmannauthor=H.+Haunerauthor=P.+E.+Schwarz&title=The+importance+and+effect+of+dietary+fiber+in+diabetes+prevention+with+particular+consideration+of+whole+grain+products&doi=10.1055%2Fs-2007-985811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products</span></div><div class="casAuthors">Kaline, K.; Bornstein, S. R.; Bergmann, A.; Hauner, H.; Schwarz, P. E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and Metabolic Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">687-693</span>CODEN:
                <span class="NLM_cas:coden">HMMRA2</span>;
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  The state of prediabetes is characterized by increased insulin resistance and decreased pancreatic islet β-cell function.  This prestage of type 2 diabetes mellitus can be identified by impaired glucose tolerance and/or impaired fasting blood sugar levels.  Apart from body wt. loss and increased phys. activity, the development of type 2 diabetes mellitus can also be prevented by dietary changes.  Low-fat diets with dietary fiber intakes of >30g/day are an effective preventive approach.  High-fiber diets have many pos. effects on the phys. health status.  In addn. to pos. effects in the gastrointestinal tract, they have obvious potential to support body wt. decrease and to improve disturbances of carbohydrate and fat metab.  Insol. dietary fibers as found in whole grain cereal products are esp. effective in the prevention of type 2 diabetes mellitus.  High intakes of fruits and vegetables and pulses also have health-promoting properties.  High-fiber diets also help in the prevention of obesity and coronary heart diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Etiz3NgzTrVg90H21EOLACvtfcHk0lhSnSKR_d68eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Kqs7bL&md5=e9327f901506b7663ec37b35efe38980</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-985811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-985811%26sid%3Dliteratum%253Aachs%26aulast%3DKaline%26aufirst%3DK.%26aulast%3DBornstein%26aufirst%3DS.%2BR.%26aulast%3DBergmann%26aufirst%3DA.%26aulast%3DHauner%26aufirst%3DH.%26aulast%3DSchwarz%26aufirst%3DP.%2BE.%26atitle%3DThe%2520importance%2520and%2520effect%2520of%2520dietary%2520fiber%2520in%2520diabetes%2520prevention%2520with%2520particular%2520consideration%2520of%2520whole%2520grain%2520products%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D2007%26volume%3D39%26spage%3D687%26epage%3D693%26doi%3D10.1055%2Fs-2007-985811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarshini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicksteed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alquier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poitout, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancebo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirmira, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layden, B. T.</span></span> <span> </span><span class="NLM_article-title">An acetate-specific GPCR, FFAR2, regulates insulin secretion</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1210/me.2015-1007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1210%2Fme.2015-1007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26075576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFykurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1055-1066&author=M.+Priyadarshiniauthor=S.+R.+Villaauthor=M.+Fullerauthor=B.+Wicksteedauthor=C.+R.+Mackayauthor=T.+Alquierauthor=V.+Poitoutauthor=H.+Manceboauthor=R.+G.+Mirmiraauthor=A.+Gilchristauthor=B.+T.+Layden&title=An+acetate-specific+GPCR%2C+FFAR2%2C+regulates+insulin+secretion&doi=10.1210%2Fme.2015-1007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An acetate-specific GPCR, FFAR2, regulates insulin secretion</span></div><div class="casAuthors">Priyadarshini, Medha; Villa, Stephanie R.; Fuller, Miles; Wicksteed, Barton; MacKay, Charles R.; Alquier, Thierry; Poitout, Vincent; Mancebo, Helena; Mirmira, Raghavendra G.; Gilchrist, Annette; Layden, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1055-1066</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">G protein-coupled receptors have been well described to contribute to the regulation of glucose-stimulated insulin secretion (GSIS).  The short-chain fatty acid-sensing G protein-coupled receptor, free fatty acid receptor 2 (FFAR2), is expressed in pancreatic β-cells, and in rodents, its expression is altered during insulin resistance.  Thus, we explored the role of FFAR2 in regulating GSIS.  First, assessing the phenotype of wild-type and Ffar2-/- mice in vivo, we obsd. no differences with regard to glucose homeostasis on normal or high-fat diet, with a marginally significant defect in insulin secretion in Ffar2(-/-) mice during hyperglycemic clamps.  In ex vivo insulin secretion studies, we obsd. diminished GSIS from Ffar2(-/-) islets relative to wild-type islets under high-glucose conditions.  Further, in the presence of acetate, the primary endogenous ligand for FFAR2, we obsd. FFAR2-dependent potentiation of GSIS, whereas FFAR2-specific agonists resulted in either potentiation or inhibition of GSIS, which we found to result from selective signaling through either Gαq/11 or Gαi/o, resp.  Lastly, in ex vivo insulin secretion studies of human islets, we obsd. that acetate and FFAR2 agonists elicited different signaling properties at human FFAR2 than at mouse FFAR2.  Taken together, our studies reveal that FFAR2 signaling occurs by divergent G protein pathways that can selectively potentiate or inhibit GSIS in mouse islets.  Further, we have identified important differences in the response of mouse and human FFAR2 to selective agonists, and we suggest that these differences warrant consideration in the continued investigation of FFAR2 as a novel type 2 diabetes target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxtSgaizuzC7Vg90H21EOLACvtfcHk0lhSnSKR_d68eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFykurjI&md5=015fd8df68e924fea4bc301a3ef33fa5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fme.2015-1007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2015-1007%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarshini%26aufirst%3DM.%26aulast%3DVilla%26aufirst%3DS.%2BR.%26aulast%3DFuller%26aufirst%3DM.%26aulast%3DWicksteed%26aufirst%3DB.%26aulast%3DMackay%26aufirst%3DC.%2BR.%26aulast%3DAlquier%26aufirst%3DT.%26aulast%3DPoitout%26aufirst%3DV.%26aulast%3DMancebo%26aufirst%3DH.%26aulast%3DMirmira%26aufirst%3DR.%2BG.%26aulast%3DGilchrist%26aufirst%3DA.%26aulast%3DLayden%26aufirst%3DB.%2BT.%26atitle%3DAn%2520acetate-specific%2520GPCR%252C%2520FFAR2%252C%2520regulates%2520insulin%2520secretion%26jtitle%3DMol.%2520Endocrinol.%26date%3D2015%26volume%3D29%26spage%3D1055%26epage%3D1066%26doi%3D10.1210%2Fme.2015-1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tolhurst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diakogiannaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.2337/db11-1019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.2337%2Fdb11-1019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22190648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=364-371&author=G.+Tolhurstauthor=H.+Heffronauthor=Y.+S.+Lamauthor=H.+E.+Parkerauthor=A.+M.+Habibauthor=E.+Diakogiannakiauthor=J.+Cameronauthor=J.+Grosseauthor=F.+Reimannauthor=F.+M.+Gribble&title=Short-chain+fatty+acids+stimulate+glucagon-like+peptide-1+secretion+via+the+G-protein-coupled+receptor+FFAR2&doi=10.2337%2Fdb11-1019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2</span></div><div class="casAuthors">Tolhurst, Gwen; Heffron, Helen; Lam, Yu Shan; Parker, Helen E.; Habib, Abdella M.; Diakogiannaki, Eleftheria; Cameron, Jennifer; Grosse, Johannes; Reimann, Frank; Gribble, Fiona M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">364-371</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened.  One postulated link is bacterial fermn. of "indigestible" prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite.  We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro.  Quant. PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1-secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture.  Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance.  These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJRcchnF-BrrVg90H21EOLACvtfcHk0lhN3Bn89FwY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOlt7Y%253D&md5=fa3f45e6f2dd3b88b217700febe3248f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2337%2Fdb11-1019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb11-1019%26sid%3Dliteratum%253Aachs%26aulast%3DTolhurst%26aufirst%3DG.%26aulast%3DHeffron%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DY.%2BS.%26aulast%3DParker%26aufirst%3DH.%2BE.%26aulast%3DHabib%26aufirst%3DA.%2BM.%26aulast%3DDiakogiannaki%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DGrosse%26aufirst%3DJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26atitle%3DShort-chain%2520fatty%2520acids%2520stimulate%2520glucagon-like%2520peptide-1%2520secretion%2520via%2520the%2520G-protein-coupled%2520receptor%2520FFAR2%26jtitle%3DDiabetes%26date%3D2012%26volume%3D61%26spage%3D364%26epage%3D371%26doi%3D10.2337%2Fdb11-1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Psichas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeth, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bewick, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanyaloglu, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghatei, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, G.</span></span> <span> </span><span class="NLM_article-title">The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1038/ijo.2014.153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fijo.2014.153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFylsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=424-429&author=A.+Psichasauthor=M.+L.+Sleethauthor=K.+G.+Murphyauthor=L.+Brooksauthor=G.+A.+Bewickauthor=A.+C.+Hanyalogluauthor=M.+A.+Ghateiauthor=S.+R.+Bloomauthor=G.+Frost&title=The+short+chain+fatty+acid+propionate+stimulates+GLP-1+and+PYY+secretion+via+free+fatty+acid+receptor+2+in+rodents&doi=10.1038%2Fijo.2014.153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents</span></div><div class="casAuthors">Psichas, A.; Sleeth, M. L.; Murphy, K. G.; Brooks, L.; Bewick, G. A.; Hanyaloglu, A. C.; Ghatei, M. A.; Bloom, S. R.; Frost, G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Obesity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">424-429</span>CODEN:
                <span class="NLM_cas:coden">IJOBDP</span>;
        ISSN:<span class="NLM_cas:issn">0307-0565</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and Objectives: The gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) acutely suppress appetite.  The short chain fatty acid (SCFA) receptor, free fatty acid receptor 2 (FFA2) is present on colonic enteroendocrine L cells, and a role has been suggested for SCFAs in appetite regulation.  Here, we characterize the in vitro and in vivo effects of colonic propionate on PYY and GLP-1 release in rodents, and investigate the role of FFA2 in mediating these effects using FFA2 knockout mice.  Methods: We used Wistar rats, C57BL6 mice and free fatty acid receptor 2 knockout (FFA-/-) mice on a C57BL6 background to explore the impact of the SCFA propionate on PYY and GLP-1 release.  Isolated colonic crypt cultures were used to assess the effects of propionate on gut hormone release in vitro.  We subsequently developed an in vivo technique to assess gut hormone release into the portal vein following colonic infusion of propionate.  Results: Propionate stimulated the secretion of both PYY and GLP-1 from wild-type primary murine colonic crypt cultures.  This effect was significantly attenuated in cultures from FFA2-/- mice.  Intra-colonic infusion of propionate elevated PYY and GLP-1 levels in jugular vein plasma in rats and in portal vein plasma in both rats and mice.  However, propionate did not significantly stimulate gut hormone release in FFA2-/- mice.  Conclusions: Intra-colonic administration of propionate stimulates the concurrent release of both GLP-1 and PYY in rats and mice.  These data demonstrate that FFA2 deficiency impairs SCFA-induced gut hormone secretion both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxcy4oI0mDMbVg90H21EOLACvtfcHk0lhN3Bn89FwY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFylsbvM&md5=b2fe1a55e9dce70ead589666dd9a8366</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fijo.2014.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fijo.2014.153%26sid%3Dliteratum%253Aachs%26aulast%3DPsichas%26aufirst%3DA.%26aulast%3DSleeth%26aufirst%3DM.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BG.%26aulast%3DBrooks%26aufirst%3DL.%26aulast%3DBewick%26aufirst%3DG.%2BA.%26aulast%3DHanyaloglu%26aufirst%3DA.%2BC.%26aulast%3DGhatei%26aufirst%3DM.%2BA.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26aulast%3DFrost%26aufirst%3DG.%26atitle%3DThe%2520short%2520chain%2520fatty%2520acid%2520propionate%2520stimulates%2520GLP-1%2520and%2520PYY%2520secretion%2520via%2520free%2520fatty%2520acid%2520receptor%25202%2520in%2520rodents%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2015%26volume%3D39%26spage%3D424%26epage%3D429%26doi%3D10.1038%2Fijo.2014.153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grone, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunaru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1038/nm.3779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnm.3779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25581519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=173-177&author=C.+Tangauthor=K.+Ahmedauthor=A.+Gilleauthor=S.+Luauthor=H.+J.+Groneauthor=S.+Tunaruauthor=S.+Offermanns&title=Loss+of+FFA2+and+FFA3+increases+insulin+secretion+and+improves+glucose+tolerance+in+type+2+diabetes&doi=10.1038%2Fnm.3779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes</span></div><div class="casAuthors">Tang, Cong; Ahmed, Kashan; Gille, Andreas; Lu, Shun; Groene, Hermann-Josef; Tunaru, Sorin; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-177</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type 2 diabetes is a major health problem worldwide, and one of its key features is the inability of elevated glucose to stimulate the release of sufficient amts. of insulin from pancreatic beta cells to maintain normal blood glucose levels.  New therapeutic strategies to improve beta cell function are therefore believed to be beneficial.  Here we demonstrate that the short-chain fatty acid receptors FFA2 (encoded by FFAR2) and FFA3 (encoded by FFAR3) are expressed in mouse and human pancreatic beta cells and mediate an inhibition of insulin secretion by coupling to Gi-type G proteins.  We also provide evidence that mice with dietary-induced obesity and type 2 diabetes, as compared to non-obese control mice, have increased local formation by pancreatic islets of acetate, an endogenous agonist of FFA2 and FFA3, as well as increased systemic levels.  This elevation may contribute to the insufficient capacity of beta cells to respond to hyperglycemia in obese states.  Indeed, we found that genetic deletion of both receptors, either on the whole-body level or specifically in pancreatic beta cells, leads to greater insulin secretion and a profound improvement of glucose tolerance when mice are on a high-fat diet compared to controls.  On the other hand, deletion of Ffar2 and Ffar3 in intestinal cells did not alter glucose tolerance in diabetic animals, suggesting these receptors act in a cell-autonomous manner in beta cells to regulate insulin secretion.  In summary, under diabetic conditions elevated acetate acts on FFA2 and FFA3 to inhibit proper glucose-stimulated insulin secretion, and we expect antagonists of FFA2 and FFA3 to improve insulin secretion in type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0-6dBfVkjLVg90H21EOLACvtfcHk0lhN3Bn89FwY-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslKkuw%253D%253D&md5=c7eeb8baf0013e07eba31bb918228f64</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnm.3779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3779%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DC.%26aulast%3DAhmed%26aufirst%3DK.%26aulast%3DGille%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DGrone%26aufirst%3DH.%2BJ.%26aulast%3DTunaru%26aufirst%3DS.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DLoss%2520of%2520FFA2%2520and%2520FFA3%2520increases%2520insulin%2520secretion%2520and%2520improves%2520glucose%2520tolerance%2520in%2520type%25202%2520diabetes%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D173%26epage%3D177%26doi%3D10.1038%2Fnm.3779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terasawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashihara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyauchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span> <span> </span><span class="NLM_article-title">The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1829</span>, <span class="refDoi"> DOI: 10.1038/ncomms2852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fncomms2852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=23652017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC3snhslWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1829&author=I.+Kimuraauthor=K.+Ozawaauthor=D.+Inoueauthor=T.+Imamuraauthor=K.+Kimuraauthor=T.+Maedaauthor=K.+Terasawaauthor=D.+Kashiharaauthor=K.+Hiranoauthor=T.+Taniauthor=T.+Takahashiauthor=S.+Miyauchiauthor=G.+Shioiauthor=H.+Inoueauthor=G.+Tsujimoto&title=The+gut+microbiota+suppresses+insulin-mediated+fat+accumulation+via+the+short-chain+fatty+acid+receptor+GPR43&doi=10.1038%2Fncomms2852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43</span></div><div class="casAuthors">Kimura Ikuo; Ozawa Kentaro; Inoue Daisuke; Imamura Takeshi; Kimura Kumi; Maeda Takeshi; Terasawa Kazuya; Kashihara Daiji; Hirano Kanako; Tani Taeko; Takahashi Tomoyuki; Miyauchi Satoshi; Shioi Go; Inoue Hiroshi; Tsujimoto Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1829</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The gut microbiota affects nutrient acquisition and energy regulation of the host, and can influence the development of obesity, insulin resistance, and diabetes.  During feeding, gut microbes produce short-chain fatty acids, which are important energy sources for the host.  Here we show that the short-chain fatty acid receptor GPR43 links the metabolic activity of the gut microbiota with host body energy homoeostasis.  We demonstrate that GPR43-deficient mice are obese on a normal diet, whereas mice overexpressing GPR43 specifically in adipose tissue remain lean even when fed a high-fat diet.  Raised under germ-free conditions or after treatment with antibiotics, both types of mice have a normal phenotype.  We further show that short-chain fatty acid-mediated activation of GPR43 suppresses insulin signalling in adipocytes, which inhibits fat accumulation in adipose tissue and promotes the metabolism of unincorporated lipids and glucose in other tissues.  These findings establish GPR43 as a sensor for excessive dietary energy, thereby controlling body energy utilization while maintaining metabolic homoeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTm37Yh3ajtm3WEEzDrymxmfW6udTcc2ebxEYMLRUeLk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snhslWrsw%253D%253D&md5=89775d6210dbd1163103f5f7f986b870</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncomms2852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2852%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DOzawa%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DD.%26aulast%3DImamura%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DTerasawa%26aufirst%3DK.%26aulast%3DKashihara%26aufirst%3DD.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DTani%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DMiyauchi%26aufirst%3DS.%26aulast%3DShioi%26aufirst%3DG.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DThe%2520gut%2520microbiota%2520suppresses%2520insulin-mediated%2520fat%2520accumulation%2520via%2520the%2520short-chain%2520fatty%2520acid%2520receptor%2520GPR43%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1829%26doi%3D10.1038%2Fncomms2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">111</span>, <span class="refDoi"> DOI: 10.3389/fendo.2012.00111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.3389%2Ffendo.2012.00111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=23060857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fks1Oquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=111&author=T.+Ulven&title=Short-chain+free+fatty+acid+receptors+FFA2%2FGPR43+and+FFA3%2FGPR41+as+new+potential+therapeutic+targets&doi=10.3389%2Ffendo.2012.00111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets</span></div><div class="casAuthors">Ulven Trond</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The deorphanization of the free fatty acid (FFA) receptors FFA1 (GPR40), FFA2 (GPR43), FFA3 (GPR41), GPR84, and GPR120 has made clear that the body is capable of recognizing and responding directly to nonesterified fatty acid of virtually any chain length.  Colonic fermentation of dietary fiber produces high concentrations of the short-chain fatty acids (SCFAs) acetate, propionate and butyrate, a process which is important to health.  The phylogenetically related 7-transmembrane (7TM) receptors free fatty acid receptor 2 (FFA2) and FFA3 are activated by these SCFAs, and several lines of evidence indicate that FFA2 and FFA3 mediate beneficial effects associated with a fiber-rich diet, and that they may be of interest as targets for treatment of inflammatory and metabolic diseases.  FFA2 is highly expressed on immune cells, in particular neutrophils, and several studies suggest that the receptor plays a role in diseases involving a dysfunctional neutrophil response, such as inflammatory bowel disease (IBD).  Both FFA2 and FFA3 have been implicated in metabolic diseases such as type 2 diabetes and in regulation of appetite.  More research is however required to clarify the potential of the receptors as drug targets and establish if activation or inhibition would be the preferred mode of action.  The availability of potent and selective receptor modulators is a prerequisite for these studies.  The few modulators of FFA2 or FFA3 that have been published hitherto in the peer-reviewed literature in general have properties that make them less than ideal as such tools, but published patent applications indicate that better tool compounds might soon become available which should enable studies critical to validate the receptors as new drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBT-ohvJN31zW1zwg2yUK5fW6udTcc2ebxEYMLRUeLk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fks1Oquw%253D%253D&md5=eeeab4914cd52398c8df549b2757efec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2012.00111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2012.00111%26sid%3Dliteratum%253Aachs%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DShort-chain%2520free%2520fatty%2520acid%2520receptors%2520FFA2%252FGPR43%2520and%2520FFA3%252FGPR41%2520as%2520new%2520potential%2520therapeutic%2520targets%26jtitle%3DFront.%2520Endocrinol.%26date%3D2012%26volume%3D3%26spage%3D111%26doi%3D10.3389%2Ffendo.2012.00111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coope, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, H.</span></span> <span> </span><span class="NLM_article-title">Selective FFA2 agonism appears to act via intestinal PYY to reduce transit and food intake but does not improve glucose tolerance in mouse models</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">3763</span>– <span class="NLM_lpage">3771</span>, <span class="refDoi"> DOI: 10.2337/db15-0481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.2337%2Fdb15-0481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=3763-3771&author=S.+Forbesauthor=S.+Staffordauthor=G.+Coopeauthor=H.+Heffronauthor=K.+Realauthor=R.+Newmanauthor=R.+Davenportauthor=M.+Barnesauthor=J.+Grosseauthor=H.+Cox&title=Selective+FFA2+agonism+appears+to+act+via+intestinal+PYY+to+reduce+transit+and+food+intake+but+does+not+improve+glucose+tolerance+in+mouse+models&doi=10.2337%2Fdb15-0481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2337%2Fdb15-0481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-0481%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DS.%26aulast%3DStafford%26aufirst%3DS.%26aulast%3DCoope%26aufirst%3DG.%26aulast%3DHeffron%26aufirst%3DH.%26aulast%3DReal%26aufirst%3DK.%26aulast%3DNewman%26aufirst%3DR.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DBarnes%26aufirst%3DM.%26aulast%3DGrosse%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DH.%26atitle%3DSelective%2520FFA2%2520agonism%2520appears%2520to%2520act%2520via%2520intestinal%2520PYY%2520to%2520reduce%2520transit%2520and%2520food%2520intake%2520but%2520does%2520not%2520improve%2520glucose%2520tolerance%2520in%2520mouse%2520models%26jtitle%3DDiabetes%26date%3D2015%26volume%3D64%26spage%3D3763%26epage%3D3771%26doi%3D10.2337%2Fdb15-0481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">FFA2 and FFA3 in metabolic regulation</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1007/164_2016_50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F164_2016_50" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2016&pages=205-220&author=C.+Tangauthor=S.+Offermanns&title=FFA2+and+FFA3+in+metabolic+regulation&doi=10.1007%2F164_2016_50"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F164_2016_50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_50%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DC.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DFFA2%2520and%2520FFA3%2520in%2520metabolic%2520regulation%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2016%26volume%3D236%26spage%3D205%26epage%3D220%26doi%3D10.1007%2F164_2016_50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priyadarshini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicksteed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiltz, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layden, B. T.</span></span> <span> </span><span class="NLM_article-title">SCFA receptors in pancreatic beta cells: novel diabetes targets?</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2016.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2Fj.tem.2016.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=27091493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=653-664&author=M.+Priyadarshiniauthor=B.+Wicksteedauthor=G.+E.+Schiltzauthor=A.+Gilchristauthor=B.+T.+Layden&title=SCFA+receptors+in+pancreatic+beta+cells%3A+novel+diabetes+targets%3F&doi=10.1016%2Fj.tem.2016.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?</span></div><div class="casAuthors">Priyadarshini, Medha; Wicksteed, Barton; Schiltz, Gary E.; Gilchrist, Annette; Layden, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">653-664</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nutrient sensing receptors are key metabolic mediators of responses to dietary and endogenously derived nutrients.  These receptors are largely G-protein-coupled receptors (GPCRs) and many are gaining significant interest as drug targets with a potential therapeutic role in metabolic diseases.  A distinct subclass of nutrient sensing GPCRs, two short chain fatty acid (SCFA) receptors (FFA2 and FFA3) are uniquely responsive to gut microbiota derived nutrients (such as acetate, propionate, and butyrate).  Pharmacol., mol., and genetic studies have investigated their role in organismal glucose metab. and recently in pancreatic β cell biol.  Here, we summarize the present knowledge on the role of these receptors as metabolic sensors in β cell function and physiol., revealing new therapeutic opportunities for type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqFrI_ojw7QbVg90H21EOLACvtfcHk0ljjgabaldQKRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOnsL4%253D&md5=456fe4a194982d0baaef397a13f44cc7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2016.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2016.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DPriyadarshini%26aufirst%3DM.%26aulast%3DWicksteed%26aufirst%3DB.%26aulast%3DSchiltz%26aufirst%3DG.%2BE.%26aulast%3DGilchrist%26aufirst%3DA.%26aulast%3DLayden%26aufirst%3DB.%2BT.%26atitle%3DSCFA%2520receptors%2520in%2520pancreatic%2520beta%2520cells%253A%2520novel%2520diabetes%2520targets%253F%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D27%26spage%3D653%26epage%3D664%26doi%3D10.1016%2Fj.tem.2016.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span> <span> </span><span class="NLM_article-title">Ligands at the free fatty acid receptors 2/3 (GPR43/GPR41)</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1007/164_2016_49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F164_2016_49" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2016&pages=17-32&author=G.+Milliganauthor=D.+Bologniniauthor=E.+Sergeev&title=Ligands+at+the+free+fatty+acid+receptors+2%2F3+%28GPR43%2FGPR41%29&doi=10.1007%2F164_2016_49"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2F164_2016_49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_49%26sid%3Dliteratum%253Aachs%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DSergeev%26aufirst%3DE.%26atitle%3DLigands%2520at%2520the%2520free%2520fatty%2520acid%2520receptors%25202%252F3%2520%2528GPR43%252FGPR41%2529%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2016%26volume%3D236%26spage%3D17%26epage%3D32%26doi%3D10.1007%2F164_2016_49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suckow, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briscoe, C. P.</span></span> <span> </span><span class="NLM_article-title">Key questions for translation of FFA receptors: From pharmacology to medicines</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1007/164_2016_45</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F164_2016_45" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2016&pages=101-131&author=A.+T.+Suckowauthor=C.+P.+Briscoe&title=Key+questions+for+translation+of+FFA+receptors%3A+From+pharmacology+to+medicines&doi=10.1007%2F164_2016_45"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2F164_2016_45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_45%26sid%3Dliteratum%253Aachs%26aulast%3DSuckow%26aufirst%3DA.%2BT.%26aulast%3DBriscoe%26aufirst%3DC.%2BP.%26atitle%3DKey%2520questions%2520for%2520translation%2520of%2520FFA%2520receptors%253A%2520From%2520pharmacology%2520to%2520medicines%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2016%26volume%3D236%26spage%3D101%26epage%3D131%26doi%3D10.1007%2F164_2016_45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwandner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiszmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeckel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1124/mol.108.049536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1124%2Fmol.108.049536" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1599-1609&author=T.+Leeauthor=R.+Schwandnerauthor=G.+Swaminathauthor=J.+Weiszmannauthor=M.+Cardozoauthor=J.+Greenbergauthor=P.+Jaeckelauthor=H.+F.+Geauthor=Y.+C.+Wangauthor=X.+Y.+Jiaoauthor=J.+Liuauthor=F.+Kayserauthor=H.+Tianauthor=Y.+Li&title=Identification+and+functional+characterization+of+allosteric+agonists+for+the+G+protein-coupled+receptor+FFA2&doi=10.1124%2Fmol.108.049536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049536%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DSchwandner%26aufirst%3DR.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DWeiszmann%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DGreenberg%26aufirst%3DJ.%26aulast%3DJaeckel%26aufirst%3DP.%26aulast%3DGe%26aufirst%3DH.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DIdentification%2520and%2520functional%2520characterization%2520of%2520allosteric%2520agonists%2520for%2520the%2520G%2520protein-coupled%2520receptor%2520FFA2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1599%26epage%3D1609%26doi%3D10.1124%2Fmol.108.049536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiszmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwandner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2Fj.bmcl.2009.11.112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=493-498&author=Y.+C.+Wangauthor=X.+Y.+Jiaoauthor=F.+Kayserauthor=J.+W.+Liuauthor=Z.+Y.+Wangauthor=M.+Wanskaauthor=J.+Greenbergauthor=J.+Weiszmannauthor=H.+F.+Geauthor=H.+Tianauthor=S.+Wongauthor=R.+Schwandnerauthor=T.+Leeauthor=Y.+Li&title=The+first+synthetic+agonists+of+FFA2%3A+Discovery+and+SAR+of+phenylacetamides+as+allosteric+modulators&doi=10.1016%2Fj.bmcl.2009.11.112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.112%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DWanska%26aufirst%3DM.%26aulast%3DGreenberg%26aufirst%3DJ.%26aulast%3DWeiszmann%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DH.%2BF.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DSchwandner%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DThe%2520first%2520synthetic%2520agonists%2520of%2520FFA2%253A%2520Discovery%2520and%2520SAR%2520of%2520phenylacetamides%2520as%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D493%26epage%3D498%26doi%3D10.1016%2Fj.bmcl.2009.11.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trankle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Extracellular loop 2 of the Free Fatty Acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1124/mol.110.070789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1124%2Fmol.110.070789" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=163-173&author=N.+J.+Smithauthor=R.+J.+Wardauthor=L.+A.+Stoddartauthor=B.+D.+Hudsonauthor=E.+Kostenisauthor=T.+Ulvenauthor=J.+C.+Morrisauthor=C.+Trankleauthor=I.+G.+Tikhonovaauthor=D.+R.+Adamsauthor=G.+Milligan&title=Extracellular+loop+2+of+the+Free+Fatty+Acid+receptor+2+mediates+allosterism+of+a+phenylacetamide+ago-allosteric+modulator&doi=10.1124%2Fmol.110.070789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.070789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.070789%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DN.%2BJ.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DTrankle%26aufirst%3DC.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DExtracellular%2520loop%25202%2520of%2520the%2520Free%2520Fatty%2520Acid%2520receptor%25202%2520mediates%2520allosterism%2520of%2520a%2520phenylacetamide%2520ago-allosteric%2520modulator%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D163%26epage%3D173%26doi%3D10.1124%2Fmol.110.070789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H.</span>; <span class="NLM_string-name">Brantis, C. E.</span>; <span class="NLM_string-name">Dutheuil, G.</span>; <span class="NLM_string-name">Zoute, L.</span>; <span class="NLM_string-name">Schils, D.</span>; <span class="NLM_string-name">Bernard, J.</span></span> <span> </span><span class="NLM_article-title">Compounds, Pharmaceutical Composition and Methods for Use in Treating Metabolic Disorders</span>. <span class="NLM_patent">WO2010066682A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+Hoveyda&author=C.+E.+Brantis&author=G.+Dutheuil&author=L.+Zoute&author=D.+Schils&author=J.+Bernard&title=Compounds%2C+Pharmaceutical+Composition+and+Methods+for+Use+in+Treating+Metabolic+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%26atitle%3DCompounds%252C%2520Pharmaceutical%2520Composition%2520and%2520Methods%2520for%2520Use%2520in%2520Treating%2520Metabolic%2520Disorders%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Due-Hansen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">17296</span>– <span class="NLM_lpage">17312</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.455337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M113.455337" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=17296-17312&author=B.%0AD.+Hudsonauthor=M.+E.+Due-Hansenauthor=E.+Christiansenauthor=A.+M.+Hansenauthor=A.+E.+Mackenzieauthor=H.+Murdochauthor=S.+K.+Pandeyauthor=R.+J.+Wardauthor=R.+Marquezauthor=I.+G.+Tikhonovaauthor=T.+Ulvenauthor=G.+Milligan&title=Defining+the+molecular+basis+for+the+first+potent+and+selective+orthosteric+agonists+of+the+FFA2+free+fatty+acid+receptor&doi=10.1074%2Fjbc.M113.455337"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.455337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.455337%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DHansen%26aufirst%3DA.%2BM.%26aulast%3DMackenzie%26aufirst%3DA.%2BE.%26aulast%3DMurdoch%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DMarquez%26aufirst%3DR.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DDefining%2520the%2520molecular%2520basis%2520for%2520the%2520first%2520potent%2520and%2520selective%2520orthosteric%2520agonists%2520of%2520the%2520FFA2%2520free%2520fatty%2520acid%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D17296%26epage%3D17312%26doi%3D10.1074%2Fjbc.M113.455337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H.</span>; <span class="NLM_string-name">Schils, D.</span>; <span class="NLM_string-name">Zoute, L.</span>; <span class="NLM_string-name">Parcq, J.</span>; <span class="NLM_string-name">Bernard, J.</span>; <span class="NLM_string-name">Fraser, G.</span></span> <span> </span><span class="NLM_article-title">Compounds, Pharmaceutical Composition and Methods for Use in Treating Inflammatory Diseases</span>. <span class="NLM_patent">WO2015078949A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Hoveyda&author=D.+Schils&author=L.+Zoute&author=J.+Parcq&author=J.+Bernard&author=G.+Fraser&title=Compounds%2C+Pharmaceutical+Composition+and+Methods+for+Use+in+Treating+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%26atitle%3DCompounds%252C%2520Pharmaceutical%2520Composition%2520and%2520Methods%2520for%2520Use%2520in%2520Treating%2520Inflammatory%2520Diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13741</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-14096-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fs41598-017-14096-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=29061999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC1M7js1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=13741&author=E.+Sergeevauthor=A.+H.+Hansenauthor=D.+Bologniniauthor=K.+Kawakamiauthor=T.+Kishiauthor=J.+Aokiauthor=T.+Ulvenauthor=A.+Inoueauthor=B.+D.+Hudsonauthor=G.+Milligan&title=A+single+extracellular+amino+acid+in+Free+Fatty+Acid+Receptor+2+defines+antagonist+species+selectivity+and+G+protein+selection+bias&doi=10.1038%2Fs41598-017-14096-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias</span></div><div class="casAuthors">Sergeev Eugenia; Bolognini Daniele; Hudson Brian D; Milligan Graeme; Hansen Anders Hojgaard; Ulven Trond; Kawakami Kouki; Kishi Takayuki; Aoki Junken; Inoue Asuka; Aoki Junken; Inoue Asuka</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13741</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Free Fatty Acid Receptor 2 is a GPCR activated by short chain fatty acids produced in high levels in the lower gut by microbial fermentation of non-digestible carbohydrates.  A major challenge in studying this receptor is that the mouse ortholog does not have significant affinity for antagonists that are able to block the human receptor.  Docking of exemplar antagonists from two chemical series to homology models of both human and mouse Free Fatty Acid Receptor 2 suggested that a single lysine - arginine variation at the extracellular face of the receptor might provide the basis for antagonist selectivity and mutational swap studies confirmed this hypothesis.  Extending these studies to agonist function indicated that although the lysine - arginine variation between human and mouse orthologs had limited effect on G protein-mediated signal transduction, removal of positive charge from this residue produced a signalling-biased variant of Free Fatty Acid Receptor 2 in which Gi-mediated signalling by both short chain fatty acids and synthetic agonists was maintained whilst there was marked loss of agonist potency for signalling via Gq/11 and G12/13 G proteins.  A single residue at the extracellular face of the receptor thus plays key roles in both agonist and antagonist function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9zxYb5ouxkH6CEoQgWY10fW6udTcc2eb8bNx9Sq8iHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7js1yqtg%253D%253D&md5=0a47510edb50136be64524ab4667eb17</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-14096-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-14096-3%26sid%3Dliteratum%253Aachs%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DA%2520single%2520extracellular%2520amino%2520acid%2520in%2520Free%2520Fatty%2520Acid%2520Receptor%25202%2520defines%2520antagonist%2520species%2520selectivity%2520and%2520G%2520protein%2520selection%2520bias%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D13741%26doi%3D10.1038%2Fs41598-017-14096-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liw-OOhzCMoMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0liw-OOhzCMoMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandrell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span> <span> </span><span class="NLM_article-title">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nrd4609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnrd4609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26091267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=475-486&author=M.+J.+Waringauthor=J.+Arrowsmithauthor=A.+R.+Leachauthor=P.+D.+Leesonauthor=S.+Mandrellauthor=R.+M.+Owenauthor=G.+Pairaudeauauthor=W.+D.+Pennieauthor=S.+D.+Pickettauthor=J.+Wangauthor=O.+Wallaceauthor=A.+Weir&title=An+analysis+of+the+attrition+of+drug+candidates+from+four+major+pharmaceutical+companies&doi=10.1038%2Fnrd4609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span></div><div class="casAuthors">Waring, Michael J.; Arrowsmith, John; Leach, Andrew R.; Leeson, Paul D.; Mandrell, Sam; Owen, Robert M.; Pairaudeau, Garry; Pennie, William D.; Pickett, Stephen D.; Wang, Jibo; Wallace, Owen; Weir, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development.  Attempts to reduce the no. of efficacy- and safety-related failures by analyzing possible links to the physicochem. properties of small-mol. drug candidates have been inconclusive because of the limited size of data sets from individual companies.  Here, we describe the compilation and anal. of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer.  The anal. reaffirms that control of physicochem. properties during compd. optimization is beneficial in identifying compds. of candidate drug quality and indicates for the first time a link between the physicochem. properties of compds. and clin. failure due to safety issues.  The results also suggest that further control of physicochem. properties is unlikely to have a significant effect on attrition rates and that addnl. work is required to address safety-related failures.  Further cross-company collaborations will be crucial to future progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsLfBWrLC3ZLVg90H21EOLACvtfcHk0liw-OOhzCMoMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM&md5=1fdc374d32816b1e91438152299dd1b1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd4609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4609%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DMandrell%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPennie%26aufirst%3DW.%2BD.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWeir%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520attrition%2520of%2520drug%2520candidates%2520from%2520four%2520major%2520pharmaceutical%2520companies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D475%26epage%3D486%26doi%3D10.1038%2Fnrd4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Due-Hansen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">A protocol for amide bond formation with electron deficient amines and sterically hindered substrates</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1039/C5OB02129D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1039%2FC5OB02129D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=26586516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyrsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=430-433&author=M.+E.+Due-Hansenauthor=S.+K.+Pandeyauthor=E.+Christiansenauthor=R.+Andersenauthor=S.+V.+Hansenauthor=T.+Ulven&title=A+protocol+for+amide+bond+formation+with+electron+deficient+amines+and+sterically+hindered+substrates&doi=10.1039%2FC5OB02129D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A protocol for amide bond formation with electron deficient amines and sterically hindered substrates</span></div><div class="casAuthors">Due-Hansen, Maria E.; Pandey, Sunil K.; Christiansen, Elisabeth; Andersen, Rikke; Hansen, Steffen V. F.; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-433</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A protocol for amide coupling by in situ formation of acyl fluorides and reaction with amines at elevated temp. has been developed and found to be efficient for coupling of sterically hindered substrates and electron deficient amines where std. methods failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-aOU75NuGLVg90H21EOLACvtfcHk0liw-OOhzCMoMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyrsLnE&md5=4ece43260172b15c7fe5fffe08e58466</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC5OB02129D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB02129D%26sid%3Dliteratum%253Aachs%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DAndersen%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DS.%2BV.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DA%2520protocol%2520for%2520amide%2520bond%2520formation%2520with%2520electron%2520deficient%2520amines%2520and%2520sterically%2520hindered%2520substrates%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D430%26epage%3D433%26doi%3D10.1039%2FC5OB02129D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. D.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.4155/fmc.11.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.4155%2Ffmc.11.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=21806380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFeisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1181-1197&author=A.+K.+Ghoshauthor=D.+D.+Anderson&title=Tetrahydrofuran%2C+tetrahydropyran%2C+triazoles+and+related+heterocyclic+derivatives+as+HIV+protease+inhibitors&doi=10.4155%2Ffmc.11.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors</span></div><div class="casAuthors">Ghosh, Arun K.; Anderson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1181-1197</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  HIV/AIDS remains a formidable disease with millions of individuals inflicted worldwide.  Although treatment regimens have improved considerably, drug resistance brought on by viral mutation continues to erode their effectiveness.  Intense research efforts are currently underway in search of new and improved therapies.  This review is concerned with the design of novel HIV-1 protease inhibitors that incorporate heterocyclic scaffolds and which have been reported within the recent literature (2005--2010).  Various examples in this review showcase the essential role heterocycles play as scaffolds and bioisosteres in HIV-1 protease inhibitor drug development.  This review will hopefully stimulate the widespread application of these heterocycles in the design of other therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRpKhwnPK7LVg90H21EOLACvtfcHk0ljlIwWNcm4OiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFeisbw%253D&md5=c5c7ac273b57adae7b8c18cabaee2c49</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.68%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DAnderson%26aufirst%3DD.%2BD.%26atitle%3DTetrahydrofuran%252C%2520tetrahydropyran%252C%2520triazoles%2520and%2520related%2520heterocyclic%2520derivatives%2520as%2520HIV%2520protease%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1181%26epage%3D1197%26doi%3D10.4155%2Ffmc.11.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinho
e Melo, T. M. V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, C. I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha Gonsalves, A. M. d. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paixão, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beja, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of tricyclic isoindoles and thiazolo[3,2-c][1,3]benzoxazines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3949</span>– <span class="NLM_lpage">3955</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2004.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2Fj.tet.2004.03.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=3949-3955&author=T.+M.+V.+D.+Pinho%0Ae+Meloauthor=C.+I.+A.+Santosauthor=A.+M.+d.+A.+Rocha+Gonsalvesauthor=J.+A.+Paix%C3%A3oauthor=A.+M.+Beja&title=Synthesis+of+tricyclic+isoindoles+and+thiazolo%5B3%2C2-c%5D%5B1%2C3%5Dbenzoxazines&doi=10.1016%2Fj.tet.2004.03.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DPinho%2Be%2BMelo%26aufirst%3DT.%2BM.%2BV.%2BD.%26aulast%3DSantos%26aufirst%3DC.%2BI.%2BA.%26aulast%3DRocha%2BGonsalves%26aufirst%3DA.%2BM.%2Bd.%2BA.%26aulast%3DPaix%25C3%25A3o%26aufirst%3DJ.%2BA.%26aulast%3DBeja%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520of%2520tricyclic%2520isoindoles%2520and%2520thiazolo%255B3%252C2-c%255D%255B1%252C3%255Dbenzoxazines%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D3949%26epage%3D3955%26doi%3D10.1016%2Fj.tet.2004.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinho
e Melo, T. M. V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, C. S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha Gonsalves, A. M. d. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paixão, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beja, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos
Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alte da Veiga, L.</span></span> <span> </span><span class="NLM_article-title">Cycloaddition reactions of 3-aryl-5-phenyl-5H,7H-thiazolo[3,4-c]oxazol-4-ium-1-olates</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5093</span>– <span class="NLM_lpage">5102</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(02)00463-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1016%2FS0040-4020%2802%2900463-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5093-5102&author=T.+M.+V.+D.+Pinho%0Ae+Meloauthor=C.+S.+B.+Gomesauthor=A.+M.+d.+A.+Rocha+Gonsalvesauthor=J.+A.+Paix%C3%A3oauthor=A.+M.+Bejaauthor=M.+Ramos%0ASilvaauthor=L.+Alte+da+Veiga&title=Cycloaddition+reactions+of+3-aryl-5-phenyl-5H%2C7H-thiazolo%5B3%2C4-c%5Doxazol-4-ium-1-olates&doi=10.1016%2FS0040-4020%2802%2900463-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900463-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900463-5%26sid%3Dliteratum%253Aachs%26aulast%3DPinho%2Be%2BMelo%26aufirst%3DT.%2BM.%2BV.%2BD.%26aulast%3DGomes%26aufirst%3DC.%2BS.%2BB.%26aulast%3DRocha%2BGonsalves%26aufirst%3DA.%2BM.%2Bd.%2BA.%26aulast%3DPaix%25C3%25A3o%26aufirst%3DJ.%2BA.%26aulast%3DBeja%26aufirst%3DA.%2BM.%26aulast%3DRamos%2BSilva%26aufirst%3DM.%26aulast%3DAlte%2Bda%2BVeiga%26aufirst%3DL.%26atitle%3DCycloaddition%2520reactions%2520of%25203-aryl-5-phenyl-5H%252C7H-thiazolo%255B3%252C4-c%255Doxazol-4-ium-1-olates%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5093%26epage%3D5102%26doi%3D10.1016%2FS0040-4020%2802%2900463-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4951</span>– <span class="NLM_lpage">4965</span>, <span class="refDoi"> DOI: 10.1096/fj.12-213314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1096%2Ffj.12-213314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22919070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCgtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=4951-4965&author=B.+D.+Hudsonauthor=E.+Christiansenauthor=I.+G.+Tikhonovaauthor=M.+Grundmannauthor=E.+Kostenisauthor=D.+R.+Adamsauthor=T.+Ulvenauthor=G.+Milligan&title=Chemically+engineering+ligand+selectivity+at+the+free+fatty+acid+receptor+2+based+on+pharmacological+variation+between+species+orthologs&doi=10.1096%2Ffj.12-213314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs</span></div><div class="casAuthors">Hudson, Brian D.; Christiansen, Elisabeth; Tikhonova, Irina G.; Grundmann, Manuel; Kostenis, Evi; Adams, David R.; Ulven, Trond; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4951-4965, 10.1096/fj.12-213314</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">When it is difficult to develop selective ligands within a family of related G-protein-coupled receptors (GPCRs), chem. engineered receptors activated solely by synthetic ligands (RASSLs) are useful alternatives for probing receptor function.  In the present work, we explored whether a RASSL of the free fatty acid receptor 2 (FFA2) could be developed on the basis of pharmacol. variation between species orhologs.  For this, bovine FFA2 was characterized, revealing distinct ligand selectivity compared with human FFA2.  Homol. modeling and mutational anal. demonstrated a single mutation in human FFA2 of C4.57G resulted in a human FFA2 receptor with ligand selectivity similar to the bovine receptor.  This was exploited to generate human FFA2-RASSL by the addn. of a second mutation at a known orthosteric ligand interaction site, H6.55Q.  The resulting FFA2-RASSL displayed a >100-fold loss of activity to endogenous ligands, while responding to the distinct ligand sorbic acid with pEC50 values for inhibition of cAMP, 5.83 ± 0.11; Ca2+ mobilization, 4.63 ± 0.05; ERK phosphorylation, 5.61 ± 0.06; and dynamic mass redistribution, 5.35 ± 0.06.  This FFA2-RASSL will be useful in future studies on this receptor and demonstrates that exploitation of pharmacol. variation between species orthologs is a powerful method to generate novel chem. engineered GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8PNDJQs2ArVg90H21EOLACvtfcHk0ljlIwWNcm4OiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCgtrnO&md5=60bc83a1b4768bb4d3641de4362cd65c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-213314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-213314%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DChemically%2520engineering%2520ligand%2520selectivity%2520at%2520the%2520free%2520fatty%2520acid%2520receptor%25202%2520based%2520on%2520pharmacological%2520variation%2520between%2520species%2520orthologs%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D4951%26epage%3D4965%26doi%3D10.1096%2Ffj.12-213314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.687939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M115.687939" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=303-317&author=E.+Sergeevauthor=A.+H.+Hansenauthor=S.+K.+Pandeyauthor=A.+E.+MacKenzieauthor=B.+D.+Hudsonauthor=T.+Ulvenauthor=G.+Milligan&title=Non-equivalence+of+key+positively+charged+residues+of+the+free+fatty+acid+2+receptor+in+the+recognition+and+function+of+agonist+versus+antagonist+ligands&doi=10.1074%2Fjbc.M115.687939"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.687939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.687939%26sid%3Dliteratum%253Aachs%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DMacKenzie%26aufirst%3DA.%2BE.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DNon-equivalence%2520of%2520key%2520positively%2520charged%2520residues%2520of%2520the%2520free%2520fatty%2520acid%25202%2520receptor%2520in%2520the%2520recognition%2520and%2520function%2520of%2520agonist%2520versus%2520antagonist%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D303%26epage%3D317%26doi%3D10.1074%2Fjbc.M115.687939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martensson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdfeldt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhrbom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bylund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hojgaard Hansen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span> <span> </span><span class="NLM_article-title">The neutrophil response induced by an agonist for free fatty acid receptor 2 (GPR43) Is primed by tumor necrosis factor alpha and by receptor uncoupling from the cytoskeleton but attenuated by tissue recruitment</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2595</span>, <span class="refDoi"> DOI: 10.1128/MCB.00161-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1128%2FMCB.00161-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=27503855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ovVKntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=2583-2595&author=L.+Bjorkmanauthor=J.+Martenssonauthor=M.+Wintherauthor=M.+Gablauthor=A.+Holdfeldtauthor=M.+Uhrbomauthor=J.+Bylundauthor=A.+Hojgaard+Hansenauthor=S.+K.+Pandeyauthor=T.+Ulvenauthor=H.+Forsmanauthor=C.+Dahlgren&title=The+neutrophil+response+induced+by+an+agonist+for+free+fatty+acid+receptor+2+%28GPR43%29+Is+primed+by+tumor+necrosis+factor+alpha+and+by+receptor+uncoupling+from+the+cytoskeleton+but+attenuated+by+tissue+recruitment&doi=10.1128%2FMCB.00161-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The Neutrophil Response Induced by an Agonist for Free Fatty Acid Receptor 2 (GPR43) Is Primed by Tumor Necrosis Factor Alpha and by Receptor Uncoupling from the Cytoskeleton but Attenuated by Tissue Recruitment</span></div><div class="casAuthors">Bjorkman Lena; Martensson Jonas; Winther Malene; Gabl Michael; Holdfeldt Andre; Uhrbom Martin; Forsman Huamei; Dahlgren Claes; Bylund Johan; Hojgaard Hansen Anders; Pandey Sunil K; Ulven Trond</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and cellular biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2583-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ligands with improved potency and selectivity for free fatty acid receptor 2 (FFA2R) have become available, and we here characterize the neutrophil responses induced by one such agonist (Cmp1) and one antagonist (CATPB).  Cmp1 triggered an increase in the cytosolic concentration of Ca(2+), and the neutrophils were then desensitized to Cmp1 and to acetate, a naturally occurring FFA2R agonist.  The antagonist CATPB selectively inhibited responses induced by Cmp1 or acetate.  The activated FFA2R induced superoxide anion secretion at a low level in naive blood neutrophils.  This response was largely increased by tumor necrosis factor alpha (TNF-α) in a process associated with a recruitment of easily mobilizable granules, but neutrophils recruited to an aseptic inflammation in vivo were nonresponding.  Superoxide production induced by Cmp1 was increased in latrunculin A-treated neutrophils, but no reactivation of desensitized FFA2R was induced by this drug, suggesting that the cytoskeleton is not directly involved in terminating the response.  The functional and regulatory differences between the receptors that recognize short-chain fatty acids and formylated peptides, respectively, imply different roles of these receptors in the orchestration of inflammation and confirm the usefulness of a selective FFA2R agonist and antagonist as tools for the exploration of the precise role of the FFA2R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5J7LL994RMlw2ofyr07jXfW6udTcc2eYgo0pfnvcU-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ovVKntw%253D%253D&md5=659fa2c5ec3199f270dbdd6273ee4e01</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.00161-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00161-16%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkman%26aufirst%3DL.%26aulast%3DMartensson%26aufirst%3DJ.%26aulast%3DWinther%26aufirst%3DM.%26aulast%3DGabl%26aufirst%3DM.%26aulast%3DHoldfeldt%26aufirst%3DA.%26aulast%3DUhrbom%26aufirst%3DM.%26aulast%3DBylund%26aufirst%3DJ.%26aulast%3DHojgaard%2BHansen%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DForsman%26aufirst%3DH.%26aulast%3DDahlgren%26aufirst%3DC.%26atitle%3DThe%2520neutrophil%2520response%2520induced%2520by%2520an%2520agonist%2520for%2520free%2520fatty%2520acid%2520receptor%25202%2520%2528GPR43%2529%2520Is%2520primed%2520by%2520tumor%2520necrosis%2520factor%2520alpha%2520and%2520by%2520receptor%2520uncoupling%2520from%2520the%2520cytoskeleton%2520but%2520attenuated%2520by%2520tissue%2520recruitment%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2016%26volume%3D36%26spage%3D2583%26epage%3D2595%26doi%3D10.1128%2FMCB.00161-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vermeire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojecký, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoflícek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinisch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kaem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beetens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, F.</span></span> <span> </span><span class="NLM_article-title">GLPG0974, an FFA2 antagonist, in ulcerative colitis: efficacy and safety in a multicenter proof-of-concept study</span>. <i>J. Crohn’s Colitis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S39</span>, <span class="refDoi"> DOI: 10.1093/ecco-jcc/jju027.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1093%2Fecco-jcc%2Fjju027.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=S39&issue=Suppl.+1&author=S.+Vermeireauthor=V.+Kojeck%C3%BDauthor=V.+Knofl%C3%ADcekauthor=W.+Reinischauthor=T.+Van+Kaemauthor=F.+Namourauthor=J.+Beetensauthor=F.+Vanhoutte&title=GLPG0974%2C+an+FFA2+antagonist%2C+in+ulcerative+colitis%3A+efficacy+and+safety+in+a+multicenter+proof-of-concept+study&doi=10.1093%2Fecco-jcc%2Fjju027.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fecco-jcc%2Fjju027.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fecco-jcc%252Fjju027.058%26sid%3Dliteratum%253Aachs%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DKojeck%25C3%25BD%26aufirst%3DV.%26aulast%3DKnofl%25C3%25ADcek%26aufirst%3DV.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DVan%2BKaem%26aufirst%3DT.%26aulast%3DNamour%26aufirst%3DF.%26aulast%3DBeetens%26aufirst%3DJ.%26aulast%3DVanhoutte%26aufirst%3DF.%26atitle%3DGLPG0974%252C%2520an%2520FFA2%2520antagonist%252C%2520in%2520ulcerative%2520colitis%253A%2520efficacy%2520and%2520safety%2520in%2520a%2520multicenter%2520proof-of-concept%2520study%26jtitle%3DJ.%2520Crohn%25E2%2580%2599s%2520Colitis%26date%3D2015%26volume%3D9%26issue%3DSuppl.%25201%26spage%3DS39%26doi%3D10.1093%2Fecco-jcc%2Fjju027.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolaczkowska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubes, P.</span></span> <span> </span><span class="NLM_article-title">Neutrophil recruitment and function in health and inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1038/nri3399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnri3399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=23435331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFygtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=159-175&author=E.+Kolaczkowskaauthor=P.+Kubes&title=Neutrophil+recruitment+and+function+in+health+and+inflammation&doi=10.1038%2Fnri3399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil recruitment and function in health and inflammation</span></div><div class="casAuthors">Kolaczkowska, Elzbieta; Kubes, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-175</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neutrophils have traditionally been thought of as simple foot soldiers of the innate immune system with a restricted set of pro-inflammatory functions.  More recently, it has become apparent that neutrophils are, in fact, complex cells capable of a vast array of specialized functions.  Although neutrophils are undoubtedly major effectors of acute inflammation, several lines of evidence indicate that they also contribute to chronic inflammatory conditions and adaptive immune responses.  Here, we discuss the key features of the life of a neutrophil, from its release from bone marrow to its death.  We discuss the possible existence of different neutrophil subsets and their putative anti-inflammatory roles.  We focus on how neutrophils are recruited to infected or injured tissues and describe differences in neutrophil recruitment between different tissues.  Finally, we explain the mechanisms that are used by neutrophils to promote protective or pathol. immune responses at different sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjXqyTwlRLmbVg90H21EOLACvtfcHk0lhsvgnGxtjDJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFygtbo%253D&md5=78d8d2753727fbddde0b6262fb8323bf</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnri3399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3399%26sid%3Dliteratum%253Aachs%26aulast%3DKolaczkowska%26aufirst%3DE.%26aulast%3DKubes%26aufirst%3DP.%26atitle%3DNeutrophil%2520recruitment%2520and%2520function%2520in%2520health%2520and%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26spage%3D159%26epage%3D175%26doi%3D10.1038%2Fnri3399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pizzonero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lemos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delerive, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopiejewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">L’Ebraly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancois, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavazais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manioc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelles, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polancec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quenehen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandeghinste, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saniere, L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: From hit to clinic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10044</span>– <span class="NLM_lpage">10057</span>, <span class="refDoi"> DOI: 10.1021/jm5012885</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012885" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10044-10057&author=M.+Pizzoneroauthor=S.+Dupontauthor=M.+Babelauthor=S.+Beaumontauthor=N.+Bienvenuauthor=R.+Blanqueauthor=L.+Cherelauthor=T.+Christopheauthor=B.+Crescenziauthor=E.+De+Lemosauthor=P.+Deleriveauthor=P.+Deprezauthor=S.+De+Vosauthor=F.+Djataauthor=S.+Fletcherauthor=S.+Kopiejewskiauthor=C.+L%E2%80%99Ebralyauthor=J.+M.+Lefrancoisauthor=S.+Lavazaisauthor=M.+Maniocauthor=L.+Nellesauthor=L.+Osteauthor=D.+Polancecauthor=V.+Quenehenauthor=F.+Soulasauthor=N.+Triballeauauthor=E.+M.+van+der+Aarauthor=N.+Vandeghinsteauthor=E.+Wakselmanauthor=R.+Brysauthor=L.+Saniere&title=Discovery+and+optimization+of+an+azetidine+chemical+series+as+a+free+fatty+acid+receptor+2+%28FFA2%29+antagonist%3A+From+hit+to+clinic&doi=10.1021%2Fjm5012885"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm5012885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012885%26sid%3Dliteratum%253Aachs%26aulast%3DPizzonero%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DBabel%26aufirst%3DM.%26aulast%3DBeaumont%26aufirst%3DS.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDe%2BLemos%26aufirst%3DE.%26aulast%3DDelerive%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DP.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DDjata%26aufirst%3DF.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DKopiejewski%26aufirst%3DS.%26aulast%3DL%25E2%2580%2599Ebraly%26aufirst%3DC.%26aulast%3DLefrancois%26aufirst%3DJ.%2BM.%26aulast%3DLavazais%26aufirst%3DS.%26aulast%3DManioc%26aufirst%3DM.%26aulast%3DNelles%26aufirst%3DL.%26aulast%3DOste%26aufirst%3DL.%26aulast%3DPolancec%26aufirst%3DD.%26aulast%3DQuenehen%26aufirst%3DV.%26aulast%3DSoulas%26aufirst%3DF.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%2BM.%26aulast%3DVandeghinste%26aufirst%3DN.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DSaniere%26aufirst%3DL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520an%2520azetidine%2520chemical%2520series%2520as%2520a%2520free%2520fatty%2520acid%2520receptor%25202%2520%2528FFA2%2529%2520antagonist%253A%2520From%2520hit%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10044%26epage%3D10057%26doi%3D10.1021%2Fjm5012885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinolo, M. A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoulakis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlooly-Y, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curi, R.</span></span> <span> </span><span class="NLM_article-title">SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e21205</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0021205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1371%2Fjournal.pone.0021205" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e21205&author=M.+A.+R.+Vinoloauthor=G.+J.+Fergusonauthor=S.+Kulkarniauthor=G.+Damoulakisauthor=K.+Andersonauthor=M.+Bohlooly-Yauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=R.+Curi&title=SCFAs+induce+mouse+neutrophil+chemotaxis+through+the+GPR43+receptor&doi=10.1371%2Fjournal.pone.0021205"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0021205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0021205%26sid%3Dliteratum%253Aachs%26aulast%3DVinolo%26aufirst%3DM.%2BA.%2BR.%26aulast%3DFerguson%26aufirst%3DG.%2BJ.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DDamoulakis%26aufirst%3DG.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DBohlooly-Y%26aufirst%3DM.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DCuri%26aufirst%3DR.%26atitle%3DSCFAs%2520induce%2520mouse%2520neutrophil%2520chemotaxis%2520through%2520the%2520GPR43%2520receptor%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De21205%26doi%3D10.1371%2Fjournal.pone.0021205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. R.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease</span>. <i>Scand. J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">sup216</span>),  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.3109/00365529609094568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.3109%2F00365529609094568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADyaK28XivFaktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1996&pages=132-148&issue=sup216&author=P.+B.+Mortensenauthor=M.+R.+Clausen&title=Short-chain+fatty+acids+in+the+human+colon%3A+relation+to+gastrointestinal+health+and+disease&doi=10.3109%2F00365529609094568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease</span></div><div class="casAuthors">Mortensen, P. Broebech; Clausen, M. Rye</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Gastroenterology, Supplement</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">216</span>),
    <span class="NLM_cas:pages">132-148</span>CODEN:
                <span class="NLM_cas:coden">SJGSB8</span>;
        ISSN:<span class="NLM_cas:issn">0085-5928</span>.
    
            (<span class="NLM_cas:orgname">Scandinavian University Press</span>)
        </div><div class="casAbstract">A review with 50 refs.  Fermn., the process whereby anaerobic bacteria break down carbohydrates to short-chain (C2-C6) fatty acids (SCAFs), is an important function of the large bowel.  SCFAs constitute approx. two-thirds of the colonic anion concn. (70-130 mmol/l), mainly as acetate, propionate, and butyrate.  Gastroenterologists have, in spite of these facts, addressed this scientific field surprisingly late, in contrast to veterinarians, for whom the fermentative prodn. of SCFAs has been acknowledged as a principal mechanism of intestinal digestion in plant-eating animals for decades.  Interest in the effects of SCFA prodn. on the human organism has been growing rapidly in the last 10 yr, because gastrointestinal functions and beneficial effects are assocd. with these acids.  SCFAs are of major importance in the understanding of the physiol. function of dietary fiber and their possible role for colonic neoplasia.  SCFA prodn. and absorption are closely related to the nourishment of the colonic mucosa and sodium and water absorption, and mechanisms of diarrhea.  Patients with severe malabsorption compensate by the fermn. of otherwise osmotic active saccharides to SCFAs, which are readily absorbed and used as energy fuels in the organism.  SCFA prodn. from dietary carbohydrates is a mechanism whereby considerable amts. of calories can be salvaged in short-bowel patients with remaining colonic function if dietary treatment is adjusted.  SCFA enemas are a new and promising treatment modality for patients with ulcerative colitis.  The effect has been attributed to the oxidn. of SCFAs in the colonocytes.  An impressive no. of papers have described the effects of butyrate on various cell functions, the significance of which is still unknown.  Up until now, attention has been related esp. to cancer prophylaxis and treatment.  Diminished prodn. of SCFAs appears to be involved in antibiotic-assocd. diarrhea, diversion colitis, and possibly in pouchitis.  The interaction between bacterial fermn., ammonia metab., and bacterial growth and protein synthesis appears to be the main mechanism of action of lactulose treatment in hepatic coma.  Pathol. and extremely high rates of saccharide fermn. explain the severe deterioration in patients with D-lactate acidosis.  Hence, this scientific field has come late to clin. working gastroenterologists, but as work is progressing the prodn. of SCFAs in the large bowel becomes involved in several well-known intestinal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8A0DXrNPRlLVg90H21EOLACvtfcHk0lia1k6PSaV8LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFaktr8%253D&md5=46fda9626415b54b0276aa0b30e04a45</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3109%2F00365529609094568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00365529609094568%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DP.%2BB.%26aulast%3DClausen%26aufirst%3DM.%2BR.%26atitle%3DShort-chain%2520fatty%2520acids%2520in%2520the%2520human%2520colon%253A%2520relation%2520to%2520gastrointestinal%2520health%2520and%2520disease%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D1996%26volume%3D31%26issue%3Dsup216%26spage%3D132%26epage%3D148%26doi%3D10.3109%2F00365529609094568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiszmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baribault, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">4519</span>– <span class="NLM_lpage">4526</span>, <span class="refDoi"> DOI: 10.1210/en.2008-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1210%2Fen.2008-0059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=4519-4526&author=H.+Geauthor=X.+Liauthor=J.+Weiszmannauthor=P.+Wangauthor=H.+Baribaultauthor=J.+L.+Chenauthor=H.+Tianauthor=Y.+Li&title=Activation+of+G+protein-coupled+receptor+43+in+adipocytes+leads+to+inhibition+of+lipolysis+and+suppression+of+plasma+free+fatty+acids&doi=10.1210%2Fen.2008-0059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1210%2Fen.2008-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2008-0059%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWeiszmann%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DBaribault%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DActivation%2520of%2520G%2520protein-coupled%2520receptor%252043%2520in%2520adipocytes%2520leads%2520to%2520inhibition%2520of%2520lipolysis%2520and%2520suppression%2520of%2520plasma%2520free%2520fatty%2520acids%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D4519%26epage%3D4526%26doi%3D10.1210%2Fen.2008-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgSa6Egd-A2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span> <i>CrysAlis PRO 1.171.39.12b</i>; <span class="NLM_publisher-name">Rigaku
Oxford Diffraction</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CrysAlis+PRO+1.171.39.12b%3B+Rigaku%0AOxford+Diffraction%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCrysAlis%2520PRO%25201.171.39.12b%26pub%3DRigaku%250AOxford%2520Diffraction%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubschle, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittrich, B.</span></span> <span> </span><span class="NLM_article-title">ShelXle: a Qt graphical user interface for SHELXL</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1107/S0021889811043202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1107%2FS0021889811043202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=22477785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A280%3ADC%252BC2sbovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1281-1284&author=C.+B.+Hubschleauthor=G.+M.+Sheldrickauthor=B.+Dittrich&title=ShelXle%3A+a+Qt+graphical+user+interface+for+SHELXL&doi=10.1107%2FS0021889811043202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">ShelXle: a Qt graphical user interface for SHELXL</span></div><div class="casAuthors">Hubschle Christian B; Sheldrick George M; Dittrich Birger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of applied crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">Pt 6</span>),
    <span class="NLM_cas:pages">1281-1284</span>
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">ShelXle is a graphical user interface for SHELXL [Sheldrick, G.  M. (2008).  Acta Cryst.  A64, 112-122], currently the most widely used program for small-molecule structure refinement.  It combines an editor with syntax highlighting for the SHELXL-associated .ins (input) and .res (output) files with an interactive graphical display for visualization of a three-dimensional structure including the electron density (F(o)) and difference density (F(o)-F(c)) maps.  Special features of ShelXle include intuitive atom (re-)naming, a strongly coupled editor, structure visualization in various mono and stereo modes, and a novel way of displaying disorder extending over special positions.  ShelXle is completely compatible with all features of SHELXL and is written entirely in C++ using the Qt4 and FFTW libraries.  It is available at no cost for Windows, Linux and Mac-OS X and as source code.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrmOUws2S_g0EgZCMqtRBifW6udTcc2eYynWDWqDq_Zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbovFKktw%253D%253D&md5=9f345940dd39778a2e921e7020ebff8f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0021889811043202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889811043202%26sid%3Dliteratum%253Aachs%26aulast%3DHubschle%26aufirst%3DC.%2BB.%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26aulast%3DDittrich%26aufirst%3DB.%26atitle%3DShelXle%253A%2520a%2520Qt%2520graphical%2520user%2520interface%2520for%2520SHELXL%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2011%26volume%3D44%26spage%3D1281%26epage%3D1284%26doi%3D10.1107%2FS0021889811043202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G.</span></span> <span> </span><span class="NLM_article-title">SHELXT - Integrated space-group and crystal-structure determination</span>. <i>Acta Crystallogr., Sect. A: Found. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053273314026370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1107%2FS2053273314026370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+Sheldrick&title=SHELXT+-+Integrated+space-group+and+crystal-structure+determination&doi=10.1107%2FS2053273314026370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">SHELXT - Integrated space-group and crystal-structure determination</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations and Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSAD7</span>;
        ISSN:<span class="NLM_cas:issn">2053-2733</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The new computer program SHELXT employs a novel dual-space algorithm to solve the phase problem for single-crystal reflection data expanded to the space group P1.  Missing data are taken into account and the resoln. extended if necessary.  All space groups in the specified Laue group are tested to find which are consistent with the P1 phases.  After applying the resulting origin shifts and space-group symmetry, the solns. are subject to further dual-space recycling followed by a peak search and summation of the electron d. around each peak.  Elements are assigned to give the best fit to the integrated peak densities and if necessary addnl. elements are considered.  An isotropic refinement is followed for non-centrosym. space groups by the calcn. of a Flack parameter and, if appropriate, inversion of the structure.  The structure is assembled to maximize its connectivity and centered optimally in the unit cell.  SHELXT has already solved many thousand structures with a high success rate, and is optimized for multiprocessor computers.  It is, however, unsuitable for severely disordered and twinned structures because it is based on the assumption that the structure consists of atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfRi0LYeHvuLVg90H21EOLACvtfcHk0lgSa6Egd-A2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ntQ%253D%253D&md5=cd76fcff223162a8fdaddbd0f3b24b94</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS2053273314026370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053273314026370%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%26atitle%3DSHELXT%2520-%2520Integrated%2520space-group%2520and%2520crystal-structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Adv.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053273314026370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+structure+refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lgSa6Egd-A2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520structure%2520refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirozane, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kefala, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruswitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span> <span> </span><span class="NLM_article-title">High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1038/nature13494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1038%2Fnature13494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=25043059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=124-127&author=A.+Srivastavaauthor=J.+Yanoauthor=Y.+Hirozaneauthor=G.+Kefalaauthor=F.+Gruswitzauthor=G.+Snellauthor=W.+Laneauthor=A.+Ivetacauthor=K.+Aertgeertsauthor=J.+Nguyenauthor=A.+Jenningsauthor=K.+Okada&title=High-resolution+structure+of+the+human+GPR40+receptor+bound+to+allosteric+agonist+TAK-875&doi=10.1038%2Fnature13494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875</span></div><div class="casAuthors">Srivastava, Ankita; Yano, Jason; Hirozane, Yoshihiko; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy; Okada, Kengo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7516</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human GPR40 receptor (hGPR40), also known as free fatty-acid receptor 1 (FFAR1), is a G-protein-coupled receptor that binds long-chain free fatty acids to enhance glucose-dependent insulin secretion.  Novel treatments for type-2 diabetes mellitus are therefore possible by targeting hGPR40 with partial or full agonists.  TAK-875, or fasiglifam, is an orally available, potent and selective partial agonist of hGPR40 receptor, which reached phase III clin. trials for the potential treatment of type-2 diabetes mellitus.  Data from clin. studies indicate that TAK-875, which is an ago-allosteric modulator of hGPR40 (ref. 3), demonstrates improved glycemic control and low hypoglycemic risk in diabetic patients.  Here the authors report the crystal structure of hGPR40 receptor bound to TAK-875 at 2.3 Å resoln.  The co-complex structure reveals a unique binding mode of TAK-875 and suggests that entry to the non-canonical binding pocket most probably occurs via the lipid bilayer.  The at. details of the extensive charge network in the ligand binding pocket reveal addnl. interactions not identified in previous studies and contribute to a clear understanding of TAK-875 binding to the receptor.  The hGPR40-TAK-875 structure also provides insights into the plausible binding of multiple ligands to the receptor, which has been obsd. in radioligand binding and Ca2+ influx assay studies.  Comparison of the transmembrane helix architecture with other G-protein-coupled receptors suggests that the crystd. TAK-875-bound hGPR40 complex is in an inactive-like state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9EJ42g7iaLVg90H21EOLACvtfcHk0lh03VRAcvuVJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhurvK&md5=06e38fa105ab0783715a541bc2008311</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature13494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13494%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DHirozane%26aufirst%3DY.%26aulast%3DKefala%26aufirst%3DG.%26aulast%3DGruswitz%26aufirst%3DF.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DOkada%26aufirst%3DK.%26atitle%3DHigh-resolution%2520structure%2520of%2520the%2520human%2520GPR40%2520receptor%2520bound%2520to%2520allosteric%2520agonist%2520TAK-875%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D124%26epage%3D127%26doi%3D10.1038%2Fnature13494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallicchio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, R. M.</span></span> <span> </span><span class="NLM_article-title">Integrated modeling program, applied chemical theory (IMPACT)</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1780</span>, <span class="refDoi"> DOI: 10.1002/jcc.20292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1002%2Fjcc.20292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=16211539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1752-1780&author=J.+L.+Banksauthor=H.+S.+Beardauthor=Y.+Caoauthor=A.+E.+Choauthor=W.+Dammauthor=R.+Faridauthor=A.+K.+Feltsauthor=T.+A.+Halgrenauthor=D.+T.+Mainzauthor=J.+R.+Mapleauthor=R.+Murphyauthor=D.+M.+Philippauthor=M.+P.+Repaskyauthor=L.+Y.+Zhangauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=E.+Gallicchioauthor=R.+M.+Levy&title=Integrated+modeling+program%2C+applied+chemical+theory+%28IMPACT%29&doi=10.1002%2Fjcc.20292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated modeling program, applied chemical theory (IMPACT)</span></div><div class="casAuthors">Banks, Jay L.; Beard, Hege S.; Cao, Yixiang; Cho, Art E.; Damm, Wolfgang; Farid, Ramy; Felts, Anthony K.; Halgren, Thomas A.; Mainz, Daniel T.; Maple, Jon R.; Murphy, Robert; Philipp, Dean M.; Repasky, Matthew P.; Zhang, Linda Y.; Berne, Bruce J.; Friesner, Richard A.; Gallicchio, Emilio; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1752-1780</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  We provide an overview of the IMPACT mol. mechanics program with an emphasis on recent developments and a description of its current functionality.  With respect to core mol. mechanics technologies we include a status report for the fixed charge and polarizable force fields that can be used with the program and illustrate how the force fields, when used together with new atom typing and parameter assignment modules, have greatly expanded the coverage of org. compds. and medicinally relevant ligands.  As we discuss in this review, explicit solvent simulations have been used to guide our design of implicit solvent models based on the generalized Born framework and a novel nonpolar estimator that have recently been incorporated into the program.  With IMPACT it is possible to use several different advanced conformational sampling algorithms based on combining features of mol. dynamics and Monte Carlo simulations.  The program includes two specialized mol. mechanics modules: Glide, a high-throughput docking program, and QSite, a mixed quantum mechanics/mol. mechanics module.  These modules employ the IMPACT infrastructure as a starting point for the construction of the protein model and assignment of mol. mechanics parameters, but have then been developed to meet specialized objectives with respect to sampling and the energy function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZX2FzcGWGM7Vg90H21EOLACvtfcHk0lh03VRAcvuVJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI&md5=0094f15727c7fb77a0fae16ccf8292f0</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20292%26sid%3Dliteratum%253Aachs%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BK.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DIntegrated%2520modeling%2520program%252C%2520applied%2520chemical%2520theory%2520%2528IMPACT%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1752%26epage%3D1780%26doi%3D10.1002%2Fjcc.20292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimpukade, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">20345</span>– <span class="NLM_lpage">20358</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.561449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M114.561449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=24860101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=20345-20358&author=B.+D.+Hudsonauthor=B.+Shimpukadeauthor=G.+Milliganauthor=T.+Ulven&title=The+molecular+basis+of+ligand+interaction+at+free+fatty+acid+receptor+4+%28FFA4%2FGPR120%29&doi=10.1074%2Fjbc.M114.561449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)</span></div><div class="casAuthors">Hudson, Brian D.; Shimpukade, Bharat; Milligan, Graeme; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">20345-20358</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The long-chain fatty acid receptor FFA4 (previously GPR120) is receiving substantial interest as a novel target for the treatment of metabolic and inflammatory disease.  This study examines for the first time the detailed mode of binding of both long-chain fatty acid and synthetic agonist ligands at FFA4 by integrating mol. modeling, receptor mutagenesis, and ligand structure-activity relationship approaches in an iterative format.  In doing so, residues required for binding of fatty acid and synthetic agonists to FFA4 have been identified.  This has allowed for the refinement of a well validated model of the mode of ligand-FFA4 interaction that will be invaluable in the identification of novel ligands and the future development of this receptor as a therapeutic target.  The model reliably predicted the effects of substituent variations on agonist potency, and it was also able to predict the qual. effect of binding site mutations in the majority of cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWoimY0slQW7Vg90H21EOLACvtfcHk0lh03VRAcvuVJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7zN&md5=d59c40e7f5ffd13e5a50f114a347e041</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.561449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.561449%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DThe%2520molecular%2520basis%2520of%2520ligand%2520interaction%2520at%2520free%2520fatty%2520acid%2520receptor%25204%2520%2528FFA4%252FGPR120%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D20345%26epage%3D20358%26doi%3D10.1074%2Fjbc.M114.561449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caltabiano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCallum, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicklin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawcett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1124%2Fmol.113.089482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=24113750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtV2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=91-104&author=A.+E.+MacKenzieauthor=G.+Caltabianoauthor=T.+C.+Kentauthor=L.+Jenkinsauthor=J.+E.+McCallumauthor=B.+D.+Hudsonauthor=S.+A.+Nicklinauthor=L.+Fawcettauthor=R.+Markwickauthor=S.+J.+Charltonauthor=G.+Milligan&title=The+antiallergic+mast+cell+stabilizers+lodoxamide+and+bufrolin+as+the+first+high+and+equipotent+agonists+of+human+and+rat+GPR35&doi=10.1124%2Fmol.113.089482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35</span></div><div class="casAuthors">MacKenzie, Amanda E.; Caltabiano, Gianluigi; Kent, Toby C.; Jenkins, Laura; McCallum, Jennifer E.; Hudson, Brian D.; Nicklin, Stuart A.; Fawcett, Lindsay; Markwick, Rachel; Charlton, Steven J.; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-104, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lack of high potency agonists has restricted anal. of the G protein-coupled receptor GPR35.  Moreover, marked variation in potency and/or affinity of current ligands between human and rodent orthologs of GPR35 has limited their productive use in rodent models of physiol.  Based on the reported modest potency of the antiasthma and antiallergic ligands cromolyn disodium and nedocromil sodium, we identified the related compds. lodoxamide and bufrolin as high potency agonists of human GPR35.  Unlike previously identified high potency agonists that are highly selective for human GPR35, both lodoxamide and bufrolin displayed equiv. potency at rat GPR35.  Further synthetic antiallergic ligands, either sharing features of the std. surrogate agonist zaprinast, or with lodoxamide and bufrolin, were also shown to display agonism at either human or rat GPR35.  Because both lodoxamide and bufrolin are sym. di-acids, their potential mode of binding was explored via mutagenesis based on swapping between the rat and human ortholog nonconserved arginine residues within proximity of a key conserved arginine at position 3.36.  Computational modeling and ligand docking predicted the contributions of different arginine residues, other than at 3.36, in human GPR35 for these two ligands and were consistent with selective loss of potency of either bufrolin or lodoxamide at distinct arginine mutants.  The computational models also suggested that bufrolin and lodoxamide would display reduced potency at a low-frequency human GPR35 single nucleotide polymorphism.  This prediction was confirmed exptl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6HODMUQaxXLVg90H21EOLACvtfcHk0lgrL2mXzQkvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtV2msrg%253D&md5=9b04b63eca46f1ec3ef97c302e138bda</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089482%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DA.%2BE.%26aulast%3DCaltabiano%26aufirst%3DG.%26aulast%3DKent%26aufirst%3DT.%2BC.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DMcCallum%26aufirst%3DJ.%2BE.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DNicklin%26aufirst%3DS.%2BA.%26aulast%3DFawcett%26aufirst%3DL.%26aulast%3DMarkwick%26aufirst%3DR.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DThe%2520antiallergic%2520mast%2520cell%2520stabilizers%2520lodoxamide%2520and%2520bufrolin%2520as%2520the%2520first%2520high%2520and%2520equipotent%2520agonists%2520of%2520human%2520and%2520rat%2520GPR35%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D91%26epage%3D104%26doi%3D10.1124%2Fmol.113.089482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Curto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Using the Flp-In T-Rex system to regulate GPCR expression</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>746</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1007/978-1-61779-126-0_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1007%2F978-1-61779-126-0_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=21607850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvVakt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=746&publication_year=2011&pages=21-37&author=R.+J.+Wardauthor=E.+Alvarez-Curtoauthor=G.+Milligan&title=Using+the+Flp-In+T-Rex+system+to+regulate+GPCR+expression&doi=10.1007%2F978-1-61779-126-0_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Flp-In T-Rex system to regulate GPCR expression</span></div><div class="casAuthors">Ward, Richard J.; Alvarez-Curto, Elisa; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">746</span>
        (<span class="NLM_cas:issue">Receptor Signal Transduction Protocols</span>),
    <span class="NLM_cas:pages">21-37</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The development of a cell-based system that allows the integration of a gene of interest (GOI), such as a G protein-coupled receptor (GPCR), into a specific site on the genome, has made the generation of mammalian cell lines able to express such proteins easy and efficient.  Flp-In stable cell lines are isogenic and hence protein expression is const. across a population of cells.  A useful addn. to the Flp-In system (Flp-In T-Rex) allows this expression to be controlled by the addn. of a small mol. inducer to the cell culture medium.  Stable cell lines generated as described here can be used to great advantage in the study of receptor pharmacol. signalling and oligomerisation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3ej4RV6KcvbVg90H21EOLACvtfcHk0lgrL2mXzQkvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvVakt78%253D&md5=3190b03c0663c4d6d17f4366dff6b155</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-126-0_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-126-0_2%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Curto%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DUsing%2520the%2520Flp-In%2520T-Rex%2520system%2520to%2520regulate%2520GPCR%2520expression%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D746%26spage%3D21%26epage%3D37%26doi%3D10.1007%2F978-1-61779-126-0_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersson, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konig, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurowska-Stolarska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">18915</span>– <span class="NLM_lpage">18931</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.736157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1074%2Fjbc.M116.736157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=27385588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGgurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=18915-18931&author=D.+Bologniniauthor=C.+E.+Mossauthor=K.+Nilssonauthor=A.+U.+Peterssonauthor=I.+Donnellyauthor=E.+Sergeevauthor=G.+M.+Konigauthor=E.+Kostenisauthor=M.+Kurowska-Stolarskaauthor=A.+Millerauthor=N.+Dekkerauthor=A.+B.+Tobinauthor=G.+Milligan&title=A+novel+allosteric+activator+of+free+fatty+acid+2+receptor+displays+unique+Gi-functional+bias&doi=10.1074%2Fjbc.M116.736157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias</span></div><div class="casAuthors">Bolognini, Daniele; Moss, Catherine E.; Nilsson, Karolina; Petersson, Annika U.; Donnelly, Iona; Sergeev, Eugenia; Konig, Gabriele M.; Kostenis, Evi; Kurowska-Stolarska, Mariola; Miller, Ashley; Dekker, Niek; Tobin, Andrew B.; Milligan, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">18915-18931</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The short chain fatty acid receptor FFA2 is able to stimulate signaling via both Gi- and Gq/G11-promoted pathways.  These pathways are believed to control distinct physiol. end points but FFA2 receptor ligands appropriate to test this hypothesis have been lacking.  Herein, we characterize AZ1729, a novel FFA2 regulator that acts as a direct allosteric agonist and as a pos. allosteric modulator, increasing the activity of the endogenously produced short chain fatty acid propionate in Gi-mediated pathways, but not at those transduced by Gq/G11.  Using AZ1729 in combination with direct inhibitors of Gi and Gq/G11 family G proteins demonstrated that although both arms contribute to propionate-mediated regulation of phospho-ERK1/2 MAP kinase signaling in FFA2-expressing 293 cells, the Gq/G11-mediated pathway is predominant.  We extend these studies by employing AZ1729 to dissect physiol. FFA2 signaling pathways.  The capacity of AZ1729 to act at FFA2 receptors to inhibit β-adrenoreceptor agonist-promoted lipolysis in primary mouse adipocytes and to promote chemotaxis of isolated human neutrophils confirmed these as FFA2 processes mediated by Gi signaling, whereas, in concert with blockade by the Gq/G11 inhibitor FR900359, the inability of AZ1729 to mimic or regulate propionate-mediated release of GLP-1 from mouse colonic prepns. defined this physiol. response as an end point transduced via activation of Gq/G11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6ZUDPWavu7Vg90H21EOLACvtfcHk0lgrL2mXzQkvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGgurjJ&md5=b06b876cff3073786d297734496afe8f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.736157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.736157%26sid%3Dliteratum%253Aachs%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DMoss%26aufirst%3DC.%2BE.%26aulast%3DNilsson%26aufirst%3DK.%26aulast%3DPetersson%26aufirst%3DA.%2BU.%26aulast%3DDonnelly%26aufirst%3DI.%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DKonig%26aufirst%3DG.%2BM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DKurowska-Stolarska%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DDekker%26aufirst%3DN.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DA%2520novel%2520allosteric%2520activator%2520of%2520free%2520fatty%2520acid%25202%2520receptor%2520displays%2520unique%2520Gi-functional%2520bias%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D18915%26epage%3D18931%26doi%3D10.1074%2Fjbc.M116.736157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. R.</span></span> <span> </span><span class="NLM_article-title">In vitro drug metabolism using liver microsomes</span>. <i>Curr. Protoc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7.8.1</span>– <span class="NLM_lpage">7.8.11</span>, <span class="refDoi"> DOI: 10.1002/0471141755.ph0708s23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;key=10.1002%2F0471141755.ph0708s23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7.8.1-7.8.11&author=J.+R.+Hill&title=In+vitro+drug+metabolism+using+liver+microsomes&doi=10.1002%2F0471141755.ph0708s23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2F0471141755.ph0708s23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471141755.ph0708s23%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BR.%26atitle%3DIn%2520vitro%2520drug%2520metabolism%2520using%2520liver%2520microsomes%26jtitle%3DCurr.%2520Protoc.%2520Pharmacol.%26date%3D2003%26volume%3D23%26spage%3D7.8.1%26epage%3D7.8.11%26doi%3D10.1002%2F0471141755.ph0708s23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PHU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PHU','PDB','4PHU'); return false;">PDB: 4PHU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00855">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30068"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00855">10.1021/acs.jmedchem.8b00855</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic procedures, collection and crystallographic data for <b>14</b>, and high- and low-temperature <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>31</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates for crystal structure of <b>14</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular strings formula and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_001.pdf">jm8b00855_si_001.pdf (1.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_002.pdb">jm8b00855_si_002.pdb (7.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00855/suppl_file/jm8b00855_si_003.csv">jm8b00855_si_003.csv (3.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00855&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00855%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00855" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679927017ebf3dbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
